{"meta":{"query_hash":"a991ddcdd147","filters":{"venue":"Drug Design Development and Therapy"},"cohort_total":97,"direct_labels_cover":0,"predictions_cover":97,"exported":97,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a991ddcdd147","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drug+Design+Development+and+Therapy"},"results":[{"id":"W1658626856","doi":"10.2147/dddt.s81891","title":"Apparent Km of mitochondria for oxygen computed from Vmax measured in permeabilized muscle fibers is lower in water enriched in oxygen by electrolysis than injection","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Cardiovascular and exercise physiology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Chemistry; Antimycin A; Oxygen; Mitochondrion; Respiration; Electrolysis; Biophysics; Diffusion; Biochemistry; Electrolyte; Nuclear chemistry; Biology; Anatomy; Electrode; Organic chemistry","score_opus":0.029357815527885495,"score_gpt":0.24383602422610964,"score_spread":0.21447820869822415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1658626856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940276,0.0023407424,0.0021993588,0.00017625146,0.00011374597,0.0011042153,0.0000034899729,0.00001753418,0.00001703484],"genre_scores_gemma":[0.9960462,0.00026335794,0.0030112863,0.0001312496,0.000031409334,0.00022619258,0.00020979026,0.000023499118,0.000057049103],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984798,0.00017225348,0.00042506203,0.00038844356,0.00022778881,0.00030667896],"domain_scores_gemma":[0.9995303,0.00006107023,0.000051929528,0.0001845056,0.00008914746,0.00008300999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006962645,0.0002051025,0.00069507986,0.00026655235,0.00002250629,0.000010091046,0.00007874669,0.00011994523,0.000017303653],"category_scores_gemma":[0.000016488535,0.00015822047,0.00011889051,0.00025571283,0.000030675623,0.000058268208,0.000019691708,0.00011019967,0.0000024276471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017347774,0.0008133884,0.0057940986,0.000037175163,0.0006454564,0.00001074321,0.05062779,0.00034307272,0.89329493,0.0000014036957,0.003127264,0.027956905],"study_design_scores_gemma":[0.05019259,0.00063148997,0.14738454,0.00015745156,0.00010578224,0.000006188039,0.0018157094,0.0034042567,0.7880021,0.0019020555,0.0055550807,0.00084278476],"about_ca_topic_score_codex":0.0005541738,"about_ca_topic_score_gemma":0.00014501259,"teacher_disagreement_score":0.14159045,"about_ca_system_score_codex":0.00017033522,"about_ca_system_score_gemma":0.00013680721,"threshold_uncertainty_score":0.64520437},"labels":[],"label_agreement":null},{"id":"W1692190376","doi":"10.2147/dddt.s84850","title":"Dolutegravir – a review of the pharmacology, efficacy, and safety in the treatment of HIV","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Dolutegravir; Elvitegravir; Raltegravir; Integrase inhibitor; Tolerability; Medicine; Pharmacology; Adverse effect; Integrase; Drug; Human immunodeficiency virus (HIV); Virology; Antiretroviral therapy; Viral load","score_opus":0.09921393294740355,"score_gpt":0.36567768045984955,"score_spread":0.266463747512446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1692190376","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043926755,0.99229354,0.0000135319915,0.0010039569,0.00011151117,0.005803778,0.000018628949,0.00001505198,0.00030071678],"genre_scores_gemma":[0.00001806433,0.9929649,0.002043731,0.00021905606,0.000049180086,0.0005221568,0.00015718571,0.000041428008,0.003984283],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996781,0.0007940005,0.0011825878,0.0004562302,0.00046515072,0.0003210473],"domain_scores_gemma":[0.9982762,0.00054187473,0.0005348021,0.0004320616,0.00010184456,0.000113272545],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015432831,0.0006528621,0.002419371,0.00021407091,0.00010927297,0.000012282897,0.00027687574,0.00016395,0.00005695759],"category_scores_gemma":[0.000019201862,0.00028869702,0.00026164655,0.0005922088,0.00022893724,0.000032979762,0.00005012961,0.00021881108,0.000012023854],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020636788,0.0009324528,0.00015405184,0.0098407585,0.0010223017,0.000018141925,0.005438306,4.5621707e-8,0.0000022017732,0.000023033319,0.0064081727,0.9759542],"study_design_scores_gemma":[0.004006561,0.00012068313,0.000164641,0.025347224,0.00095582794,0.0000675263,0.00005131542,3.1250644e-7,0.00008177508,0.000016108826,0.9689261,0.00026196922],"about_ca_topic_score_codex":0.0000062361687,"about_ca_topic_score_gemma":0.0000052257055,"teacher_disagreement_score":0.9756922,"about_ca_system_score_codex":0.0002263721,"about_ca_system_score_gemma":0.0013135561,"threshold_uncertainty_score":0.9999565},"labels":[],"label_agreement":null},{"id":"W1703213295","doi":"10.2147/dddt.s78036","title":"Spotlight on pembrolizumab in the treatment of advanced melanoma","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Melanoma; Metastatic melanoma; Food and drug administration; Immune system; Immunotherapy; Disease; Cancer; Drug; Immune checkpoint; Oncology; Immunology; Cancer research; Internal medicine; Pharmacology","score_opus":0.08665092685978829,"score_gpt":0.3368170679676156,"score_spread":0.2501661411078273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1703213295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023506975,0.99460775,0.00000508735,0.000095443684,0.00011716341,0.002171033,0.000004546778,0.000017316012,0.00063096074],"genre_scores_gemma":[0.000133184,0.9977085,0.0005105703,0.00013577181,0.000058332153,0.00038853323,0.00006392332,0.000039393577,0.00096178945],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837655,0.00022395505,0.0005544347,0.00031453092,0.00030640693,0.00022411291],"domain_scores_gemma":[0.9991852,0.00018941195,0.0002186699,0.0003163903,0.000034873836,0.000055420016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005091771,0.00042448353,0.0012910276,0.00024576794,0.00004855628,0.000016184453,0.00014777404,0.00013580598,0.00003233482],"category_scores_gemma":[0.0000031116706,0.00021162131,0.0001970345,0.00030014332,0.000060984225,0.000024951152,0.0000053225913,0.0001114492,0.000010430108],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021194187,0.00044242453,0.00000823013,0.00046624124,0.00036252307,0.00004027714,0.0036324176,9.215763e-8,0.000003826537,0.00001693937,0.0003044834,0.9926031],"study_design_scores_gemma":[0.0049986932,0.0011215205,0.000087816756,0.0025495742,0.00009145744,0.000043246517,0.00010504551,3.175289e-7,0.00028567866,0.00002000829,0.9904679,0.00022876299],"about_ca_topic_score_codex":0.000009970238,"about_ca_topic_score_gemma":0.000003863965,"teacher_disagreement_score":0.99237436,"about_ca_system_score_codex":0.00027314737,"about_ca_system_score_gemma":0.00069907727,"threshold_uncertainty_score":0.8629667},"labels":[],"label_agreement":null},{"id":"W1805190643","doi":"10.2147/dddt.s91116","title":"Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute on Drug Abuse; National Institutes of Health","keywords":"Hydrogen sulfide; Naproxen; NFKB1; Cancer research; Chemistry; Kappa; NF-κB; Colorectal cancer; Signal transduction; Cell growth; Caco-2; Cancer; Pharmacology; Medicine; Biochemistry; Internal medicine; Cell; Pathology; Gene","score_opus":0.043780844002484984,"score_gpt":0.2624685227081209,"score_spread":0.21868767870563588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1805190643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97919726,0.019002965,0.00033825173,0.00019088999,0.00016064428,0.0007349915,0.0000016840868,0.00008111798,0.000292213],"genre_scores_gemma":[0.9918384,0.002921228,0.0040311515,0.00041625608,0.00020529937,0.000108455926,0.000019821271,0.000049258797,0.0004101617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985045,0.00012840818,0.00030147503,0.00035533926,0.0003367627,0.0003735224],"domain_scores_gemma":[0.99913365,0.0001591141,0.000105518564,0.000119297256,0.00012038271,0.00036202915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005532391,0.0002885679,0.0003796388,0.00009438051,0.0001767558,0.00005631329,0.00006660198,0.00011374179,0.00003525251],"category_scores_gemma":[0.000040482402,0.00023189059,0.000031375195,0.00013435596,0.000072668285,0.00016414459,0.00003701951,0.0001475467,0.00001131495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034995205,0.00038432312,0.06544686,0.00075093796,0.0005081998,0.0001844388,0.044655345,0.00003508267,0.8112632,0.000117499185,0.0055748834,0.06757973],"study_design_scores_gemma":[0.003671133,0.0001201577,0.0006464215,0.00020118711,0.00003697147,0.000022252783,0.00026360678,0.00006937256,0.9804618,0.00014949286,0.014007598,0.00035001905],"about_ca_topic_score_codex":0.00010135475,"about_ca_topic_score_gemma":0.000014126679,"teacher_disagreement_score":0.1691986,"about_ca_system_score_codex":0.0000775386,"about_ca_system_score_gemma":0.0004317602,"threshold_uncertainty_score":0.9456223},"labels":[],"label_agreement":null},{"id":"W1856761374","doi":"10.2147/dddt.s88845","title":"Paget’s disease of bone: an osteoimmunological disorder?","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Bone health and treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Amgen Canada; Université Laval; Arthritis Society; Eli Lilly and Company; Amgen","keywords":"Osteoimmunology; RANKL; Osteoprotegerin; Medicine; Immunology; Proinflammatory cytokine; Osteoclast; Bone disease; Osteoporosis; Bone resorption; Cancer research; Pathology; Internal medicine; Inflammation; Receptor; Activator (genetics)","score_opus":0.1686114903308565,"score_gpt":0.37739820737697866,"score_spread":0.20878671704612214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1856761374","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026590105,0.99485,0.000085032094,0.00006130933,0.00011088722,0.0020624402,0.000015341746,0.000071740025,0.00008426065],"genre_scores_gemma":[0.00033271805,0.9929274,0.0036902498,0.00010203594,0.000032528755,0.00032799854,0.0006728865,0.00006256801,0.0018516708],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976687,0.000314498,0.0007768862,0.0004953477,0.00035515503,0.0003894011],"domain_scores_gemma":[0.99845815,0.000108559456,0.00031933867,0.00042836275,0.000100386664,0.0005852179],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058726413,0.0005305461,0.0018912352,0.00021687584,0.00011583481,0.000020378568,0.000113449896,0.00023427473,0.0000715726],"category_scores_gemma":[0.000028815552,0.00033903675,0.00017401707,0.00022623484,0.00010253187,0.00006623996,0.00004196507,0.00026892393,0.000059369333],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042942946,0.0005867855,0.0005312226,0.0024448377,0.00030718715,0.00006298621,0.00040208304,2.6104882e-8,3.2109014e-7,0.00001815061,0.00025276866,0.9949642],"study_design_scores_gemma":[0.0021062063,0.00023983634,0.0008436566,0.002458417,0.0003439553,0.000034642002,0.000018216431,7.1580695e-7,0.0000034141858,0.00011048204,0.9935041,0.00033636138],"about_ca_topic_score_codex":0.000016864611,"about_ca_topic_score_gemma":0.000002814469,"teacher_disagreement_score":0.99462783,"about_ca_system_score_codex":0.00008610921,"about_ca_system_score_gemma":0.0016496063,"threshold_uncertainty_score":0.9999062},"labels":[],"label_agreement":null},{"id":"W1891914108","doi":"10.2147/dddt.s84177","title":"Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"American Society of Clinical Oncology","keywords":"Pasireotide; Octreotide; Medicine; Gastroenterology; Internal medicine; Somatostatin; Adverse effect; Neuroendocrine tumors; Carcinoid syndrome; Refractory (planetary science); Acromegaly; Hormone","score_opus":0.04525629135987289,"score_gpt":0.30482834823620364,"score_spread":0.2595720568763307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1891914108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972265,0.00042658226,0.00007526609,0.00006944102,0.000022462707,0.002108704,0.0000028293616,0.00003576893,0.00003245862],"genre_scores_gemma":[0.99697286,0.00008248774,0.0023614776,0.00011885095,0.000007875717,0.00011601217,0.000019780517,0.000042412317,0.00027823937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778783,0.0002526574,0.0004936168,0.00045554567,0.00058897014,0.00042137835],"domain_scores_gemma":[0.9988588,0.00017767328,0.00015958534,0.00022649362,0.00017601125,0.00040142628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029157248,0.0002759708,0.0005501148,0.00041262672,0.00007155183,0.000030371975,0.00009456565,0.0000031268837,0.000012848634],"category_scores_gemma":[0.0001369135,0.0002071526,0.000013583759,0.0004129501,0.00006609423,0.00022423228,0.000063465755,0.00018302555,0.000004127448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015465219,0.00541127,0.92823935,0.00013325269,0.00019660308,0.0040003066,0.007592705,0.00003227893,0.000689056,0.0000021857445,0.00028879507,0.037948977],"study_design_scores_gemma":[0.2588125,0.047435205,0.5567341,0.0009147707,0.00015756264,0.000467135,0.014166065,0.0002800501,0.11643236,0.000070368595,0.0029399004,0.0015900349],"about_ca_topic_score_codex":0.00015055288,"about_ca_topic_score_gemma":0.00006789016,"teacher_disagreement_score":0.3715053,"about_ca_system_score_codex":0.000057614958,"about_ca_system_score_gemma":0.00024264293,"threshold_uncertainty_score":0.8447438},"labels":[],"label_agreement":null},{"id":"W1971992666","doi":"10.2147/dddt.s66236","title":"Effect of administration of water enriched in O2 by injection or electrolysis on transcutaneous oxygen pressure in anesthetized pigs","year":2014,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Hydrogen's biological and therapeutic effects","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Danone","keywords":"Anesthesia; Oxygen; Medicine; Oxygen pressure; Blood pressure; Chemistry; Internal medicine","score_opus":0.01048036583788475,"score_gpt":0.2480426046725239,"score_spread":0.23756223883463914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971992666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828464,0.00044808202,0.00033014241,0.00012637374,0.000013772232,0.0007303629,5.145918e-7,0.000015901838,0.00005020003],"genre_scores_gemma":[0.99925053,0.00021302966,0.00013194792,0.00010083761,0.000009308849,0.00006718765,0.000027345252,0.000010655838,0.00018916394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986823,0.0004706922,0.00030987602,0.00020814639,0.00014911788,0.00017986374],"domain_scores_gemma":[0.99951464,0.0002801935,0.000058957306,0.000086553686,0.00001918588,0.00004049633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009525043,0.00016661623,0.00044033714,0.00012152531,0.000020224848,0.0000043087366,0.00004777278,0.000114805625,0.00003901392],"category_scores_gemma":[0.000016806413,0.000087585824,0.000040157014,0.00015370961,0.000032669508,0.000020323278,0.0000029493551,0.00010252198,0.0000016194541],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027995324,0.00042856767,0.0036188986,0.00014492629,0.00014170657,0.000018351082,0.0021784976,0.000023232516,0.85318834,0.0000122024485,0.0000068178583,0.11224313],"study_design_scores_gemma":[0.00476869,0.0060496684,0.0023705307,0.00006379533,0.00002580686,0.000026541178,0.000009002032,0.00025096364,0.98523486,0.00008232283,0.0009957928,0.000122051555],"about_ca_topic_score_codex":0.000012745453,"about_ca_topic_score_gemma":0.000006126008,"teacher_disagreement_score":0.13204649,"about_ca_system_score_codex":0.000015606525,"about_ca_system_score_gemma":0.000034101497,"threshold_uncertainty_score":0.35716462},"labels":[],"label_agreement":null},{"id":"W1981220884","doi":"10.2147/dddt.s34976","title":"Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib","year":2012,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Cholesterylester transfer protein; Dyslipidemia; Medicine; Cholesterol; Pharmacology; Lipoprotein; Bioinformatics; Internal medicine; Disease; Biology","score_opus":0.09489177903714113,"score_gpt":0.3135815514196455,"score_spread":0.21868977238250437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981220884","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036528826,0.98363423,0.004677007,0.00016994287,0.00030535983,0.010585745,0.000009799307,0.000089964306,0.0001626702],"genre_scores_gemma":[0.00028863002,0.9884125,0.004203196,0.00030902828,0.0012462912,0.0038499078,0.00011806632,0.00019438256,0.0013779731],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968942,0.00029502832,0.00088724017,0.00069448224,0.0005358881,0.00069318095],"domain_scores_gemma":[0.99876016,0.00013431661,0.00013668403,0.00052843615,0.00007370159,0.00036669805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021235764,0.0007879022,0.002264749,0.0003144383,0.00020578966,0.00005980023,0.00014848985,0.00053307484,0.000030292],"category_scores_gemma":[0.000012205533,0.00052402524,0.0007352885,0.00022765723,0.000054340315,0.00009711752,0.000018493227,0.00055137073,0.00004044919],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001678596,0.00015791805,0.0000035336557,0.007169389,0.00081943447,0.00000845012,0.00048128518,2.844087e-8,0.0000069798725,0.000092308226,0.00024488143,0.99084795],"study_design_scores_gemma":[0.0025248288,0.00025120593,0.000013413446,0.008517007,0.00043914642,0.000040234696,0.000013754971,2.9358992e-7,0.0016938719,0.000045965433,0.9858505,0.00060977624],"about_ca_topic_score_codex":0.000004643248,"about_ca_topic_score_gemma":0.0000014061005,"teacher_disagreement_score":0.99023813,"about_ca_system_score_codex":0.00017300251,"about_ca_system_score_gemma":0.0007581651,"threshold_uncertainty_score":0.9997211},"labels":[],"label_agreement":null},{"id":"W1982595853","doi":"10.2147/dddt.s73891","title":"Apparent histological changes of adipocytes after treatment with CL 316,243, a ß-3-adrenergic receptor agonist","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Agonist; Adipose tissue; Internal medicine; Endocrinology; Receptor; White adipose tissue; Thermogenin; Adrenergic agonist; Saline; Body weight; Medicine; Immunohistochemistry; Obesity; Chemistry; Adrenergic","score_opus":0.07728343598737959,"score_gpt":0.2750052235637691,"score_spread":0.19772178757638953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982595853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9473137,0.049922783,0.00077438494,0.00050380605,0.00013757605,0.0007420686,0.000005262813,0.0000705259,0.00052987214],"genre_scores_gemma":[0.9468257,0.0062318495,0.034514442,0.00039184344,0.0001761699,0.00039019805,0.000113327435,0.000041986143,0.0113144815],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987612,0.00007670227,0.00025267777,0.00033301205,0.0002835284,0.00029292965],"domain_scores_gemma":[0.9992518,0.000040600367,0.00011272369,0.00021092137,0.00010545647,0.00027851926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002273829,0.00030288746,0.0005420174,0.00011930857,0.000065508335,0.00001662402,0.0000633449,0.00008741815,0.00015910616],"category_scores_gemma":[0.000005130763,0.0001806145,0.000042731164,0.00012533192,0.00013886583,0.000042266834,0.000018053452,0.000069843474,0.000029393097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0210723,0.002908168,0.03472163,0.0001574992,0.0023590426,0.00030104758,0.06438745,0.000005149525,0.032420292,0.0003975964,0.005604049,0.83566576],"study_design_scores_gemma":[0.0056998883,0.0012214996,0.0034520733,0.00011660474,0.00012989868,0.000060865215,0.0003104982,0.0000039675124,0.121403545,0.000064892214,0.867201,0.000335279],"about_ca_topic_score_codex":0.000030832154,"about_ca_topic_score_gemma":0.00003137069,"teacher_disagreement_score":0.86159694,"about_ca_system_score_codex":0.000095547126,"about_ca_system_score_gemma":0.00027265403,"threshold_uncertainty_score":0.7365245},"labels":[],"label_agreement":null},{"id":"W1991311930","doi":"10.2147/dddt.s40215","title":"Aflibercept in wet AMD: specific role and optimal use","year":2013,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Aflibercept; Medicine; Computer science; Ophthalmology; Bevacizumab; Surgery; Chemotherapy","score_opus":0.09628446476675699,"score_gpt":0.3128199846076987,"score_spread":0.21653551984094171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991311930","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0111679165,0.9867137,0.000030514266,0.000014007917,0.000057233498,0.0018292852,0.0000061983487,0.000028399116,0.00015271518],"genre_scores_gemma":[0.00009047408,0.9898113,0.005857885,0.000040357776,0.000049248276,0.0003154023,0.00015543013,0.000060185565,0.0036197035],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984837,0.00011770602,0.00042879273,0.00046984662,0.00019758941,0.00030233694],"domain_scores_gemma":[0.9993185,0.00011681773,0.000119902106,0.00019409084,0.000028893866,0.00022183075],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001435675,0.00046880209,0.0010942852,0.00022587673,0.00006707437,0.00014062064,0.000070345195,0.00014850129,0.00014389405],"category_scores_gemma":[0.00000422949,0.00031702805,0.000098533936,0.00015038326,0.000055780773,0.00011413626,0.00003642415,0.00018448781,0.00008481881],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009387539,0.00016580004,0.0004948019,0.00053957076,0.00023165658,0.00010938745,0.0004063585,1.6631378e-7,8.8055407e-7,0.000015190787,0.0005440158,0.9973983],"study_design_scores_gemma":[0.0012402333,0.00007923962,0.0026089745,0.002520896,0.000103345636,0.000050948755,0.000046487523,0.000005789508,0.0000057690168,0.000019636778,0.9929888,0.00032987227],"about_ca_topic_score_codex":0.000024482086,"about_ca_topic_score_gemma":5.6694165e-7,"teacher_disagreement_score":0.9970684,"about_ca_system_score_codex":0.00007487084,"about_ca_system_score_gemma":0.00020281598,"threshold_uncertainty_score":0.9999282},"labels":[],"label_agreement":null},{"id":"W1993998711","doi":"10.2147/dddt.s19931","title":"Flavonoids targeting of IκB phosphorylation abrogates carcinogen-induced MMP-9 and COX-2 expression in human brain endothelial cells","year":2011,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Flavonoids in Medical Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Fonds Québécois de la Recherche sur la Nature et les Technologies","keywords":"Neuroinflammation; Phosphorylation; Signal transduction; Luteolin; Matrix metalloproteinase; Blood–brain barrier; Downregulation and upregulation; Chemistry; Cell biology; Pharmacology; Apigenin; Cancer research; Biochemistry; Biology; Inflammation; Immunology; Endocrinology; Flavonoid; Central nervous system","score_opus":0.07462496248851534,"score_gpt":0.3088408561781034,"score_spread":0.23421589368958806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993998711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963157,0.0013000873,0.0011454987,0.00007812588,0.000063518986,0.00069632404,0.0000013340057,0.000029978395,0.00036940372],"genre_scores_gemma":[0.97261304,0.0005595269,0.026007019,0.000115957584,0.00004842249,0.000051255058,0.000018266295,0.000031662046,0.0005548466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819833,0.00019946325,0.00046874193,0.0003518073,0.00043096126,0.00035072284],"domain_scores_gemma":[0.9991737,0.00028716173,0.000105127096,0.00016127389,0.00008243006,0.00019029614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015723268,0.00020847736,0.00035471475,0.00022723907,0.00012582207,0.000015556854,0.000112292466,0.00013601636,0.00021433111],"category_scores_gemma":[0.0001410643,0.00016925675,0.000030913274,0.0001786931,0.00013883975,0.00008421332,0.000059193473,0.0002793191,0.000006287426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004725807,0.00014118601,0.0141194,0.00006566002,0.000028184202,0.000012924468,0.013917283,3.6132e-7,0.94431305,0.00003408456,0.00033690516,0.02655841],"study_design_scores_gemma":[0.0028834247,0.00016076742,0.017773524,0.00020000825,0.0000047400904,0.0000012758479,0.0003839144,0.000057230824,0.97696114,0.00037077226,0.0010289941,0.00017418408],"about_ca_topic_score_codex":0.00007963476,"about_ca_topic_score_gemma":0.000008615681,"teacher_disagreement_score":0.032648142,"about_ca_system_score_codex":0.000051506926,"about_ca_system_score_gemma":0.00017016353,"threshold_uncertainty_score":0.690209},"labels":[],"label_agreement":null},{"id":"W1996090165","doi":"10.2147/dddt.s3255","title":"Surface activity of surfactant spiked with vitamin A","year":2008,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Pulmonary surfactant; Vitamin; Retinol; Retinyl acetate; Retinoic acid; Retinyl palmitate; Chemistry; Miscibility; Chromatography; Pharmacology; Medicine; Biochemistry; Organic chemistry","score_opus":0.08727916174307818,"score_gpt":0.3201511810938398,"score_spread":0.2328720193507616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996090165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959393,0.0018087346,0.0009553139,0.00029352534,0.000016905427,0.00069823064,0.0000010359197,0.000031171177,0.000255777],"genre_scores_gemma":[0.98354805,0.0022857976,0.012698089,0.00015810848,0.000010656071,0.000016885266,0.000002156634,0.00002340728,0.0012568726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987157,0.000103784754,0.00019372746,0.0002405082,0.00045819295,0.00028811154],"domain_scores_gemma":[0.99928004,0.00018081364,0.00007173168,0.00017803573,0.00008961032,0.00019976938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045805564,0.00015497363,0.00031545866,0.00008764148,0.0001257082,0.000005706329,0.000065649685,0.000048932132,0.000047252608],"category_scores_gemma":[0.000013820476,0.000107734595,0.000020597854,0.00024046323,0.00016128545,0.000113875765,0.000018671917,0.00016143906,0.000008110957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017899456,0.0009621619,0.07637092,0.00051329046,0.00031871637,0.00065224525,0.006148693,0.000010216807,0.48343346,0.00007176503,0.00023558401,0.4133835],"study_design_scores_gemma":[0.0038143378,0.0006515533,0.13603494,0.0000940635,0.0000042356,0.00006511218,0.00004425858,0.000050538023,0.8370559,0.00000771176,0.021999773,0.00017754712],"about_ca_topic_score_codex":0.000016847982,"about_ca_topic_score_gemma":0.0000024943938,"teacher_disagreement_score":0.41320595,"about_ca_system_score_codex":0.000040937633,"about_ca_system_score_gemma":0.00088545104,"threshold_uncertainty_score":0.43932894},"labels":[],"label_agreement":null},{"id":"W1999772350","doi":"10.2147/dddt.s32328","title":"New and emerging treatments for symptomatic tardive dyskinesia","year":2013,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Parks Canada; The Scarborough Hospital; Parkinson's Clinic of Eastern Toronto & Movement Disorders Centre; World Wildlife Fund Canada","funders":"","keywords":"Tardive dyskinesia; Tetrabenazine; Medicine; Levetiracetam; Pharmacology; Bioinformatics; Psychiatry; Dopamine; Internal medicine; Biology; Schizophrenia (object-oriented programming); Epilepsy","score_opus":0.06372742804327497,"score_gpt":0.32002404832385223,"score_spread":0.25629662028057726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999772350","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005209134,0.99119717,0.0035316877,0.000035156252,0.00012286846,0.004444845,0.000011021148,0.000070580616,0.00006574098],"genre_scores_gemma":[0.000026909587,0.9480874,0.045548994,0.00006823882,0.000092748625,0.0012957074,0.00022783113,0.00008949086,0.004562707],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983273,0.00006985086,0.00045284216,0.0005729564,0.00021117572,0.00036584225],"domain_scores_gemma":[0.99902815,0.00013023113,0.00022266195,0.00021103393,0.000044789278,0.0003631499],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015016196,0.00065839384,0.0014941352,0.00023430103,0.00019248352,0.00007741621,0.00008061412,0.00015634816,0.000088898865],"category_scores_gemma":[0.000007165033,0.00043744902,0.00019507243,0.00012901235,0.000020732838,0.000082362945,0.000030572868,0.00008177617,0.000043904987],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048466787,0.00010063325,0.000042187345,0.0016707253,0.0025002512,0.000027444867,0.0003848419,1.4019142e-8,0.0000018057848,0.000030884134,0.0010751118,0.9941176],"study_design_scores_gemma":[0.0037299015,0.00016043008,0.0001378397,0.0040340926,0.0017281921,0.00005786023,0.000025151681,0.000011290442,0.00009940534,0.00033130558,0.98922175,0.00046275067],"about_ca_topic_score_codex":0.000010485061,"about_ca_topic_score_gemma":3.404155e-7,"teacher_disagreement_score":0.9936549,"about_ca_system_score_codex":0.00011270315,"about_ca_system_score_gemma":0.00052568986,"threshold_uncertainty_score":0.9998077},"labels":[],"label_agreement":null},{"id":"W2007084442","doi":"10.2147/dddt.s14071","title":"A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCG-refractory and BCG-intolerant patients","year":2010,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Medicine; Tolerability; Refractory (planetary science); Adverse effect; Bladder cancer; Urology; Toxicity; Pharmacokinetics; Internal medicine; Maximum tolerated dose; Clinical endpoint; Gastroenterology; Surgery; Clinical trial; Cancer","score_opus":0.031168867441170423,"score_gpt":0.31676000066883975,"score_spread":0.2855911332276693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007084442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951558,0.0013675137,0.000064556756,0.00006684577,0.00012584792,0.0031738938,0.000022933225,0.000009776753,0.000012791401],"genre_scores_gemma":[0.9962613,0.0013690523,0.0014769385,0.00006685591,0.00004612296,0.0006826164,0.000021104066,0.000028391109,0.00004761114],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987538,0.000070421906,0.0004609244,0.0003002549,0.00019956935,0.00021505938],"domain_scores_gemma":[0.99918324,0.00023275017,0.0001749596,0.00019257341,0.00012358796,0.00009288238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022053083,0.00024684996,0.000441879,0.000099679964,0.00010613414,0.000016028165,0.00007864922,0.000060853898,0.00004168862],"category_scores_gemma":[0.000013981615,0.00015108613,0.00004213485,0.00009124906,0.00008170124,0.00007458591,0.0000111293675,0.000087347464,2.4343666e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008878768,0.021728404,0.03727768,0.00006254874,0.0011978686,0.000011652901,0.09580312,0.0000030909698,0.07179661,0.000003977026,0.000018607558,0.7632177],"study_design_scores_gemma":[0.105874725,0.026347844,0.39700404,0.00016068501,0.0003113608,0.000004064525,0.0062715802,0.00021513403,0.4614384,0.00005083389,0.0018284249,0.0004929246],"about_ca_topic_score_codex":0.00020270713,"about_ca_topic_score_gemma":0.00026614306,"teacher_disagreement_score":0.76272476,"about_ca_system_score_codex":0.000046269404,"about_ca_system_score_gemma":0.00029297508,"threshold_uncertainty_score":0.6161114},"labels":[],"label_agreement":null},{"id":"W2009241154","doi":"10.2147/dddt.s39100","title":"Clinical effectiveness and safety of montelukast in asthma. What are the conclusions from clinical trials and meta-analyses?","year":2014,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Montelukast; Asthma; Clinical trial; Meta-analysis; Medicine; MEDLINE; Intensive care medicine; Internal medicine","score_opus":0.40565417235875295,"score_gpt":0.5102049939172079,"score_spread":0.10455082155845491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009241154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076734833,0.98878217,0.0006157756,0.000107805114,0.00016670601,0.0026015027,0.000029608187,0.000014038302,0.000008940329],"genre_scores_gemma":[0.0024073727,0.9961964,0.0005672817,0.0003406572,0.00016736121,0.00018309374,0.000047536763,0.000041163396,0.000049150578],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98498976,0.0109465085,0.002822942,0.0007075654,0.00031708888,0.00021614492],"domain_scores_gemma":[0.98085254,0.017110324,0.001270992,0.0003948174,0.00009769406,0.00027364958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.015828067,0.0005553573,0.007877805,0.00016104967,0.00016088455,0.000070659735,0.000165167,0.00041330466,0.00005519143],"category_scores_gemma":[0.0009733191,0.0002549928,0.0009432791,0.00018852435,0.00044862935,0.00008807607,0.00013693038,0.00053892407,0.000003254319],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007700038,0.00018960863,0.002321354,0.00093683315,0.0064653414,0.000025451287,0.00017217878,1.8530508e-7,8.016271e-7,0.000007156932,0.000073333424,0.98903775],"study_design_scores_gemma":[0.005054018,0.00025034667,0.024408305,0.0061725597,0.012184931,0.000012153852,0.00039094113,0.000009267157,0.000016744074,0.00008177296,0.95095795,0.00046102246],"about_ca_topic_score_codex":0.000010869277,"about_ca_topic_score_gemma":0.000007934882,"teacher_disagreement_score":0.9885767,"about_ca_system_score_codex":0.000022778831,"about_ca_system_score_gemma":0.00054293877,"threshold_uncertainty_score":0.9999902},"labels":[],"label_agreement":null},{"id":"W2017282092","doi":"10.2147/dddt.s30342","title":"Potential role of rivaroxaban in patients with acute coronary syndrome","year":2012,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Rivaroxaban; Medicine; Dabigatran; Acute coronary syndrome; Apixaban; Clopidogrel; Warfarin; Aspirin; Myocardial infarction; Stroke (engine); Internal medicine; Ticagrelor; Cardiology; Atrial fibrillation","score_opus":0.047886802797551586,"score_gpt":0.28971310068247824,"score_spread":0.24182629788492666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017282092","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030181194,0.9674587,0.00008739452,0.000013771032,0.00010059234,0.0020489304,0.0000041852286,0.000027086864,0.000078125086],"genre_scores_gemma":[0.01394147,0.9815939,0.0031358253,0.000017109143,0.00005037129,0.000017836848,0.0002814743,0.000051925483,0.00091006455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985694,0.00009448219,0.0005293945,0.00024883955,0.0003162954,0.00024156232],"domain_scores_gemma":[0.9993798,0.000052262465,0.00027825442,0.00016626425,0.000038889877,0.00008451744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023304766,0.00034228122,0.001220624,0.00032666454,0.000043568984,0.000012769031,0.00009013555,0.00012250607,0.0000828812],"category_scores_gemma":[0.0000020129935,0.00022599846,0.00011393174,0.0002362627,0.000038639704,0.00009775637,0.00004299307,0.00012644168,0.000016808368],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003968148,0.000051102088,0.07137838,0.0008096632,0.0009604025,0.000027618702,0.00026245785,2.1856759e-7,5.087291e-7,0.000028151404,0.000016259635,0.9260684],"study_design_scores_gemma":[0.004251714,0.00022983293,0.23620893,0.002593902,0.0009106148,0.000035639627,0.000023194234,0.0000012715942,0.000016962718,0.000031030922,0.7551726,0.00052428007],"about_ca_topic_score_codex":0.0000024271653,"about_ca_topic_score_gemma":3.454612e-7,"teacher_disagreement_score":0.92554414,"about_ca_system_score_codex":0.000042047566,"about_ca_system_score_gemma":0.00017969088,"threshold_uncertainty_score":0.921595},"labels":[],"label_agreement":null},{"id":"W2020239218","doi":"10.2147/dddt.s3314","title":"Troglitazone reverses the multiple drug resistance phenotype in cancer cells","year":2009,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Troglitazone; Vorinostat; Doxorubicin; Downregulation and upregulation; Cancer research; Cancer cell; P-glycoprotein; Pharmacology; Multiple drug resistance; Histone deacetylase inhibitor; K562 cells; Cancer; Biology; Drug resistance; Medicine; Peroxisome proliferator-activated receptor; Histone deacetylase; Immunology; Receptor; Internal medicine; Histone; Chemotherapy; Leukemia; Biochemistry","score_opus":0.02539059993474002,"score_gpt":0.24942950304144082,"score_spread":0.2240389031067008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020239218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96338564,0.024150435,0.002190603,0.007254024,0.0003300092,0.0014411252,0.0000036125364,0.00011153244,0.0011330383],"genre_scores_gemma":[0.9622042,0.006543485,0.013243452,0.0016019761,0.00008339164,0.00007798321,0.000010073528,0.000025222966,0.016210226],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986866,0.00006320608,0.00031468325,0.0003178002,0.0002770933,0.00034059846],"domain_scores_gemma":[0.9994952,0.0000840425,0.000071202485,0.00020718241,0.00005136552,0.00009101111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005054185,0.00023045842,0.00031256134,0.000092074566,0.00017402913,0.000025856943,0.00012808834,0.000055168053,0.000066899105],"category_scores_gemma":[0.0000057014413,0.00014540061,0.00004894478,0.00026624437,0.000059417365,0.000073836185,0.0000059115505,0.00018268568,0.0000097696],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012910055,0.0022922948,0.021676889,0.0003327263,0.0005927269,0.00059585477,0.09273767,0.00009929891,0.38593712,0.0030042082,0.030994808,0.44882634],"study_design_scores_gemma":[0.008203821,0.00007347654,0.06400664,0.00060148985,0.000046811383,0.00000338474,0.0013343367,0.000065081935,0.6340706,0.0021556853,0.28872147,0.00071720476],"about_ca_topic_score_codex":0.000022209653,"about_ca_topic_score_gemma":0.00023000689,"teacher_disagreement_score":0.44810912,"about_ca_system_score_codex":0.00006740881,"about_ca_system_score_gemma":0.00018682722,"threshold_uncertainty_score":0.59292644},"labels":[],"label_agreement":null},{"id":"W2028427382","doi":"10.2147/dddt.s10812","title":"Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease – a perspective","year":2010,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Medicine; C-reactive protein; Dyslipidemia; Rosuvastatin Calcium; Internal medicine; Statin; Risk factor; Disease; Inflammation; Asymptomatic; Cardiology","score_opus":0.045768458980056353,"score_gpt":0.300191932783629,"score_spread":0.25442347380357266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028427382","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044303136,0.9842217,0.0043866113,0.00003968914,0.000067239205,0.0066777035,0.000011740753,0.000050263392,0.00011471341],"genre_scores_gemma":[0.00009315552,0.9836301,0.013953589,0.000019517836,0.00023217121,0.0011664359,0.00021233014,0.00008477667,0.00060789887],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997021,0.00048608432,0.0007414524,0.00070183986,0.00074986904,0.00029970953],"domain_scores_gemma":[0.9981709,0.000067751076,0.00041350964,0.00065689796,0.00039314642,0.0002977822],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017534931,0.000552031,0.002092563,0.00030753098,0.00016797011,0.00004843228,0.00010293778,0.0002438963,0.000015337415],"category_scores_gemma":[0.000073716765,0.00041757428,0.00072440115,0.0002704564,0.00013619765,0.0001482474,0.000059822665,0.0004765922,0.0000059732615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018131419,0.00010974228,0.000007582882,0.0068069226,0.003658938,0.00001893153,0.0017480416,2.596942e-7,0.000028435228,0.00007968301,0.00001646741,0.98734367],"study_design_scores_gemma":[0.0017521268,0.00008844176,0.00021759914,0.006521402,0.001418265,0.00005794282,0.000074031355,8.04283e-7,0.00028285035,0.00033484862,0.9887944,0.00045728395],"about_ca_topic_score_codex":0.00004498191,"about_ca_topic_score_gemma":0.0000023521154,"teacher_disagreement_score":0.98877794,"about_ca_system_score_codex":0.0001871481,"about_ca_system_score_gemma":0.0020234254,"threshold_uncertainty_score":0.9998276},"labels":[],"label_agreement":null},{"id":"W2034838201","doi":"10.2147/dddt.s77597","title":"Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"microRNA; Pancreatic cancer; Long non-coding RNA; Non-coding RNA; Pancreatic ductal adenocarcinoma; Bioinformatics; RNA; Biology; Computational biology; Biomarker; Cancer; Gene; Genetics","score_opus":0.06433265195639923,"score_gpt":0.35616491162870595,"score_spread":0.29183225967230675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034838201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037736984,0.99122477,0.00581277,0.00012317172,0.0002726372,0.0020225446,0.000010751548,0.000014238667,0.00014174797],"genre_scores_gemma":[0.0002679169,0.99584866,0.0010064191,0.00024013878,0.00015959628,0.00093259965,0.00009579655,0.00008390586,0.0013649954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975877,0.00039904125,0.000524988,0.0006163718,0.00039800463,0.00047392873],"domain_scores_gemma":[0.9991813,0.00003497943,0.00014393262,0.00036742518,0.000081686885,0.00019068713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012758811,0.00044661338,0.00069927605,0.00022571154,0.00012605147,0.00008899572,0.00047127958,0.0002945591,0.000034537177],"category_scores_gemma":[0.0000443925,0.00030667763,0.00014122343,0.00035603563,0.000054663546,0.0000043421696,0.00019911559,0.00027847555,0.000025632016],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015447137,0.000027159173,0.00000831322,0.00029619297,0.0005356781,0.00002878941,0.00021651805,0.000017712171,0.0009586286,0.00000512142,0.001885153,0.99586624],"study_design_scores_gemma":[0.0006361809,0.00008684536,0.000005186419,0.00087792083,0.0000644493,0.000026154432,0.00004179676,0.000011970188,0.003504118,0.000019561787,0.9943117,0.00041415408],"about_ca_topic_score_codex":0.00009537857,"about_ca_topic_score_gemma":0.00003480643,"teacher_disagreement_score":0.9954521,"about_ca_system_score_codex":0.00017930267,"about_ca_system_score_gemma":0.0014535281,"threshold_uncertainty_score":0.99993855},"labels":[],"label_agreement":null},{"id":"W2043889318","doi":"10.2147/dddt.s49778","title":"Profile of epratuzumab and its potential in the treatment of systemic lupus erythematosus","year":2014,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"University of Toronto; University Health Network","keywords":"Medicine; Lupus erythematosus; Systemic disease; Immunology; Dermatology; Immunopathology; Antibody","score_opus":0.06197174375582932,"score_gpt":0.3249779138467009,"score_spread":0.26300617009087157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043889318","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03644545,0.9582119,0.00006562808,0.000016920969,0.00012964604,0.004995826,0.000006953705,0.000015199709,0.00011246173],"genre_scores_gemma":[0.009481157,0.9880079,0.00047698125,0.0000058603937,0.00006534532,0.00072902004,0.000036558813,0.0000571231,0.0011400463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967859,0.0007027318,0.0011626168,0.00044658207,0.00056298106,0.0003391969],"domain_scores_gemma":[0.99831975,0.00053831696,0.0005215642,0.00041140025,0.00011793008,0.00009107286],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013238266,0.00048991706,0.0025264597,0.0004406227,0.000060294722,0.000023158784,0.00021722303,0.00023592604,0.000020266123],"category_scores_gemma":[0.00002410045,0.00025926152,0.0001885936,0.0003441785,0.00009090182,0.000033856377,0.000029288432,0.00016616077,0.000010580405],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040551816,0.00058403605,0.00066068245,0.058952972,0.001011839,0.000116451694,0.018433798,2.3839826e-7,0.00008986139,0.00014991449,0.00023488482,0.9193598],"study_design_scores_gemma":[0.020977512,0.0027084223,0.000051884177,0.15145177,0.001220881,0.06298046,0.0042691254,0.00014092654,0.0028893787,0.00010179336,0.7516709,0.0015369345],"about_ca_topic_score_codex":0.000009689598,"about_ca_topic_score_gemma":0.0000014227539,"teacher_disagreement_score":0.9178229,"about_ca_system_score_codex":0.00015357314,"about_ca_system_score_gemma":0.00077208696,"threshold_uncertainty_score":0.99998593},"labels":[],"label_agreement":null},{"id":"W2050653904","doi":"10.2147/dddt.s46289","title":"Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases","year":2013,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Repurposing; Drug repositioning; Drug development; Intellectual property; Data sharing; Drug discovery; Computer science; Variety (cybernetics); Knowledge management; Data science; Business; Medicine; Drug; Pharmacology; Bioinformatics; Engineering; Biology; Alternative medicine; Artificial intelligence","score_opus":0.23991502315300325,"score_gpt":0.3708165682158213,"score_spread":0.13090154506281806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050653904","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045213764,0.98763627,0.005952866,0.0008430614,0.00006794223,0.0049440293,0.000007904654,0.000055772816,0.000040025458],"genre_scores_gemma":[0.00079896575,0.99124914,0.0036476695,0.00011021587,0.000064367014,0.0019863977,0.00007636262,0.00005625078,0.0020106037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984274,0.00019568007,0.0005000414,0.00044581993,0.00013133348,0.00029974856],"domain_scores_gemma":[0.9974205,0.0017383862,0.0004470746,0.00029376874,0.00003832371,0.0000619413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086739025,0.00036658742,0.001037371,0.000057645448,0.0010600758,0.00016185356,0.00037929317,0.0008121245,0.000013871938],"category_scores_gemma":[0.000089763234,0.00015826347,0.00010238295,0.00018425059,0.0003032392,0.0000635334,0.00024306671,0.0012142153,0.0000012744804],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015814166,0.0000279999,0.000030277548,0.0008463639,0.0009405104,0.0000023564905,0.005189902,0.0000017928606,0.0000034874292,0.00006591952,0.0001094634,0.9926238],"study_design_scores_gemma":[0.0010199893,0.000051146773,0.000021815322,0.0048759226,0.0005010591,0.000019102219,0.0033699465,0.0002336763,0.00017553884,0.00005480105,0.98941076,0.00026626533],"about_ca_topic_score_codex":0.00005543922,"about_ca_topic_score_gemma":0.000004382194,"teacher_disagreement_score":0.9923575,"about_ca_system_score_codex":0.000024568191,"about_ca_system_score_gemma":0.00027063244,"threshold_uncertainty_score":0.81533533},"labels":[],"label_agreement":null},{"id":"W2054633103","doi":"10.2147/dddt.s81524","title":"Efficacy and safety of cross-linked hyaluronic acid single injection on osteoarthritis of the knee: a post-marketing phase IV study","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Viscosupplementation; Osteoarthritis; Hyaluronic acid; Confidence interval; Physical therapy; Orthopedic surgery; Surgery; Internal medicine; Alternative medicine; Intra articular","score_opus":0.0388719649710327,"score_gpt":0.2907197675178046,"score_spread":0.2518478025467719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054633103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953564,0.0022777116,0.000029644016,0.00006778813,0.00015238166,0.001862059,0.000003994615,0.000029474,0.00022059045],"genre_scores_gemma":[0.99861234,0.00008045221,0.00078697444,0.000066334454,0.000030556967,0.00004471565,0.000011406487,0.00002307272,0.00034412023],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986389,0.00022148386,0.00038488858,0.0002585688,0.0003089035,0.00018723984],"domain_scores_gemma":[0.9992041,0.0001678354,0.00016818497,0.00019103261,0.0001679172,0.00010093044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008736084,0.00019907723,0.00033441524,0.00010019695,0.00014021367,0.000024213185,0.00005631124,0.000060443468,0.000015079699],"category_scores_gemma":[0.00011591406,0.00013915557,0.000041434105,0.00016137074,0.00009638582,0.000062709805,0.00003590505,0.0001016074,0.0000018133945],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021359242,0.0024020246,0.010908703,0.000036748646,0.00016146517,0.000018975321,0.014128249,0.00000367064,0.09687169,0.000024897414,0.000015255246,0.85406905],"study_design_scores_gemma":[0.17926562,0.05329119,0.05732566,0.0011404635,0.00015320421,0.00010716579,0.004544732,0.000025713245,0.70186824,0.00012766755,0.0016064638,0.00054391136],"about_ca_topic_score_codex":0.000005613852,"about_ca_topic_score_gemma":0.000011613054,"teacher_disagreement_score":0.85352516,"about_ca_system_score_codex":0.000050182218,"about_ca_system_score_gemma":0.00021181177,"threshold_uncertainty_score":0.56745994},"labels":[],"label_agreement":null},{"id":"W2055943571","doi":"10.2147/dddt.s40032","title":"Does fesoterodine have a role in the treatment of poorly managed patients with overactive bladder?","year":2014,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Overactive bladder; Tolterodine; Nocturia; Medicine; Polypharmacy; Urinary urgency; Urology; Urinary incontinence; Quality of life (healthcare); Urinary system; Intensive care medicine; Internal medicine; Alternative medicine; Nursing","score_opus":0.04019319151786374,"score_gpt":0.3116987007777201,"score_spread":0.2715055092598564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055943571","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00983866,0.98485506,0.000052641786,0.00008964564,0.000036004883,0.0046461667,0.00001486758,0.0000157736,0.00045116857],"genre_scores_gemma":[0.0026835941,0.9946705,0.00066315616,0.000047272373,0.000045068617,0.00046340618,0.00021539327,0.000046333655,0.0011652391],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99789166,0.0004984394,0.00044520013,0.00040067916,0.00044496125,0.00031908308],"domain_scores_gemma":[0.9989245,0.0004146407,0.00019904436,0.00030585684,0.000075864555,0.00008008955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048140727,0.00044450234,0.0012391575,0.00029076927,0.0000937401,0.00003825078,0.00014433198,0.00010244368,0.000042102725],"category_scores_gemma":[0.0000052985133,0.00016822387,0.00011252794,0.00021326658,0.000075940785,0.00005633364,0.000016168784,0.00021364327,0.000007108371],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008593724,0.0010260079,0.0015654401,0.0009652161,0.0007809213,0.000040963474,0.007921878,8.025461e-8,4.286413e-7,0.000003532549,0.000057326477,0.98677886],"study_design_scores_gemma":[0.004394427,0.0020177558,0.0042455047,0.0020930218,0.0002060187,0.000009417949,0.00029325843,0.0000023440625,0.00010088538,0.00004531696,0.98628753,0.00030452135],"about_ca_topic_score_codex":0.000036597095,"about_ca_topic_score_gemma":0.000013805547,"teacher_disagreement_score":0.98647434,"about_ca_system_score_codex":0.00010845321,"about_ca_system_score_gemma":0.00030072316,"threshold_uncertainty_score":0.685997},"labels":[],"label_agreement":null},{"id":"W2059050231","doi":"10.2147/dddt.s71352","title":"Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine","year":2014,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research; Aerospace Center Hospital; Manitoba Health Research Council; Bill and Melinda Gates Foundation","keywords":"Hydroxychloroquine; Medicine; Pharmacology; Internal medicine; Coronavirus disease 2019 (COVID-19)","score_opus":0.021532386069187212,"score_gpt":0.25029089587023373,"score_spread":0.2287585098010465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059050231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96993244,0.002693765,0.025852092,0.00040048233,0.0000650874,0.000877691,9.3477064e-7,0.00001946252,0.00015803013],"genre_scores_gemma":[0.9606805,0.00034503292,0.037470367,0.00021299382,0.000049281374,0.00007763283,0.000014225292,0.000021575852,0.0011283999],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905455,0.000033998673,0.00032511828,0.00017883403,0.00018692375,0.00022056715],"domain_scores_gemma":[0.9993112,0.00024461155,0.00012773565,0.00014076178,0.00010695334,0.000068745685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068359403,0.00018288431,0.00033402524,0.00008026689,0.00014768436,0.000007813413,0.00008118466,0.00005547374,0.000027026319],"category_scores_gemma":[0.000014232944,0.00010239365,0.000042649546,0.00009474375,0.000081845545,0.000036235106,0.000020222345,0.000058032965,0.0000015214766],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036395139,0.0005072325,0.004173705,0.0002793572,0.0012395331,0.00000430431,0.01907802,0.0000067318374,0.07161972,0.00054917985,0.0009054381,0.89799726],"study_design_scores_gemma":[0.00789942,0.0007029501,0.013586924,0.00019230215,0.00010612062,0.000011780422,0.00077515555,0.0004823231,0.8778451,0.0001858715,0.09793162,0.00028043133],"about_ca_topic_score_codex":0.000009497634,"about_ca_topic_score_gemma":0.0000021725534,"teacher_disagreement_score":0.8977168,"about_ca_system_score_codex":0.000022582286,"about_ca_system_score_gemma":0.00019555846,"threshold_uncertainty_score":0.4175492},"labels":[],"label_agreement":null},{"id":"W2085903398","doi":"10.2147/dddt.s67349","title":"Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol","year":2014,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Advanced Drug Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Curtin Health Innovation Research Institute, Curtin University; Curtin University of Technology","keywords":"Dispersity; Transdermal; Thixotropy; Drug delivery; Materials science; Probucol; Zeta potential; Polymer; Thermal analysis; Chemical engineering; Chromatography; Chemistry; Biomedical engineering; Nanotechnology; Pharmacology; Nanoparticle; Antioxidant; Organic chemistry; Polymer chemistry; Medicine; Thermal; Composite material","score_opus":0.08454579430934943,"score_gpt":0.38115576021509545,"score_spread":0.296609965905746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085903398","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25580665,0.0029253887,0.7362747,0.0009382028,0.0010127819,0.002799832,0.000008646438,0.0001111134,0.0001226705],"genre_scores_gemma":[0.87800986,0.0009171408,0.11408582,0.0027447988,0.00037136264,0.0008008856,0.000033033713,0.00006320879,0.0029739046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99791443,0.00055702514,0.00043349736,0.00044316734,0.00018600874,0.0004658579],"domain_scores_gemma":[0.9979517,0.0013554456,0.00020776161,0.00019062584,0.0001650933,0.00012938192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024344749,0.00031274772,0.00030070337,0.00010770002,0.0007551224,0.00005490055,0.0002763083,0.00015180203,0.0000815667],"category_scores_gemma":[0.00004365234,0.00023374138,0.00008176581,0.00015964393,0.00010845008,0.00015000295,0.000047949048,0.0002769343,0.00005121661],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014738014,0.00031649257,0.0005923632,0.00007324653,0.0006489271,0.000004164132,0.0068308082,0.0068408884,0.34344792,0.00094940746,0.0042036776,0.6346183],"study_design_scores_gemma":[0.004931528,0.00008378585,0.00067034725,0.000026692745,0.00009037248,0.000030218698,0.00032756102,0.09556923,0.39391407,0.0011840046,0.50266856,0.00050362106],"about_ca_topic_score_codex":0.000014522225,"about_ca_topic_score_gemma":0.0000036404724,"teacher_disagreement_score":0.6341147,"about_ca_system_score_codex":0.00005033959,"about_ca_system_score_gemma":0.00014115628,"threshold_uncertainty_score":0.95316964},"labels":[],"label_agreement":null},{"id":"W2086247967","doi":"10.2147/dddt.s36984","title":"The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol","year":2013,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Institut de Cardiologie de Montréal; Fondation Institut de Cardiologie de Montréal; Heart and Stroke Foundation of Canada","keywords":"PCSK9; LDL receptor; Kexin; Proprotein convertase; Cholesterol; Lipoprotein; Low-density lipoprotein; Endocrinology; Medicine; Internal medicine; Pharmacology; Biology","score_opus":0.0452173383743127,"score_gpt":0.2978546919823394,"score_spread":0.2526373536080267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086247967","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01488606,0.97229475,0.0039511644,0.0018932935,0.00020568425,0.0067080846,0.000009277459,0.000032608667,0.000019094497],"genre_scores_gemma":[0.0019446356,0.9923994,0.0025830823,0.0018127285,0.00035867718,0.00051876146,0.000021397993,0.000067925444,0.00029341746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99718434,0.0006208083,0.00078362314,0.00057066325,0.0003710259,0.00046952846],"domain_scores_gemma":[0.9980151,0.0005257933,0.0002799602,0.00075219554,0.0001222505,0.000304695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014485525,0.00054401025,0.0017257663,0.000111613364,0.00032308107,0.00009055024,0.00031744788,0.00022787214,0.000016117916],"category_scores_gemma":[0.000046115223,0.000264372,0.00025754765,0.00026077344,0.00010617226,0.0000337666,0.00009626775,0.00038141786,0.000028338432],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009917734,0.000023417242,0.000031753683,0.0003377556,0.001315315,0.0000027622466,0.0015930105,1.5685515e-7,0.00008672068,0.00003422635,0.0002251218,0.99625057],"study_design_scores_gemma":[0.0016007219,0.0001668994,0.00032025986,0.0026736772,0.0003475884,0.000027850661,0.00012824147,0.0000037493724,0.0018845098,0.00012445176,0.99239445,0.00032763244],"about_ca_topic_score_codex":0.0006431204,"about_ca_topic_score_gemma":0.000055839366,"teacher_disagreement_score":0.9959229,"about_ca_system_score_codex":0.000059495003,"about_ca_system_score_gemma":0.0006837782,"threshold_uncertainty_score":0.99998087},"labels":[],"label_agreement":null},{"id":"W2101968968","doi":"10.2147/dddt.s70299","title":"Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Dabigatran; Medicine; Apixaban; Rivaroxaban; Edoxaban; Intensive care medicine; Direct thrombin inhibitor; Dosing; Warfarin; Atrial fibrillation; Pharmacology; Internal medicine","score_opus":0.09982856678948611,"score_gpt":0.3585364966659736,"score_spread":0.2587079298764875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101968968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027066449,0.9670598,0.0001826452,0.00008119125,0.00032590612,0.004556987,0.000038358805,0.00003292865,0.00065571687],"genre_scores_gemma":[0.0070690853,0.9900883,0.0016575676,0.000029099834,0.00012805093,0.00059869565,0.00013836626,0.00008939793,0.00020146165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967067,0.00031600546,0.0012396375,0.00060421944,0.0006871328,0.000446274],"domain_scores_gemma":[0.99795216,0.00030405648,0.00078593363,0.0006756756,0.00011769863,0.00016445169],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006475184,0.000766391,0.0040995744,0.0004420611,0.00012301291,0.000034311306,0.0002780931,0.00023391936,0.00008823536],"category_scores_gemma":[0.000008091092,0.0004475875,0.00039553325,0.00035484438,0.00013844745,0.00004088983,0.00004766598,0.00027875783,0.000008778123],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009269812,0.0049615484,0.00013553433,0.0014531766,0.002000756,0.000016765498,0.0035698437,0.000006776641,0.000004927839,0.00043178358,0.00026955563,0.9870566],"study_design_scores_gemma":[0.0043715565,0.0024170952,0.0057262015,0.005619762,0.0020764999,0.000012702177,0.00012687198,0.000008014955,0.0004514251,0.0006736727,0.9778627,0.00065347395],"about_ca_topic_score_codex":0.00017205697,"about_ca_topic_score_gemma":0.000049698483,"teacher_disagreement_score":0.98640317,"about_ca_system_score_codex":0.00037509954,"about_ca_system_score_gemma":0.000714435,"threshold_uncertainty_score":0.9997976},"labels":[],"label_agreement":null},{"id":"W2112867551","doi":"10.2147/dddt.s90580","title":"Maraviroc: a review of its use in HIV infection and beyond","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Mental Health","keywords":"Maraviroc; CCR5 receptor antagonist; Medicine; Chemokine receptor CCR5; CXCR4; Drug resistance; Chemokine receptor; Entry inhibitor; Pharmacology; Boswellia serrata; Drug; Viral load; Virology; Viral entry; Immunology; Human immunodeficiency virus (HIV); Internal medicine; Virus; Chemokine; Biology; Viral replication; Receptor; Microbiology","score_opus":0.09617880986677699,"score_gpt":0.3299175114230901,"score_spread":0.23373870155631313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112867551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027525902,0.9980192,0.00001663748,0.00002050728,0.000060206978,0.0014563943,0.000027143173,0.0000140553175,0.000110582616],"genre_scores_gemma":[0.000014031456,0.9969885,0.00030140925,0.000036715504,0.000005888606,0.00026855888,0.00040800025,0.00002090587,0.0019560186],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982427,0.0006241552,0.000496078,0.0003186892,0.000059356036,0.0002590575],"domain_scores_gemma":[0.9993572,0.00019835663,0.00018163314,0.00014597406,0.00007296958,0.000043826716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087034464,0.00031742797,0.0011445447,0.00025519048,0.000058603862,0.000016701551,0.0000838361,0.0002023896,0.000103353326],"category_scores_gemma":[0.00004000706,0.00022096424,0.00006794005,0.00020030487,0.00007524179,0.000092908514,0.000053757973,0.000240975,0.00016099536],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040998744,0.00010083199,0.00013016812,0.009435875,0.00032077558,0.000010964011,0.00020107429,7.566171e-9,0.0000075823395,0.000024163743,0.002729642,0.9869979],"study_design_scores_gemma":[0.0009237369,0.00006654811,0.000106510124,0.016321212,0.000056806337,0.000041029336,0.0000031549482,3.4435566e-8,0.000113729984,0.000012190291,0.9821512,0.0002038667],"about_ca_topic_score_codex":0.0000143569205,"about_ca_topic_score_gemma":0.000007764263,"teacher_disagreement_score":0.98679405,"about_ca_system_score_codex":0.00006623335,"about_ca_system_score_gemma":0.00043626432,"threshold_uncertainty_score":0.901066},"labels":[],"label_agreement":null},{"id":"W2116491845","doi":"10.2147/dddt.s90170","title":"Therapeutic designed poly (lactic-co-glycolic acid) cylindrical oseltamivir phosphate-loaded implants impede tumor neovascularization, growth and metastasis in mouse model of human pancreatic carcinoma","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"PLGA; Neovascularization; Pancreatic cancer; Metastasis; Cancer research; Irinotecan; Medicine; In vivo; Angiogenesis; Pharmacology; Colorectal cancer; Pathology; Chemistry; In vitro; Cancer; Internal medicine; Biology; Biochemistry","score_opus":0.04500067962431849,"score_gpt":0.28329784147999193,"score_spread":0.23829716185567346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116491845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97986645,0.0129256,0.006545084,0.00002810631,0.0000111700565,0.0005504349,0.000014170881,0.000012264802,0.000046695837],"genre_scores_gemma":[0.995763,0.00094016816,0.0027729843,0.00010469611,0.000015735444,0.00013436422,0.00009663984,0.000035304067,0.000137128],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844307,0.00020353432,0.00032284303,0.0004034975,0.00026096049,0.0003661245],"domain_scores_gemma":[0.9993899,0.000025597343,0.00010284133,0.00019800387,0.0000795207,0.00020417919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039552557,0.00026850708,0.00033783272,0.00014365757,0.0001116123,0.00004882691,0.00014560351,0.00008012819,0.0000039860993],"category_scores_gemma":[0.000021261107,0.00022633983,0.000046731686,0.00014330188,0.00008949558,0.000021812744,0.000047698686,0.00007923144,0.0000012708088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020132696,0.00039774194,0.044124577,0.000046555946,0.0006509381,0.000021797976,0.0025876416,0.000011744705,0.92930484,0.000093739436,0.000044630862,0.02070254],"study_design_scores_gemma":[0.00468167,0.00031238812,0.00439563,0.00000979801,0.000026062042,0.000011739139,0.00013365815,0.00023091376,0.98953366,0.0003737836,0.000035619294,0.00025506315],"about_ca_topic_score_codex":0.0002012862,"about_ca_topic_score_gemma":0.000037233716,"teacher_disagreement_score":0.06022885,"about_ca_system_score_codex":0.000041102347,"about_ca_system_score_gemma":0.00038631033,"threshold_uncertainty_score":0.92298704},"labels":[],"label_agreement":null},{"id":"W2126469018","doi":"10.2147/dddt.s65396","title":"Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study","year":2014,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Curtin University of Technology","keywords":"Gliclazide; Deoxycholic acid; Thixotropy; Chromatography; Chemistry; Pharmacokinetics; Permeation; Pharmacology; Bile acid; Materials science; Insulin; Biochemistry; Medicine; Membrane","score_opus":0.05547251103098966,"score_gpt":0.2617466584976248,"score_spread":0.20627414746663514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126469018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94263124,0.000043579934,0.056171536,0.00010004906,0.000065547036,0.00072148215,0.0000015417601,0.000042674423,0.00022235763],"genre_scores_gemma":[0.9906246,0.000018168617,0.008571095,0.00025884053,0.00006970703,0.000044222998,0.000115342395,0.000015177951,0.0002828425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990692,0.000057359288,0.00035465768,0.00019457251,0.0001907884,0.00013341742],"domain_scores_gemma":[0.9995012,0.00005578886,0.00014309728,0.00012979012,0.00010487121,0.00006524445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037385733,0.00013728997,0.0002527206,0.00014372138,0.00010227371,0.000023211962,0.00003587732,0.000040186078,0.00008702881],"category_scores_gemma":[0.000019027744,0.00011399328,0.000028337736,0.00018822598,0.000020788419,0.000087304754,0.000009746364,0.000046247733,0.000012180542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032111548,0.00053792744,0.015095762,0.00002094917,0.000042395914,2.6977585e-7,0.0033628936,0.000003227538,0.9429011,0.000052986037,0.000033110402,0.037628293],"study_design_scores_gemma":[0.0036818583,0.000314953,0.35914955,0.000028186452,0.000025590156,0.000002759229,0.00018752264,0.0027311612,0.62955445,0.000074521166,0.0040907855,0.00015868663],"about_ca_topic_score_codex":0.0000056939602,"about_ca_topic_score_gemma":7.798254e-7,"teacher_disagreement_score":0.34405378,"about_ca_system_score_codex":0.000020997211,"about_ca_system_score_gemma":0.00005752323,"threshold_uncertainty_score":0.4648511},"labels":[],"label_agreement":null},{"id":"W2156954694","doi":"10.2147/dddt.s89338","title":"A novel small-molecule inhibitor of HIV-1 entry","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, San Francisco; McGill University","keywords":"Human immunodeficiency virus (HIV); Small molecule; Drug; Drug resistance; Antiretroviral therapy; ANTIRETROVIRAL AGENTS; Pharmacology; Lentivirus; Medicine; Virology; Chemistry; Viral load; Biology; Viral disease; Biochemistry; Microbiology","score_opus":0.0504161142988806,"score_gpt":0.25327954943224573,"score_spread":0.20286343513336513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156954694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774051,0.003506487,0.0115921665,0.0020186554,0.00018871817,0.0011686075,0.0000045230217,0.00012596503,0.0039897775],"genre_scores_gemma":[0.78146315,0.0007629077,0.1727462,0.00057941227,0.00015349682,0.00017605908,0.00013658546,0.000083073886,0.04389914],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856985,0.00004344717,0.0004093271,0.0003225,0.00035129362,0.000303576],"domain_scores_gemma":[0.9991975,0.00006053719,0.000112125854,0.00018690634,0.00015061125,0.00029231946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044362695,0.0002815836,0.00041099152,0.00019267197,0.00007122854,0.000022640781,0.00008775742,0.00008093406,0.00004342286],"category_scores_gemma":[0.000024161025,0.00021845535,0.00005686505,0.00022817087,0.00007119822,0.00006454335,0.000043445725,0.00010137259,0.000061485924],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0115832165,0.010255226,0.19376807,0.0005102241,0.005269732,0.0007124509,0.13893895,0.000018509172,0.18795641,0.0018956464,0.11993583,0.32915574],"study_design_scores_gemma":[0.016172113,0.00021694013,0.0040177274,0.00026448356,0.000069801914,0.000088896115,0.0010820896,0.00008991289,0.8681191,0.00011856285,0.10918743,0.0005729069],"about_ca_topic_score_codex":0.0000049729774,"about_ca_topic_score_gemma":0.0000019897839,"teacher_disagreement_score":0.6801627,"about_ca_system_score_codex":0.0000817,"about_ca_system_score_gemma":0.0006292715,"threshold_uncertainty_score":0.89083505},"labels":[],"label_agreement":null},{"id":"W2165775264","doi":"10.2147/dddt.s88473","title":"Pain relief and improved physical function in knee osteoarthritis patients receiving ongoing hylan G-F 20, a high-molecular-weight hyaluronan, versus other treatment options: data from a large real-world longitudinal cohort in Canada","year":2015,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sanofi (Canada); Lawson Health Research Institute; Western University","funders":"Sanofi; Amgen","keywords":"Medicine; Osteoarthritis; Visual analogue scale; Viscosupplementation; Cohort; Physical therapy; Internal medicine; Intra articular","score_opus":0.03046307116537179,"score_gpt":0.24608155390389141,"score_spread":0.21561848273851963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165775264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995837,0.002142909,0.000117677686,0.00010719748,0.00026923392,0.0013259705,0.00005504795,0.000031096868,0.00011391576],"genre_scores_gemma":[0.99497014,0.00043752065,0.0027364981,0.000111834204,0.00007359959,0.00026258122,0.0011197614,0.00004425171,0.00024378259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998101,0.00024115828,0.00033721785,0.00062999385,0.00030107485,0.00038955075],"domain_scores_gemma":[0.9991641,0.0001772249,0.00009255845,0.0003184896,0.00004976134,0.00019783655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005110367,0.00031896634,0.00044983628,0.00016446326,0.00008448551,0.00004164655,0.00007334903,0.000058023386,0.000020036196],"category_scores_gemma":[0.000028338589,0.00027928106,0.000021826447,0.00020964687,0.00002008011,0.00017578198,0.000055040236,0.00012758726,0.0000036823583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003364551,0.00067101396,0.58853984,0.000009219853,0.0001863099,0.00011793358,0.0013256436,0.0000012712379,0.0010770905,0.000060931718,0.00012632713,0.40451986],"study_design_scores_gemma":[0.14160159,0.01238741,0.8104378,0.0011660447,0.00027956013,0.0000048923157,0.0013539835,0.001520155,0.0094541665,0.0007351325,0.019443184,0.0016160534],"about_ca_topic_score_codex":0.12424911,"about_ca_topic_score_gemma":0.6457033,"teacher_disagreement_score":0.5214542,"about_ca_system_score_codex":0.00071310875,"about_ca_system_score_gemma":0.00079900736,"threshold_uncertainty_score":0.99996597},"labels":[],"label_agreement":null},{"id":"W2299034615","doi":"10.2147/dddt.s98323","title":"Computational and nonglycosylated systems: a simpler approach for development of nanosized PEGylated proteins","year":2016,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Tech University","funders":"","keywords":"Computational biology; Computer science; Bioinformatics; Chemistry; Biology","score_opus":0.036646402415503355,"score_gpt":0.27236581205005983,"score_spread":0.23571940963455648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299034615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56559587,0.0011039117,0.43166783,0.00005285743,0.00001750544,0.0014899705,0.000006953917,0.000014843288,0.000050293227],"genre_scores_gemma":[0.8626569,0.00017510098,0.13560282,0.000025487658,0.000020209138,0.0004543489,0.00012417877,0.000024075032,0.00091691833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987772,0.00008980357,0.00035276293,0.00034288494,0.0002024505,0.00023491243],"domain_scores_gemma":[0.9994142,0.0000518072,0.00010815877,0.000106197054,0.0002279998,0.00009161467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005442541,0.00018004638,0.00019896819,0.000098530065,0.00016863903,0.000030879524,0.00009838578,0.00010195171,0.000010073198],"category_scores_gemma":[0.000026433949,0.00012330468,0.000026473852,0.00009027523,0.00007403571,0.000008638054,0.000046619905,0.0000333326,0.0000014426962],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020052323,0.00023934351,0.0008503482,0.0001477478,0.00041348848,0.0000011032517,0.0013485752,0.00014429673,0.77820873,0.0002385096,0.00046672774,0.2159359],"study_design_scores_gemma":[0.0070205764,0.00022994792,0.0017851596,0.00007047816,0.000005721863,0.000010764273,0.000090403206,0.0024691292,0.8998593,0.00011459403,0.08789977,0.00044413513],"about_ca_topic_score_codex":0.0000030792532,"about_ca_topic_score_gemma":0.0000010586372,"teacher_disagreement_score":0.29706103,"about_ca_system_score_codex":0.000016629556,"about_ca_system_score_gemma":0.00033840307,"threshold_uncertainty_score":0.50282186},"labels":[],"label_agreement":null},{"id":"W2464934251","doi":"10.2147/dddt.s106802","title":"Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod","year":2016,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"Novartis Pharma; World Health Organization","keywords":"Fingolimod; Medicine; Food and drug administration; Marketing authorization; Quality (philosophy); Authorization; Good manufacturing practice; Documentation; Agency (philosophy); Bioequivalence; Pharmacy; Risk analysis (engineering); Intensive care medicine; Business; Family medicine; Multiple sclerosis; Pharmacology; Marketing; Computer security; Bioinformatics; Computer science","score_opus":0.3702865754020696,"score_gpt":0.3829632242045164,"score_spread":0.012676648802446788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464934251","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015903788,0.99287003,0.0021449884,0.0019598743,0.00031518284,0.0017064579,0.0003484529,0.000028580474,0.00046739355],"genre_scores_gemma":[0.0010067283,0.99482155,0.0018707552,0.0008305626,0.00027127087,0.00092153356,0.00005555608,0.0000698507,0.00015220011],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714214,0.000063907806,0.0016208196,0.0007197261,0.000028070921,0.00042531724],"domain_scores_gemma":[0.9978202,0.0011371626,0.00052703236,0.00031602476,0.000025490928,0.00017409516],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018301223,0.00041035897,0.0016617851,0.00036848694,0.00014696608,0.000058315483,0.00032990653,0.00027036146,0.000042813655],"category_scores_gemma":[0.000096090786,0.00032948868,0.00027539628,0.00016301245,0.00009441703,0.000081211816,0.00003987102,0.00024743797,0.0001357071],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000566333,0.00009870876,0.0006021404,0.00025384792,0.00016229716,4.413407e-7,0.0001307051,2.1529955e-7,1.519295e-7,0.011157542,0.0018224937,0.98571485],"study_design_scores_gemma":[0.0018634418,0.000054513293,0.0006289183,0.00132724,0.000011941909,0.0000010994011,0.0000020854297,0.000017037823,0.000006002764,0.023349304,0.97228014,0.0004582599],"about_ca_topic_score_codex":0.000008353294,"about_ca_topic_score_gemma":0.000011907353,"teacher_disagreement_score":0.98525655,"about_ca_system_score_codex":0.00014444995,"about_ca_system_score_gemma":0.00022581172,"threshold_uncertainty_score":0.9999157},"labels":[],"label_agreement":null},{"id":"W2489361700","doi":"10.2147/dddt.s104037","title":"Rational design and synthesis of novel diphenyl ether derivatives as antitubercular agents","year":2016,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Antimicrobial agents and applications","field":"Chemistry","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Indian Council of Medical Research; All India Council for Technical Education; Department of Science and Technology, Ministry of Science and Technology, India","keywords":"Cytotoxicity; Triclosan; Diphenyl ether; Chemistry; Vero cell; Mycobacterium tuberculosis; Ether; In vitro; Minimum inhibitory concentration; IC50; Stereochemistry; Lead compound; Microsome; INHA; Combinatorial chemistry; Reductase; Biochemistry; Enzyme; Organic chemistry; Tuberculosis","score_opus":0.041192303203665445,"score_gpt":0.25406855203717865,"score_spread":0.2128762488335132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2489361700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7439513,0.00033271385,0.25455043,0.00046039472,0.000013286305,0.00019869856,0.000007835543,0.000029389066,0.00045590138],"genre_scores_gemma":[0.9304317,0.0008469255,0.06709973,0.00012825086,0.000022384478,0.000072663905,0.0000047652156,0.000022013734,0.0013715496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992483,0.000026720674,0.00021381347,0.00023954545,0.00012892867,0.00014268198],"domain_scores_gemma":[0.99945563,0.00023714612,0.000093475894,0.0001103665,0.00004788975,0.000055471894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019049102,0.00015552914,0.0001617913,0.000037044992,0.00014730661,0.000025315443,0.00010186951,0.00005557481,0.0004515721],"category_scores_gemma":[0.000019122277,0.000104091654,0.000024127205,0.00005736525,0.00011871876,0.00009301619,0.000028714792,0.000032251468,0.000008791776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008356995,0.00021680872,0.0012301258,0.000019211802,0.00015926729,0.0000011167052,0.0010948539,0.0000050209906,0.93457186,0.0014716601,0.00034070775,0.06080579],"study_design_scores_gemma":[0.0008602309,0.0000065118948,0.0012729664,0.00007833284,0.0000094780835,0.0000036819827,0.00005985756,0.00006291112,0.98636997,0.00055470254,0.0105258925,0.00019545155],"about_ca_topic_score_codex":0.000005510199,"about_ca_topic_score_gemma":2.5877506e-7,"teacher_disagreement_score":0.1874507,"about_ca_system_score_codex":0.000013475503,"about_ca_system_score_gemma":0.0000737934,"threshold_uncertainty_score":0.49443978},"labels":[],"label_agreement":null},{"id":"W2508827030","doi":"10.2147/dddt.s112181","title":"Pharmacokinetic profile of defibrotide in patients with renal impairment","year":2016,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec Rehabilitation Research Network","funders":"Jazz Pharmaceuticals","keywords":"Defibrotide; Medicine; Hepatic veno-occlusive disease; Pharmacokinetics; Dialysis; Cmax; Dosing; Hemodialysis; Internal medicine; Confidence interval; Gastroenterology; Urology; Surgery; Transplantation; Hematopoietic stem cell transplantation","score_opus":0.014355227916114453,"score_gpt":0.22922254691676197,"score_spread":0.2148673190006475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508827030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950381,0.00009984124,0.0036641185,0.0000883225,0.000017104227,0.00087013334,0.0000016911281,0.0000151914155,0.00020548215],"genre_scores_gemma":[0.9851255,0.00013768187,0.0143554015,0.00004545042,0.0000059838903,0.000060867507,0.0000099303115,0.000013654515,0.00024553743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992217,0.000040489373,0.00022946406,0.0001496783,0.00021418835,0.0001445185],"domain_scores_gemma":[0.99970704,0.00006201082,0.000056799243,0.00007091846,0.00004674722,0.00005648837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018715985,0.00010949724,0.00017380962,0.00009943847,0.000016724172,0.000003060398,0.000029602332,0.000022276321,0.00010377117],"category_scores_gemma":[0.0000021314738,0.00006037959,0.000011828798,0.00009501249,0.000031583444,0.00004191457,0.0000041043377,0.000029787294,0.0000075336707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039862483,0.0004924509,0.8544834,0.00014173941,0.000096417985,0.000013659411,0.0033037565,0.0000013438207,0.04260169,0.000022505068,0.00014751345,0.09470926],"study_design_scores_gemma":[0.009657248,0.00024987644,0.53028226,0.0004348202,0.000009260021,0.0000033180272,0.000016498334,0.0000035364724,0.4589128,0.000015805428,0.00031844783,0.000096141805],"about_ca_topic_score_codex":0.0000022199308,"about_ca_topic_score_gemma":6.9446844e-7,"teacher_disagreement_score":0.41631112,"about_ca_system_score_codex":0.000030500261,"about_ca_system_score_gemma":0.00009841026,"threshold_uncertainty_score":0.24622083},"labels":[],"label_agreement":null},{"id":"W2531727627","doi":"10.2147/dddt.s99600","title":"Yellow fever vaccine-associated viscerotropic disease: current perspectives","year":2016,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Yellow fever vaccine; Medicine; Pharmacovigilance; Disease; Yellow fever; Family medicine; Incidence (geometry); Pediatrics; Adverse effect; Virology; Internal medicine","score_opus":0.04583121891987053,"score_gpt":0.32399229414635045,"score_spread":0.2781610752264799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531727627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016616263,0.99637353,0.00045749263,0.00018906819,0.00027215757,0.0023114965,0.00002921669,0.0001256411,0.00007525924],"genre_scores_gemma":[0.0003149452,0.9936665,0.00012055454,0.00009917728,0.00033266083,0.0006051034,0.00015574311,0.00010656809,0.0045987363],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973893,0.00027032165,0.0006076065,0.0007935449,0.00042391234,0.00051530515],"domain_scores_gemma":[0.99850065,0.00016136888,0.00031371822,0.0003948586,0.00014669752,0.00048269975],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027523303,0.00072686654,0.0016464294,0.00023684361,0.00019173816,0.00007676545,0.00020743218,0.00014881573,0.00050639117],"category_scores_gemma":[0.00004838556,0.00044687476,0.0004751814,0.00021883009,0.000046597495,0.00007669456,0.00005314823,0.0002762479,0.00013408571],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019829789,0.0003643866,0.00014212166,0.0014724174,0.0010125572,0.00004535198,0.00037716562,1.8230624e-8,8.6893164e-7,0.00007435246,0.004491747,0.9918207],"study_design_scores_gemma":[0.0026657416,0.000047408845,0.0010959571,0.010970382,0.0006155346,0.0000044364815,0.0000353847,0.0000038127037,0.0000027434046,0.00006953333,0.9838944,0.0005946661],"about_ca_topic_score_codex":0.0000017577838,"about_ca_topic_score_gemma":6.79204e-7,"teacher_disagreement_score":0.9912261,"about_ca_system_score_codex":0.0002744168,"about_ca_system_score_gemma":0.0012751024,"threshold_uncertainty_score":0.9997983},"labels":[],"label_agreement":null},{"id":"W2548371687","doi":"10.2147/dddt.s119214","title":"Evaluating the cytotoxic effects of the water extracts of four anticancer herbs against human malignant melanoma cells","year":2016,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Flavonoids in Medical Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; Queen's University","funders":"College of Pharmacy and Nutrition, University of Saskatchewan","keywords":"Cytotoxicity; Herb; Traditional medicine; Cytotoxic T cell; Melanoma; Cancer cell; Cancer; Medicine; Medicinal herbs; Pharmacology; Chemistry; Biology; In vitro; Cancer research; Internal medicine; Biochemistry","score_opus":0.0755976652955106,"score_gpt":0.3469543211764928,"score_spread":0.2713566558809822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548371687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963256,0.0005748688,0.00058987434,0.0011049107,0.000119603625,0.0011341072,4.799258e-7,0.000011844241,0.00013869307],"genre_scores_gemma":[0.9947688,0.0007463884,0.0019316607,0.00030721928,0.00005618942,0.00007535283,8.1762397e-7,0.000025282397,0.0020883197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978153,0.0003872482,0.00038465572,0.00022998003,0.000831434,0.000351398],"domain_scores_gemma":[0.99847245,0.00085493654,0.00010816354,0.00034667447,0.00012343118,0.00009433817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023528812,0.00016665856,0.0002990346,0.00006202011,0.00016103938,0.0000109790635,0.00026590208,0.00006753053,0.00010555914],"category_scores_gemma":[0.00018520489,0.000052625684,0.000064884116,0.00011430987,0.00033271837,0.000038509235,0.000084833075,0.00015389558,0.000009645302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016643423,0.00007327119,0.0011115893,0.00009895755,0.00010678753,0.000009836053,0.0018857295,7.346037e-7,0.8786306,0.000025013327,0.00016289786,0.11772815],"study_design_scores_gemma":[0.002133951,0.00025595684,0.009565443,0.0007428445,0.000014124022,0.0000020762163,0.00004236842,0.000037368343,0.98609287,0.0002738478,0.00074149575,0.00009768582],"about_ca_topic_score_codex":0.0000051870948,"about_ca_topic_score_gemma":0.0000012950279,"teacher_disagreement_score":0.11763047,"about_ca_system_score_codex":0.000050241244,"about_ca_system_score_gemma":0.00024959494,"threshold_uncertainty_score":0.21460131},"labels":[],"label_agreement":null},{"id":"W2558346154","doi":"10.2147/dddt.s117078","title":"Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells","year":2016,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Dialysis and Renal Disease Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Viability assay; Cell adhesion molecule; Cell adhesion; Biochemistry; Chemistry; Endothelial stem cell; Pharmacology; Biology; Immunology; In vitro; Cell","score_opus":0.02594054227768645,"score_gpt":0.2799810474981427,"score_spread":0.25404050522045624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558346154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997092,0.00064343726,0.00044853947,0.00010795247,0.00011704982,0.0006112036,0.0000044030626,0.00003357269,0.00094183383],"genre_scores_gemma":[0.9966071,0.00084533467,0.00034517882,0.0002180396,0.000110068,0.00007431395,0.000012227406,0.00002584595,0.0017618837],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985682,0.00019276148,0.00033051305,0.0003009514,0.00036521791,0.00024239748],"domain_scores_gemma":[0.9993671,0.00015121252,0.00010627445,0.00019365943,0.000038793267,0.00014295203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007689239,0.000236376,0.0005225514,0.0002181278,0.00012002551,0.000023031385,0.00009085783,0.000042600022,0.00021329385],"category_scores_gemma":[0.00001287241,0.00012849143,0.00014265289,0.0001226606,0.00006725814,0.000041054984,0.000028598108,0.00004470968,0.00003440115],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003118672,0.00035133772,0.006261839,0.00007720058,0.0012370973,0.000045583132,0.0019362721,0.000003603805,0.42094132,0.0002673179,0.00084021426,0.56491953],"study_design_scores_gemma":[0.0064386567,0.00074110937,0.010481279,0.00018127264,0.0001720531,7.583506e-7,0.000032062308,0.0000125339375,0.954377,0.000026287335,0.027325502,0.00021150154],"about_ca_topic_score_codex":0.000008294647,"about_ca_topic_score_gemma":5.767048e-7,"teacher_disagreement_score":0.56470805,"about_ca_system_score_codex":0.000028323127,"about_ca_system_score_gemma":0.00004487767,"threshold_uncertainty_score":0.5239728},"labels":[],"label_agreement":null},{"id":"W2566999893","doi":"10.2147/dddt.s123386","title":"Folic acid-conjugated amphiphilic alternating copolymer as a new active tumor targeting drug delivery platform","year":2016,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Royal Military College of Canada","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Amphiphile; Drug delivery; Chemistry; Biophysics; Conjugated system; Cancer cell; Internalization; Targeted drug delivery; Copolymer; SMA*; Biochemistry; Combinatorial chemistry; Cell; Polymer; Cancer; Organic chemistry; Biology","score_opus":0.022327190536447543,"score_gpt":0.23421429898015578,"score_spread":0.21188710844370823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566999893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99444735,0.0020733841,0.0014398748,0.0007466031,0.00030853413,0.0005987943,0.0000070560272,0.00027609835,0.00010228695],"genre_scores_gemma":[0.9903334,0.00031526352,0.0068781716,0.0011930014,0.00018416755,0.000085009146,0.0000069977964,0.00006674333,0.00093727635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997116,0.00017571339,0.0006005376,0.00071306585,0.0005273516,0.0008673202],"domain_scores_gemma":[0.99838984,0.0004610263,0.000306015,0.0002725563,0.0001241717,0.00044637817],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010029468,0.00044669452,0.00040400864,0.0001906831,0.00043968557,0.0001865778,0.00041200416,0.00006393787,0.00075787044],"category_scores_gemma":[0.0001115984,0.00031868197,0.000067368506,0.00025155826,0.00014105228,0.0008469732,0.00012684331,0.00011982562,0.0006572027],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063143845,0.00006789887,0.00033650734,0.000007355046,0.00005829643,0.000043944106,0.0036378189,0.00000387327,0.91684294,0.00010536033,0.001392806,0.076871775],"study_design_scores_gemma":[0.0029206765,0.000058470032,0.0001221915,0.00013193114,0.0000111954105,0.000016040274,0.0002940134,0.000059602273,0.99076045,0.001307683,0.0037669484,0.0005508024],"about_ca_topic_score_codex":0.00029970251,"about_ca_topic_score_gemma":0.000015232096,"teacher_disagreement_score":0.076320976,"about_ca_system_score_codex":0.00019847348,"about_ca_system_score_gemma":0.00080578326,"threshold_uncertainty_score":0.9999265},"labels":[],"label_agreement":null},{"id":"W2579853360","doi":"10.2147/dddt.s118154","title":"Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Future Earth","funders":"","keywords":"Medicine; Tacrolimus; Hazard ratio; Confidence interval; Internal medicine; Proportional hazards model; Kidney transplant; Observational study; Single Center; Kidney transplantation; Kidney; Transplantation","score_opus":0.04780615045640875,"score_gpt":0.3191769288478833,"score_spread":0.27137077839147455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579853360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802107,0.00062223664,0.00043897165,0.00012845745,0.00004855639,0.0006327915,0.0000065698177,0.000005910481,0.000095461764],"genre_scores_gemma":[0.9947659,0.0019100235,0.0030708904,0.00004287714,0.0000069837884,0.000015117709,0.000019571326,0.000011325128,0.0001573501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991313,0.000042097163,0.00030084737,0.00017721999,0.00019957582,0.00014894853],"domain_scores_gemma":[0.9994615,0.00004284685,0.00019011403,0.00018670151,0.00003290423,0.000085964304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015163056,0.0001550959,0.00035180154,0.000059337526,0.00014730361,0.000018039897,0.00010384574,0.000037937352,0.000009032169],"category_scores_gemma":[0.000002726594,0.00008582971,0.00002827471,0.00006968745,0.00012809793,0.000051976476,0.0000090008425,0.00007582303,5.3002594e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031589686,0.00032232172,0.9655163,0.00011854098,0.0002017435,0.000022494785,0.0034466959,0.000004325196,0.0011117656,0.000014274785,0.000003832617,0.026078716],"study_design_scores_gemma":[0.009932318,0.00019083713,0.93167293,0.0010431912,0.00004855266,0.000023205863,0.000014369828,0.000013637755,0.05678883,0.0000044228905,0.00017298808,0.00009469343],"about_ca_topic_score_codex":0.000021914417,"about_ca_topic_score_gemma":0.000016351847,"teacher_disagreement_score":0.055677064,"about_ca_system_score_codex":0.000016314398,"about_ca_system_score_gemma":0.00011156905,"threshold_uncertainty_score":0.3500034},"labels":[],"label_agreement":null},{"id":"W2583669122","doi":"10.2147/dddt.s121518","title":"<em>Kelussia odoratissima</em> Mozaff. activates intrinsic pathway of apoptosis in breast cancer cells associated with S phase cell cycle arrest via involvement of p21/p27 in vitro and in vivo","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Plant chemical constituents analysis","field":"Agricultural and Biological Sciences","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Apoptosis; MCF-7; Cell cycle checkpoint; Programmed cell death; MTT assay; Cell cycle; In vivo; Chemistry; Cancer research; Cell growth; Annexin; Cytotoxicity; Cancer cell; Cancer; In vitro; Biology; Biochemistry","score_opus":0.01629617305963993,"score_gpt":0.2128400323415158,"score_spread":0.19654385928187587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583669122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990482,0.0003070788,0.000008072024,0.00015185152,0.000023795308,0.0003316736,0.00008548937,0.000009197691,0.000034689314],"genre_scores_gemma":[0.9987712,0.0008055448,0.0002589143,0.000042616266,0.000011991459,0.00004236209,0.000037937803,0.000002772713,0.000026670254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985196,0.00010768805,0.0004360392,0.00036599804,0.0002700675,0.0003006243],"domain_scores_gemma":[0.99922895,0.00016634952,0.0003725366,0.00008200817,0.0000586492,0.000091504386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044398443,0.00024652964,0.0004926272,0.00008206778,0.00011520641,0.00007223529,0.00025101192,0.00009897396,0.00006014507],"category_scores_gemma":[0.000011397417,0.00011579806,0.00003265152,0.00032707636,0.00012296543,0.00020889357,0.000068532296,0.00011917105,4.191575e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054174353,0.0005176225,0.02852556,0.000012939613,0.000055180437,0.0000067453448,0.0007747596,0.000011647199,0.9235999,0.0000018137065,0.000015981435,0.045936115],"study_design_scores_gemma":[0.0018786921,0.000034792516,0.06858897,0.00016509656,0.000009283594,3.2562323e-7,0.00015314277,0.0001457048,0.9286424,0.000045081117,0.00008397828,0.00025252975],"about_ca_topic_score_codex":0.00063426525,"about_ca_topic_score_gemma":0.003618806,"teacher_disagreement_score":0.045683585,"about_ca_system_score_codex":0.00007820453,"about_ca_system_score_gemma":0.000055242177,"threshold_uncertainty_score":0.47221076},"labels":[],"label_agreement":null},{"id":"W2593956993","doi":"10.2147/dddt.s97635","title":"Eteplirsen in the treatment of Duchenne muscular dystrophy","year":2017,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":488,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates; Muscular Dystrophy Canada; Children's Health Research Institute; Women and Children's Health Research Institute; Ministry of Advanced Education, Government of Alberta; Alberta Innovates - Health Solutions","keywords":"Exon skipping; Duchenne muscular dystrophy; Medicine; Muscular dystrophy; Dystrophin; Exon; Bioinformatics; Genetics; Internal medicine; Biology; Gene; Alternative splicing","score_opus":0.10158412888656976,"score_gpt":0.33786707257114035,"score_spread":0.2362829436845706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593956993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072169933,0.99175566,0.000059808222,0.000014325651,0.000059737602,0.00075504836,0.00000410161,0.0000030611811,0.00013126539],"genre_scores_gemma":[0.001544667,0.9973283,0.00040104458,0.0000276726,0.00006447884,0.00026389412,0.00016142873,0.000020617235,0.00018788932],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988574,0.000250263,0.00029540845,0.0003345294,0.000075769916,0.00018667382],"domain_scores_gemma":[0.9992665,0.000040913405,0.00020034605,0.00044481104,0.00001912606,0.000028301461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026962935,0.00030525375,0.0006252799,0.0000629925,0.000112116795,0.000018788192,0.00029528502,0.00019340558,0.0000063635075],"category_scores_gemma":[0.0000076275523,0.000178261,0.00017222753,0.000044568646,0.00010452927,0.0000023798214,0.0000207223,0.00006521788,0.0000035287892],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006636751,0.00018125492,0.000012882446,0.00023836485,0.00025429451,0.000004677636,0.00048485608,5.615465e-7,0.00008470761,0.000017256516,0.00011176991,0.998543],"study_design_scores_gemma":[0.00061400724,0.00022600676,0.00008218401,0.00019261627,0.000037845723,0.0000035819244,0.000030509527,3.018947e-7,0.00047024107,0.00005009731,0.99808437,0.00020824949],"about_ca_topic_score_codex":0.000011747221,"about_ca_topic_score_gemma":0.000006941424,"teacher_disagreement_score":0.99833477,"about_ca_system_score_codex":0.00001072152,"about_ca_system_score_gemma":0.00020173007,"threshold_uncertainty_score":0.7269273},"labels":[],"label_agreement":null},{"id":"W2606323667","doi":"10.2147/dddt.s117277","title":"Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension","year":2017,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Bayer Fund; Bayer","keywords":"Riociguat; Guanylate cyclase; Pulmonary hypertension; GUCY1A3; Medicine; GUCY2D; GUCY1B3; Chronic thromboembolic pulmonary hypertension; Internal medicine; Cardiology; Guanylate cyclase 2C; Receptor","score_opus":0.26077551548955813,"score_gpt":0.3896840185365592,"score_spread":0.12890850304700108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606323667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005393152,0.99359816,0.000109144254,0.00014104627,0.00019405452,0.0053001647,0.000025650546,0.0000334905,0.000058960188],"genre_scores_gemma":[0.00034524102,0.9887157,0.0021022125,0.000045860103,0.00010727113,0.0011108458,0.00022332513,0.000083711995,0.0072658276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99787676,0.000118118456,0.0005973915,0.0005577665,0.00037697403,0.00047298617],"domain_scores_gemma":[0.9977487,0.0007647957,0.00035251267,0.0007188803,0.00016869378,0.00024644582],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037558383,0.00061393774,0.001961497,0.00021274082,0.00059873925,0.000049153445,0.0002252403,0.00020990848,0.000031849475],"category_scores_gemma":[0.000032502245,0.00030223277,0.00049613573,0.000103086306,0.00015351221,0.00006616388,0.00004051735,0.0001324187,0.000024366624],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007043052,0.0014159572,0.00002284685,0.0010575632,0.001863847,0.00056066137,0.00010014959,2.4138157e-7,0.000016508468,0.0000028736897,0.00050719245,0.99374783],"study_design_scores_gemma":[0.003029739,0.00069976645,0.000082347586,0.002458267,0.0007834114,0.00027281852,0.000015646965,0.00024539264,0.0002332358,0.00003275289,0.9918524,0.0002942425],"about_ca_topic_score_codex":0.000024106781,"about_ca_topic_score_gemma":9.4639614e-7,"teacher_disagreement_score":0.9934536,"about_ca_system_score_codex":0.00011992182,"about_ca_system_score_gemma":0.0009580226,"threshold_uncertainty_score":0.99994296},"labels":[],"label_agreement":null},{"id":"W2606957323","doi":"10.2147/dddt.s131213","title":"Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"Dissolution; Dissolution testing; Materials science; Diffusion; Chemistry; Biochemical engineering; Computer science; Thermodynamics; Physics; Engineering","score_opus":0.3897675016050524,"score_gpt":0.4523156752787801,"score_spread":0.06254817367372767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606957323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99395657,0.0025445744,0.0024607093,0.00008598232,0.00033497738,0.00043042435,0.0000052804644,0.000012101777,0.00016935791],"genre_scores_gemma":[0.9960726,0.0005826256,0.003189984,0.00004342354,0.000033035365,0.000029283812,0.000010717562,0.000008988558,0.000029334127],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998815,0.00027848955,0.00039228794,0.00023738832,0.000088452085,0.0001883805],"domain_scores_gemma":[0.99934644,0.00020938706,0.00020402932,0.00012218642,0.000060979022,0.00005698951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00124763,0.00014657789,0.0002299298,0.00013857358,0.00025885305,0.000059709764,0.000121214674,0.00009852441,0.000007358887],"category_scores_gemma":[0.000043714816,0.00013799897,0.000013736163,0.00007985631,0.00011536776,0.0003250517,0.000034548313,0.00020216782,0.0000010442892],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012370967,0.00040254154,0.045640912,0.00015007853,0.000043077136,0.000008423342,0.017583633,0.0010859672,0.4110607,0.00023911548,0.000046657213,0.5225018],"study_design_scores_gemma":[0.004201346,0.000038660346,0.048632514,0.00025244974,0.000025750021,0.000010337311,0.0007261615,0.48312566,0.45638943,0.004258207,0.0017984358,0.00054102973],"about_ca_topic_score_codex":0.00009425568,"about_ca_topic_score_gemma":0.000031239088,"teacher_disagreement_score":0.5219608,"about_ca_system_score_codex":0.000043988002,"about_ca_system_score_gemma":0.0000958334,"threshold_uncertainty_score":0.5627435},"labels":[],"label_agreement":null},{"id":"W2616264501","doi":"10.2147/dddt.s130909","title":"Ten years of clinical experience with biosimilar human growth hormone: a review of safety data","year":2017,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children’s Health Research Institute","funders":"","keywords":"Biosimilar; Medicine; Adverse effect; Patient safety; Clinical trial; Safety profile; Pharmacology; Intensive care medicine; Internal medicine; Health care","score_opus":0.2994236157995498,"score_gpt":0.437390202776585,"score_spread":0.13796658697703523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616264501","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058261066,0.99695206,0.00008965881,0.000042043153,0.000074477015,0.0018580132,0.000040726944,0.000026466592,0.00033392195],"genre_scores_gemma":[0.00021129187,0.9942087,0.004488132,0.00018124277,0.000082694794,0.00007022887,0.00049535156,0.0000703816,0.00019200605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958121,0.0002917583,0.0022131365,0.00077484,0.0005919248,0.00031624822],"domain_scores_gemma":[0.9961155,0.00026404965,0.0016240777,0.0015585806,0.00021456342,0.00022323718],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022865285,0.0005385101,0.0038325686,0.00021158531,0.00013228196,0.0000196913,0.0009586753,0.00027678983,0.000032548796],"category_scores_gemma":[0.00021342863,0.0003573729,0.00025740147,0.0002748267,0.00042347037,0.00018447533,0.0002292464,0.0004338545,0.000006164787],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020450032,0.00020477685,0.0005992262,0.02029443,0.0007672707,0.000042178464,0.00044445143,7.846186e-10,0.0000044379626,0.000017729288,0.0028546385,0.97456634],"study_design_scores_gemma":[0.0014367069,0.0003740898,0.0031868373,0.06176889,0.00051780225,0.00003150443,0.00002196105,3.0718908e-7,0.00007832434,0.000005942468,0.93214405,0.0004336146],"about_ca_topic_score_codex":0.000014721408,"about_ca_topic_score_gemma":5.875869e-7,"teacher_disagreement_score":0.9741327,"about_ca_system_score_codex":0.000026989139,"about_ca_system_score_gemma":0.0012046613,"threshold_uncertainty_score":0.9998878},"labels":[],"label_agreement":null},{"id":"W2721615787","doi":"10.2147/dddt.s102500","title":"Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Bioavailability; Solid lipid nanoparticle; Pharmacokinetics; Pharmacology; Nasal administration; Drug delivery; In vivo; Chemistry; First pass effect; Zeta potential; Agomelatine; Chromatography; Drug; Nanoparticle; Materials science; Medicine; Nanotechnology; Antidepressant; Internal medicine; Organic chemistry","score_opus":0.07019639001687886,"score_gpt":0.4005162602364778,"score_spread":0.33031987021959897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2721615787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9522374,0.000843804,0.043344613,0.002220308,0.00032462305,0.0008215963,0.0000084635485,0.00004836693,0.00015079921],"genre_scores_gemma":[0.97135407,0.003824066,0.022031788,0.00211721,0.00008809307,0.00008968424,0.000008869452,0.000028392358,0.00045783725],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851656,0.00018663584,0.0003956399,0.0003665477,0.00014847926,0.00038614596],"domain_scores_gemma":[0.99921733,0.00023486972,0.00013790105,0.00015879843,0.00007026305,0.00018080865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007072354,0.0002497183,0.00023959519,0.00013874583,0.00058297813,0.00007887814,0.00022139538,0.000110701185,0.0002584461],"category_scores_gemma":[0.000034437908,0.00024968295,0.000017775916,0.00009113731,0.00011798464,0.00035865707,0.00007231608,0.00022759565,0.000008914158],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028738985,0.00042698495,0.016975457,0.00006086544,0.00027122203,0.000043976408,0.012604703,0.09862194,0.40415215,0.00015667823,0.0021799973,0.46163213],"study_design_scores_gemma":[0.0030018294,0.00007226455,0.0027788563,0.000039267856,0.000018970952,0.0000040785344,0.0000705672,0.043736078,0.90000486,0.00016298091,0.04967356,0.00043670367],"about_ca_topic_score_codex":0.0000068651607,"about_ca_topic_score_gemma":0.000022498292,"teacher_disagreement_score":0.49585268,"about_ca_system_score_codex":0.00004393012,"about_ca_system_score_gemma":0.000060988397,"threshold_uncertainty_score":0.9999955},"labels":[],"label_agreement":null},{"id":"W2741339609","doi":"10.2147/dddt.s137934","title":"Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(D,L-lactic-co-glycolic acid) cylinders disables human pancreatic cancer cell survival","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Glycolic acid; Gemcitabine; PLGA; Lactic acid; Pancreatic cancer; Pharmacology; Chemistry; Medicine; Cancer; Biology; Internal medicine; Biochemistry; Bacteria","score_opus":0.05728142097212312,"score_gpt":0.332939632993578,"score_spread":0.27565821202145485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741339609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98161346,0.016029457,0.00012654385,0.00010849343,0.00017826185,0.0005759242,0.000023595596,0.000021178268,0.0013230928],"genre_scores_gemma":[0.9819851,0.015930647,0.0012241063,0.000056374993,0.00011951244,0.00006514016,0.000042751068,0.000028378256,0.00054797984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847144,0.00013423628,0.00034514916,0.00036721106,0.00030344265,0.00037850594],"domain_scores_gemma":[0.99897754,0.00025611883,0.00021454328,0.00025909505,0.00007976662,0.0002129332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057322235,0.00026097978,0.0007474043,0.000064841675,0.00062632764,0.00009304595,0.00013521015,0.00013161411,0.00014818223],"category_scores_gemma":[0.00002090307,0.00021208331,0.000032451422,0.000037266618,0.00040255825,0.00020824197,0.00007793691,0.00015967657,0.000002623147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039846166,0.0003970463,0.8921764,0.00020199154,0.0011232235,0.000055574783,0.005510918,8.522163e-8,0.06259122,0.00030157247,0.0003618163,0.033295553],"study_design_scores_gemma":[0.024103954,0.000567975,0.59198457,0.0002897185,0.0004225197,0.000020487458,0.0011605507,0.00020004401,0.3770553,0.0017882792,0.0018043743,0.0006022086],"about_ca_topic_score_codex":0.0042757974,"about_ca_topic_score_gemma":0.00022698016,"teacher_disagreement_score":0.31446406,"about_ca_system_score_codex":0.00007161768,"about_ca_system_score_gemma":0.0003771456,"threshold_uncertainty_score":0.86485064},"labels":[],"label_agreement":null},{"id":"W2741826338","doi":"10.2147/dddt.s136240","title":"Antibiotic susceptibility, heteroresistance, and updated treatment strategies in <em>Helicobacter pylori</em> infection","year":2017,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metronidazole; Clarithromycin; Helicobacter pylori; Amoxicillin; Antibiotics; Antibiotic resistance; Medicine; Drug resistance; Tetracycline; Internal medicine; Microbiology; Biology","score_opus":0.06558470192644412,"score_gpt":0.3174042359082693,"score_spread":0.2518195339818252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741826338","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24818471,0.7483077,0.000059100574,0.00010469518,0.00038534295,0.0026250535,0.00001685282,0.00014011454,0.0001764396],"genre_scores_gemma":[0.020394789,0.9768389,0.0008561653,0.00008755717,0.00014526934,0.00021637788,0.000352609,0.000114872375,0.0009934903],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995828,0.0005147362,0.0012442118,0.0012315676,0.0003463128,0.0008351943],"domain_scores_gemma":[0.9981344,0.00015018643,0.0005947872,0.00070591975,0.00016864315,0.00024611576],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084485183,0.0012336104,0.0029284428,0.0007124796,0.00039290613,0.00030266197,0.00020214274,0.0005847767,0.00003458289],"category_scores_gemma":[0.000033217646,0.00090426824,0.00023240245,0.0003254044,0.00031850775,0.00032536697,0.00012182889,0.00054030254,0.000042448217],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005561646,0.0005310542,0.017820688,0.0019298681,0.002743668,0.00019847267,0.0027496584,2.98817e-7,0.00008702174,0.000021337006,0.00033463954,0.9730271],"study_design_scores_gemma":[0.005396984,0.00097240205,0.06651246,0.0058895443,0.00073644804,0.0001469929,0.000102192105,0.0000038062772,0.00013983082,0.0000545557,0.91911155,0.00093325396],"about_ca_topic_score_codex":0.00003322308,"about_ca_topic_score_gemma":0.0010231874,"teacher_disagreement_score":0.9720939,"about_ca_system_score_codex":0.00052075845,"about_ca_system_score_gemma":0.0005687801,"threshold_uncertainty_score":0.9993408},"labels":[],"label_agreement":null},{"id":"W2743191900","doi":"10.2147/dddt.s133944","title":"Modeling the human Na<sub>v</sub>1.5 sodium channel: structural and mechanistic insights of ion permeation and drug blockade","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Ion channel regulation and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; University of Toronto; Western Canada Research Grid","keywords":"Molecular dynamics; Sodium channel; Chemistry; Permeation; Ion channel; Lipid bilayer; Homology modeling; Biophysics; Ion; Membrane; Sodium; Computational chemistry; Biochemistry; Biology; Receptor","score_opus":0.023354775554868402,"score_gpt":0.23845133398224572,"score_spread":0.21509655842737732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743191900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856161,0.0015128681,0.012119074,0.00015421209,0.0002211178,0.00032026522,0.0000017344746,0.000012388984,0.000042226424],"genre_scores_gemma":[0.9979959,0.0011309934,0.000297056,0.000056669443,0.00019716879,0.000024254108,0.000057991492,0.000019064406,0.00022088553],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999088,0.00007460556,0.00022237987,0.00030553897,0.0001540827,0.00015538794],"domain_scores_gemma":[0.9994892,0.000013012089,0.00014287017,0.00019235871,0.00010363178,0.00005895877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029811528,0.00019231364,0.00015426704,0.00006003545,0.0008621998,0.000101723694,0.000109306035,0.00009986861,0.0000030887763],"category_scores_gemma":[0.00001527952,0.00014084508,0.000027496353,0.000028117987,0.00010188269,0.000020911071,0.00006446922,0.00006199599,5.146279e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017295333,0.000017264001,0.00011406989,0.000021214099,0.00006879517,7.2145036e-7,0.0028326372,0.00019052126,0.98468626,0.00055535085,0.00006076664,0.011279426],"study_design_scores_gemma":[0.0013868805,0.000087478096,0.002433011,0.000035646604,0.000017187358,0.000010392964,0.0002188175,0.042840287,0.9493572,0.0023975524,0.00091563124,0.000299925],"about_ca_topic_score_codex":0.0000066576645,"about_ca_topic_score_gemma":0.000018355786,"teacher_disagreement_score":0.042649765,"about_ca_system_score_codex":0.000010117843,"about_ca_system_score_gemma":0.00004044559,"threshold_uncertainty_score":0.6631431},"labels":[],"label_agreement":null},{"id":"W2752934452","doi":"10.2147/dddt.s133943","title":"Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations","year":2017,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Nausea and vomiting management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System","funders":"","keywords":"Aprepitant; NK1 receptor antagonist; Chemotherapy-induced nausea and vomiting; Medicine; CYP3A4; Pharmacology; Internal medicine; Oncology; Vomiting; Substance P; Cytochrome P450; Receptor; Antiemetic","score_opus":0.5975365174808033,"score_gpt":0.5173394257454302,"score_spread":0.08019709173537304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752934452","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018134252,0.9948154,0.000038542574,0.0002189192,0.0004318188,0.0021363567,0.0000017004857,0.000012363283,0.0005314364],"genre_scores_gemma":[0.00070120423,0.9948726,0.0035264515,0.000164534,0.00012854172,0.00020194244,0.00007742367,0.000029853634,0.00029739278],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99679005,0.000695409,0.0014711145,0.00043802898,0.00029683165,0.00030859353],"domain_scores_gemma":[0.9985725,0.00040496036,0.000571243,0.00033065013,0.000055169494,0.00006546197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032750063,0.00035151537,0.0016003276,0.00055654865,0.00011982665,0.000037093367,0.00036864102,0.00017346957,0.000055497658],"category_scores_gemma":[0.000046460813,0.00022414493,0.00014762346,0.0003600618,0.00009283521,0.000050455208,0.000063171916,0.00043275184,0.000014831384],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097695236,0.0003371659,0.0037658268,0.00056205253,0.00027347208,0.00008103173,0.0007061703,1.918086e-7,5.986199e-7,0.000054749205,0.001523288,0.99259776],"study_design_scores_gemma":[0.0017746142,0.000040642266,0.012632252,0.0021739642,0.0001355657,0.000010559685,0.000055979322,0.0000014427097,0.00001186452,0.000043119762,0.98289424,0.00022574185],"about_ca_topic_score_codex":0.000007064929,"about_ca_topic_score_gemma":0.000017832783,"teacher_disagreement_score":0.99237204,"about_ca_system_score_codex":0.000110857625,"about_ca_system_score_gemma":0.0005742627,"threshold_uncertainty_score":0.91403645},"labels":[],"label_agreement":null},{"id":"W2770164160","doi":"10.2147/dddt.s149214","title":"In silico-based identification of human α-enolase inhibitors to block cancer cell growth metabolically","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Chang Gung Medical Foundation; National Science Council","keywords":"Cancer cell; Enolase; In silico; Glycolysis; Cancer; Cancer research; Biochemistry; Chemistry; Biology; Docking (animal); Pharmacology; Metabolism; Medicine; Immunology; Genetics","score_opus":0.02402148462264244,"score_gpt":0.2862611366473175,"score_spread":0.2622396520246751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770164160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329627,0.0050450107,0.00048416195,0.00024187111,0.0004549545,0.0003837061,0.000008470905,0.0000064396936,0.000079131816],"genre_scores_gemma":[0.9942894,0.0021765057,0.0012007933,0.00034410786,0.00035228903,0.00014136976,0.000024484467,0.000022701142,0.0014483391],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989229,0.00005632393,0.0003299903,0.0003410282,0.00014560427,0.00020414656],"domain_scores_gemma":[0.99927115,0.0000088458355,0.00018736366,0.00033215352,0.000104567385,0.0000958948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039887594,0.00017146733,0.00021106914,0.000074020645,0.00018406221,0.000053605276,0.00024280451,0.00008409928,0.000016928425],"category_scores_gemma":[0.000018298055,0.00016205641,0.000045344117,0.000056428442,0.000059131446,0.000013482341,0.000044858163,0.000051796993,0.0000034415893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001471099,0.000107897955,0.001344009,0.000015890384,0.000028467359,3.2582454e-7,0.0007289514,0.000010096043,0.98633343,0.0000135777655,0.0022843312,0.008985942],"study_design_scores_gemma":[0.0011254154,0.000026531856,0.015040574,0.000012765154,0.000007910993,2.9642408e-7,0.00001912779,0.000002682263,0.8783277,0.000039294537,0.10520568,0.00019197515],"about_ca_topic_score_codex":0.00041154542,"about_ca_topic_score_gemma":0.00064311724,"teacher_disagreement_score":0.10800565,"about_ca_system_score_codex":0.00001736148,"about_ca_system_score_gemma":0.00019457996,"threshold_uncertainty_score":0.6608469},"labels":[],"label_agreement":null},{"id":"W2772982640","doi":"10.2147/dddt.s142580","title":"EUREKA study – the evaluation of real-life use of a biophotonic system in chronic wound management: an interim analysis","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Laser Applications in Dentistry and Medicine","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Klox Technologies (Canada)","funders":"","keywords":"Medicine; Context (archaeology); Quality of life (healthcare); Venous leg ulcer; Wound healing; Interim analysis; Prospective cohort study; Adverse effect; Internal medicine; Surgery; Clinical trial; Nursing","score_opus":0.17963371830400557,"score_gpt":0.39320295221716556,"score_spread":0.21356923391316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772982640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567926,0.00047556547,0.0015549738,0.000057618458,0.000050905193,0.0019921875,0.0000017557026,0.000013501114,0.00017422214],"genre_scores_gemma":[0.99750376,0.00072301686,0.0010743821,0.00002012746,0.00002163243,0.00027442077,0.000028381115,0.000010445859,0.00034381886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984574,0.00021758104,0.0004677506,0.0002604216,0.0004683453,0.00012855575],"domain_scores_gemma":[0.99859226,0.000055915698,0.00031601565,0.0008102028,0.00016620084,0.000059413363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00263684,0.00013525956,0.00036544283,0.00025154595,0.00016256206,0.000037917565,0.00022288857,0.00003783229,0.000035358105],"category_scores_gemma":[0.00002705219,0.00008958635,0.00004111107,0.00032479243,0.00011450708,0.000112825466,0.000048470334,0.00007917744,0.0000019442905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033912985,0.004190116,0.6273185,0.001128838,0.013476355,0.000060708244,0.049369816,0.0006466764,0.02100899,0.0011950516,0.0003031584,0.27791053],"study_design_scores_gemma":[0.0058832094,0.00022063173,0.9767949,0.00024672007,0.0012886333,0.000004862451,0.0029003504,0.003358048,0.007742563,0.000029774243,0.0013781395,0.00015215122],"about_ca_topic_score_codex":0.00019468585,"about_ca_topic_score_gemma":0.00021481774,"teacher_disagreement_score":0.34947646,"about_ca_system_score_codex":0.00015252653,"about_ca_system_score_gemma":0.0002301862,"threshold_uncertainty_score":0.36532253},"labels":[],"label_agreement":null},{"id":"W2780401732","doi":"10.2147/dddt.s144602","title":"Intra-articular collagenase injection increases range of motion in a rat knee flexion contracture model","year":2017,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Dupuytren's Contracture and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Canadian Institutes of Health Research; University of Ottawa","keywords":"Collagenase; Contracture; Capsule; Range of motion; Muscle contracture; Microbial collagenase; Medicine; Knee Joint; Joint capsule; Chemistry; Extracellular matrix; Anatomy; Pathology; Surgery; Biology; Enzyme; Biochemistry","score_opus":0.027909627960670442,"score_gpt":0.26865058979467915,"score_spread":0.2407409618340087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2780401732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297804,0.0014168319,0.004244125,0.0002478599,0.000070365706,0.0008493523,0.0000020099446,0.000026584994,0.00016482365],"genre_scores_gemma":[0.9963813,0.0004767005,0.0024335308,0.00020978913,0.000030409723,0.00007186336,0.000025110045,0.00001724687,0.00035406873],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999047,0.00006267373,0.00027826783,0.00023245561,0.00019271894,0.00018689198],"domain_scores_gemma":[0.99938095,0.00005084323,0.00016754639,0.00023322846,0.00007496763,0.000092465205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003139152,0.00019712716,0.0003450506,0.00014084576,0.000167706,0.000045751927,0.000056589368,0.00010137904,0.00002151319],"category_scores_gemma":[0.000044792305,0.00014702119,0.000045687608,0.00005852221,0.000053048483,0.00020728292,0.000013115876,0.00009287057,0.0000036109734],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019027032,0.0034262359,0.22948907,0.00018825966,0.001090611,0.00044040824,0.014499904,0.0005997794,0.03726431,0.00029563613,0.0007110831,0.69296765],"study_design_scores_gemma":[0.032948736,0.0006628179,0.3950046,0.0005097615,0.0002024255,0.00007584454,0.00026329176,0.00663811,0.5594919,0.0021436482,0.0014277905,0.0006311243],"about_ca_topic_score_codex":0.000091675436,"about_ca_topic_score_gemma":0.00005185087,"teacher_disagreement_score":0.69233656,"about_ca_system_score_codex":0.000060049137,"about_ca_system_score_gemma":0.00014063295,"threshold_uncertainty_score":0.599535},"labels":[],"label_agreement":null},{"id":"W2790600717","doi":"10.2147/dddt.s156724","title":"Intra-articular platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Periodontal Regeneration and Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"WOMAC; Osteoarthritis; Medicine; Platelet-rich plasma; Hyaluronic acid; Cochrane Library; Confidence interval; Meta-analysis; Randomized controlled trial; Internal medicine; Visual analogue scale; Physical therapy; Platelet; Pathology","score_opus":0.14823570821055748,"score_gpt":0.33608691061642887,"score_spread":0.1878512024058714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790600717","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013514944,0.98428494,0.0000338411,0.00003839973,0.00008932561,0.0019227774,0.000011461904,0.000017485754,0.000086830565],"genre_scores_gemma":[0.003699802,0.99264467,0.0014093745,0.00004513823,0.000039092774,0.0011667779,0.00026969443,0.000033042852,0.0006924388],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977386,0.0003916255,0.00073525513,0.0004679374,0.00037696067,0.0002896408],"domain_scores_gemma":[0.9990083,0.00019233975,0.00025155226,0.00040163065,0.000052783085,0.00009336752],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003772253,0.00054428255,0.0025752992,0.00039836913,0.000107147294,0.000049469098,0.00011944261,0.00016119916,0.000196626],"category_scores_gemma":[0.000009202394,0.0002803172,0.00088474574,0.00070029555,0.00008418882,0.000046586512,0.00001133727,0.00010326274,0.000038365768],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003175808,0.0006191517,0.000012127366,0.00018366033,0.10831582,0.0001242917,0.0031870056,7.590964e-7,0.0000029554355,0.000014406344,0.00004363837,0.8871786],"study_design_scores_gemma":[0.0067076376,0.0022809466,0.00003437412,0.00018886662,0.08640504,0.000047401387,0.000108917986,0.000005993085,0.0023785809,0.0000051964357,0.901459,0.00037807],"about_ca_topic_score_codex":0.000011811457,"about_ca_topic_score_gemma":0.0000869535,"teacher_disagreement_score":0.90141535,"about_ca_system_score_codex":0.00017688317,"about_ca_system_score_gemma":0.0003996769,"threshold_uncertainty_score":0.9999649},"labels":[],"label_agreement":null},{"id":"W2794378246","doi":"10.2147/dddt.s130809","title":"Rucaparib: a novel PARP inhibitor for <em>BRCA</em> advanced ovarian cancer","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"PARP inhibitor; Ovarian cancer; Cancer research; Medicine; Poly ADP ribose polymerase; Chemistry; Pharmacology; Cancer; Internal medicine; Biochemistry; DNA; Polymerase","score_opus":0.11202327551983936,"score_gpt":0.3535853993551428,"score_spread":0.24156212383530345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794378246","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008782032,0.9626936,0.024622101,0.0004677256,0.0026006084,0.007617833,0.00028534114,0.0004405814,0.00039402893],"genre_scores_gemma":[0.00006040504,0.8894089,0.08951828,0.0014182942,0.0024152633,0.0064317994,0.0011373454,0.0005048276,0.009104894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921333,0.00035409958,0.002456389,0.0021646146,0.0012799435,0.0016116176],"domain_scores_gemma":[0.99505997,0.0006953867,0.0014210969,0.0013117081,0.0007529686,0.0007588478],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0021064938,0.0020701354,0.004070671,0.00086199515,0.0007184327,0.0002935382,0.0006953277,0.0010195978,0.0008414518],"category_scores_gemma":[0.00011600411,0.0017190531,0.00082136126,0.0010884487,0.00034974414,0.00033624857,0.00013378829,0.00086911966,0.00027465844],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015037991,0.00054567185,0.000015994017,0.004501616,0.0023039426,0.00001482532,0.005527198,0.0000022595484,0.0014276908,0.00025359372,0.03922874,0.9446747],"study_design_scores_gemma":[0.00966324,0.00023772941,0.000023386248,0.014150593,0.0005056446,0.00011229264,0.00006424277,0.000006321678,0.0016521373,0.00036346764,0.9712301,0.0019908291],"about_ca_topic_score_codex":0.00001502683,"about_ca_topic_score_gemma":0.00013815219,"teacher_disagreement_score":0.9426838,"about_ca_system_score_codex":0.0012138358,"about_ca_system_score_gemma":0.003912806,"threshold_uncertainty_score":0.99920404},"labels":[],"label_agreement":null},{"id":"W2800001750","doi":"10.2147/dddt.s163476","title":"Identification of novel drug targets in bovine respiratory disease: an essential step in applying biotechnologic techniques to develop more effective therapeutic treatments","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Microbial infections and disease research","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Mitacs; King Saud University","keywords":"Bovine respiratory disease; Druggability; Drug resistance; Antimicrobial; Medicine; Antibiotic resistance; Disease; Drug; Biology; Biotechnology; Antibiotics; Pharmacology; Microbiology; Immunology; Gene; Internal medicine; Genetics","score_opus":0.026797771367215267,"score_gpt":0.30955541747535614,"score_spread":0.28275764610814086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800001750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98019016,0.0033104564,0.014097534,0.0000961976,0.00007803957,0.0021242087,0.000013322182,0.00007875597,0.000011325956],"genre_scores_gemma":[0.9970866,0.00024401394,0.0015430067,0.000114658265,0.0000145839485,0.00080850074,0.000045628447,0.00002034011,0.00012267554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984571,0.0002767571,0.00042828848,0.00044454166,0.000065318,0.00032799988],"domain_scores_gemma":[0.99938047,0.00007687413,0.000104732964,0.00022637175,0.00016256039,0.000049000028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082608795,0.00022011893,0.0002648501,0.00067932316,0.00019668325,0.00002630555,0.00018343015,0.00013555797,0.00003902161],"category_scores_gemma":[0.000037549136,0.00018782952,0.00002470499,0.0007585008,0.00021739287,0.00013888557,0.000067858964,0.00015029467,0.000018513012],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089613855,0.0007784022,0.0060585444,0.000017778206,0.00008634624,0.000003837165,0.0015966279,0.0000019736542,0.83452225,0.00010351569,0.00006745881,0.15586714],"study_design_scores_gemma":[0.0016187623,0.00015674025,0.046257343,0.000071521004,0.000008182335,0.0000016055909,0.00023960871,0.000020197449,0.9481344,0.00010182773,0.0031541118,0.00023566691],"about_ca_topic_score_codex":0.00009294146,"about_ca_topic_score_gemma":0.00007263626,"teacher_disagreement_score":0.15563147,"about_ca_system_score_codex":0.00011966612,"about_ca_system_score_gemma":0.00023094888,"threshold_uncertainty_score":0.76594657},"labels":[],"label_agreement":null},{"id":"W2807347319","doi":"10.2147/dddt.s166893","title":"Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Medicine; Hydroxychloroquine; Relative risk; Internal medicine; Meta-analysis; Odds ratio; Hazard ratio; Confidence interval; Randomized controlled trial; Chloroquine; Disease; Immunology; Malaria","score_opus":0.10031656046798645,"score_gpt":0.2998698002566381,"score_spread":0.19955323978865167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807347319","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038364853,0.9918306,0.00026537364,0.000083816434,0.000022619419,0.0072338744,0.000033192937,0.00010519407,0.00004169398],"genre_scores_gemma":[0.00025536554,0.99503404,0.0016791422,0.00028425426,0.000037366386,0.0011761523,0.0001893071,0.00014135579,0.0012030422],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9942099,0.0015950279,0.0014717685,0.0013199646,0.000880006,0.0005233564],"domain_scores_gemma":[0.99637914,0.00038896312,0.001434361,0.0011007672,0.00031052166,0.00038627916],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0052017793,0.0012531532,0.014869517,0.0005742229,0.0002872284,0.000115805866,0.00022445449,0.00035040983,0.000043819917],"category_scores_gemma":[0.0003425292,0.00072261534,0.0017544342,0.0013773764,0.00019487487,0.00011345505,0.0000968692,0.00051618455,0.000011772836],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024007331,0.00011651529,0.000011626581,0.2637983,0.7228257,0.0001068446,0.00038411302,2.136383e-7,4.790113e-7,0.0000012729785,0.00010289169,0.01262805],"study_design_scores_gemma":[0.0010653916,0.000107447384,0.000045998688,0.05337126,0.91000783,0.00017187497,0.00002416433,0.000005740313,0.00003709706,0.0000058735886,0.03421281,0.000944495],"about_ca_topic_score_codex":0.000014664084,"about_ca_topic_score_gemma":0.00001242687,"teacher_disagreement_score":0.21042705,"about_ca_system_score_codex":0.00016019345,"about_ca_system_score_gemma":0.0003336255,"threshold_uncertainty_score":0.9997558},"labels":[],"label_agreement":null},{"id":"W2886448521","doi":"10.2147/dddt.s171269","title":"Preclinical safety evaluation of hepatic arterial infusion of oncolytic poxvirus","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"National Research Foundation of Korea; Ministry of Science, ICT and Future Planning; National Research Foundation","keywords":"Oncolytic virus; Medicine; Cirrhosis; Vaccinia; Hepatocellular carcinoma; Liver cancer; Cancer; Pathology; Internal medicine; Biology; Gene","score_opus":0.07173052238067792,"score_gpt":0.35809555017354733,"score_spread":0.28636502779286943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886448521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712455,0.0008926919,0.001092109,0.000035615773,0.00009994293,0.0005414032,0.0000026542748,0.00000478653,0.00020621879],"genre_scores_gemma":[0.9967496,0.0008321001,0.0020665629,0.000060494527,0.00012289188,0.000031791937,0.000030344014,0.0000149711095,0.0000912711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984584,0.00038533434,0.00038571662,0.0002330205,0.00038200535,0.00015553916],"domain_scores_gemma":[0.99922645,0.000049166887,0.00013526563,0.00021922623,0.0003174354,0.000052456646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023008897,0.00012136689,0.00018068549,0.000062054314,0.00006960232,0.000007953699,0.00013629277,0.00009093726,0.00013093771],"category_scores_gemma":[0.00006823221,0.00010383645,0.00003815705,0.000091514754,0.00016492933,0.0000045289153,0.00004595797,0.00004413848,0.0000055931355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073090848,0.00012121221,0.000715022,0.00000890569,0.00009454799,1.58851e-7,0.0006171419,0.000008877771,0.7568615,0.0000037916031,0.000108497254,0.23415126],"study_design_scores_gemma":[0.002785488,0.001863885,0.004219547,0.000024488334,0.0000114903005,9.209168e-7,0.000026662105,0.00038271816,0.9880927,0.00017005416,0.002297303,0.00012469711],"about_ca_topic_score_codex":0.0000057422926,"about_ca_topic_score_gemma":0.000029511353,"teacher_disagreement_score":0.23402657,"about_ca_system_score_codex":0.000018524644,"about_ca_system_score_gemma":0.0005097291,"threshold_uncertainty_score":0.42343277},"labels":[],"label_agreement":null},{"id":"W2886610362","doi":"10.2147/dddt.s147276","title":"Current research for a vaccine against Lassa hemorrhagic fever virus","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Manitoba","funders":"","keywords":"Lassa virus; Lassa fever; Arenavirus; Case fatality rate; Virology; Viral hemorrhagic fever; Medicine; Outbreak; Transmission (telecommunications); Immunology; Clinical trial; Ebola virus; Immune system; Virus; Environmental health; Population","score_opus":0.31617845031761993,"score_gpt":0.47198514887017323,"score_spread":0.1558066985525533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886610362","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022150266,0.99339646,0.00128977,0.0001053289,0.00031223515,0.0042916294,0.000014793589,0.00007088181,0.00029741853],"genre_scores_gemma":[0.000019856978,0.98959124,0.0029293187,0.0000783835,0.00066977344,0.0014762045,0.00024944663,0.00010780166,0.004877971],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681026,0.00041047035,0.0006680164,0.0007330004,0.00059689407,0.00078136794],"domain_scores_gemma":[0.9981462,0.0005220013,0.00013411394,0.0003674076,0.0005279352,0.00030235972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030395507,0.0005079415,0.0013595867,0.00084520783,0.0005533208,0.0001345389,0.000218573,0.00025292224,0.00014576],"category_scores_gemma":[0.000076718774,0.00034162894,0.00028374064,0.0007642249,0.000104792205,0.0000772136,0.000114298455,0.00075848436,0.00026249717],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014914054,0.00022841146,0.000008379985,0.0037974764,0.00029153295,0.000014445159,0.000194369,2.0288239e-8,0.000013702566,0.000019550678,0.0318318,0.96345115],"study_design_scores_gemma":[0.0015735242,0.00022337727,0.000012085863,0.0046715993,0.00007221473,0.000034671804,0.000014812458,0.000024788755,0.00045589768,0.000069497466,0.9924711,0.00037642822],"about_ca_topic_score_codex":0.00000888549,"about_ca_topic_score_gemma":0.0000062073636,"teacher_disagreement_score":0.96307474,"about_ca_system_score_codex":0.00028185442,"about_ca_system_score_gemma":0.0015250995,"threshold_uncertainty_score":0.99990356},"labels":[],"label_agreement":null},{"id":"W2890299984","doi":"10.2147/dddt.s172068","title":"Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptoms","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nimesulide; Medicine; Esomeprazole; Nausea; Pantoprazole; Internal medicine; Adverse effect; Visual analogue scale; Gastroenterology; Anesthesia","score_opus":0.010983453292885966,"score_gpt":0.23002410831797548,"score_spread":0.21904065502508951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890299984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565566,0.00025993623,0.0023616813,0.0001777738,0.000010681881,0.0015090101,0.000005068821,0.0000115087905,0.000008703881],"genre_scores_gemma":[0.9930372,0.000022507755,0.006723417,0.00011831058,0.0000046360765,0.000038384078,0.000028528957,0.000010841145,0.000016171916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999135,0.000066142115,0.00028497147,0.00020827023,0.00015361085,0.00015199704],"domain_scores_gemma":[0.9993532,0.00021017235,0.0000861406,0.00009787671,0.00014732569,0.00010528856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037055206,0.0001308246,0.00028420892,0.000114657894,0.000057461137,0.000009547462,0.00003401598,0.000023640814,0.000004113891],"category_scores_gemma":[0.00011283339,0.00010361669,0.000012937838,0.0001414918,0.00013427017,0.000057052075,0.0000177131,0.000035034347,3.4329662e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016820535,0.0011421174,0.91871387,0.00021134604,0.000085939246,0.0000013573147,0.00580891,0.000008658282,0.0014624519,0.000053824388,0.00006065569,0.055630337],"study_design_scores_gemma":[0.016797626,0.0024731078,0.9756848,0.00040195687,0.000026413765,0.0000011303299,0.00026774098,0.0003072201,0.003661756,0.00011158791,0.00015358752,0.00011302557],"about_ca_topic_score_codex":0.000009532346,"about_ca_topic_score_gemma":0.000005914013,"teacher_disagreement_score":0.05697098,"about_ca_system_score_codex":0.000016148413,"about_ca_system_score_gemma":0.00006186493,"threshold_uncertainty_score":0.42253658},"labels":[],"label_agreement":null},{"id":"W2890671849","doi":"10.2147/dddt.s168878","title":"Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Biochemical Acid Research Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Guangzhou University; National Natural Science Foundation of China","keywords":"Peripheral neuropathy; Medicine; Peripheral; Diabetic neuropathy; Lipoic acid; Alpha-Lipoic Acid; Diabetes mellitus; Pharmacology; Surgery; Internal medicine; Endocrinology; Chemistry; Biochemistry","score_opus":0.029194135093338743,"score_gpt":0.2734795362707481,"score_spread":0.24428540117740938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890671849","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015401399,0.97833467,0.0031326818,0.000025415353,0.00007173726,0.0029707912,0.000022226894,0.000027208262,0.000013864253],"genre_scores_gemma":[0.0038685626,0.9879288,0.00556621,0.00011015605,0.0001265658,0.001348362,0.00062976254,0.0001173462,0.0003042038],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979449,0.00019892753,0.00033393083,0.00073928037,0.00028027684,0.00050266937],"domain_scores_gemma":[0.99907434,0.00006227489,0.00019787591,0.00029874156,0.00023538542,0.00013135404],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026000768,0.00060809363,0.00074990623,0.00008049783,0.00024901822,0.00008229939,0.0002806315,0.00019279175,0.0000055773476],"category_scores_gemma":[0.000018598443,0.00036062615,0.00011032307,0.00015760981,0.00027600426,0.000007469792,0.00008837182,0.0001597034,0.000003953686],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027296075,0.00042407695,0.00030234444,0.0019014453,0.0014697163,0.0000038302874,0.00028393455,1.8900633e-7,0.0005282579,0.000007434602,0.00044559856,0.99190354],"study_design_scores_gemma":[0.003642283,0.0050220024,0.00021772143,0.0012570156,0.00015790312,0.000005559678,0.000016553759,0.000004824203,0.0073815007,0.00003217788,0.9812755,0.0009869493],"about_ca_topic_score_codex":5.659621e-7,"about_ca_topic_score_gemma":0.0000020597765,"teacher_disagreement_score":0.9909166,"about_ca_system_score_codex":0.00003532247,"about_ca_system_score_gemma":0.00031446887,"threshold_uncertainty_score":0.99988455},"labels":[],"label_agreement":null},{"id":"W2891834094","doi":"10.2147/dddt.s174928","title":"The effect of food and liquid pH on the integrity of enteric-coated beads from cysteamine bitartrate delayed-release capsules","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Biomedical Research and Pathophysiology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Horizon Pharma; American Pharmacists Association","keywords":"Cysteamine; Enteric coated; Chemistry; Pharmacology; Chromatography; Medicine; Biochemistry","score_opus":0.027843459954816623,"score_gpt":0.27507944021318476,"score_spread":0.24723598025836813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891834094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961288,0.0021477586,0.0002953244,0.0008028489,0.000053138687,0.00048713156,0.000014643924,0.000010769781,0.00005957306],"genre_scores_gemma":[0.9979154,0.0014710958,0.00022558082,0.00019107867,0.00005590294,0.00003624324,0.000023237222,0.000009540725,0.00007193354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877256,0.00038387728,0.00023721527,0.00017566544,0.00022714163,0.00020355408],"domain_scores_gemma":[0.99839777,0.001149359,0.00007931407,0.00017054127,0.000089751,0.000113253605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009059338,0.00014410506,0.00027126007,0.000049780436,0.00013920658,0.000009116453,0.000108556545,0.00007078527,0.000037374964],"category_scores_gemma":[0.00015214464,0.000056981957,0.000033734625,0.0001320197,0.00057841087,0.000018194909,0.00003462318,0.00018567813,0.000004624517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020200359,0.00015699203,0.0007696904,0.000049464838,0.0006705433,0.00000935874,0.002167338,4.4939092e-8,0.82137483,0.0001364964,0.000996643,0.15346825],"study_design_scores_gemma":[0.00199403,0.009292223,0.0036297238,0.00012758696,0.0000164095,0.0000026132536,0.00009579187,0.00008165866,0.9827171,0.00017942129,0.0017886352,0.000074789874],"about_ca_topic_score_codex":0.00011401896,"about_ca_topic_score_gemma":0.000025869576,"teacher_disagreement_score":0.1613423,"about_ca_system_score_codex":0.000013921004,"about_ca_system_score_gemma":0.00010305223,"threshold_uncertainty_score":0.23236568},"labels":[],"label_agreement":null},{"id":"W2891907584","doi":"10.2147/dddt.s172538","title":"Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Parasitic Diseases Research and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Institut National de la Santé et de la Recherche Médicale","keywords":"Nasopharyngeal carcinoma; In vivo; Cytotoxic T cell; Medicine; Cancer research; Cancer; Pharmacology; Cytotoxicity; In vitro; Immunology; Biology; Radiation therapy; Internal medicine; Biochemistry","score_opus":0.03305226841364001,"score_gpt":0.29481395273461763,"score_spread":0.26176168432097763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891907584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961167,0.0015828148,0.0001848963,0.00041169816,0.00004134602,0.0010123816,0.000005264313,0.000036017762,0.0006088595],"genre_scores_gemma":[0.99495703,0.0009663268,0.0028614842,0.0004593022,0.000108812754,0.00016970324,0.000032679225,0.000020341555,0.00042429185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987234,0.00009576926,0.0002454429,0.00035083562,0.00026140126,0.00032313634],"domain_scores_gemma":[0.9995311,0.000055113356,0.00004876246,0.000098731194,0.00008706342,0.00017923635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019882321,0.00020673432,0.00023956089,0.00013262722,0.00015564972,0.000056867113,0.00003097972,0.00004374597,0.00005650666],"category_scores_gemma":[0.000011941166,0.00016494837,0.00002369976,0.000170123,0.0001316771,0.00020452573,0.00002213981,0.000087894034,0.000021812299],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01712136,0.008066347,0.27029538,0.00058412465,0.0006788979,0.0023289274,0.03874412,6.0566094e-7,0.58715373,0.0012833655,0.007994422,0.06574871],"study_design_scores_gemma":[0.008716801,0.0003789537,0.04069148,0.000111503214,0.000014401301,0.000051461924,0.00013751401,0.00005733917,0.9479403,0.0006846744,0.00102102,0.00019453994],"about_ca_topic_score_codex":0.00004609209,"about_ca_topic_score_gemma":0.000012061591,"teacher_disagreement_score":0.3607866,"about_ca_system_score_codex":0.00008329628,"about_ca_system_score_gemma":0.00023813637,"threshold_uncertainty_score":0.6726399},"labels":[],"label_agreement":null},{"id":"W2894830330","doi":"10.2147/dddt.s167382","title":"Synthesis and anticancer activity of dimeric podophyllotoxin derivatives","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Plant-derived Lignans Synthesis and Bioactivity","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"Institute of Botany, Chinese Academy of Sciences; National Key Research and Development Program of China; Kunming Institute of Botany, Chinese Academy of Sciences; State Key Laboratory of Phytochemistry and Plant Resources in West China; Chinese Academy of Sciences","keywords":"Podophyllotoxin; Etoposide; Chemistry; Triazole; Cytotoxicity; MTT assay; Click chemistry; Combinatorial chemistry; Stereochemistry; Cell growth; In vitro; Biochemistry; Biology; Chemotherapy; Organic chemistry","score_opus":0.022126889974903283,"score_gpt":0.23917903709522956,"score_spread":0.21705214712032628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894830330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938849,0.0009385858,0.0047332584,0.00006862816,0.000039853327,0.00016304693,0.0000048173883,0.000008623222,0.00015827069],"genre_scores_gemma":[0.9914957,0.0019624538,0.0062840637,0.00006370924,0.00005382202,0.00002543704,0.0000024345036,0.000013543863,0.000098815464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991965,0.00012089953,0.00012677656,0.00028757102,0.00009613625,0.00017206078],"domain_scores_gemma":[0.99960613,0.00007970805,0.00008872079,0.00012635413,0.000043784632,0.000055311775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002829667,0.00016401258,0.00019887151,0.000042445907,0.00011575435,0.000017153672,0.00008165024,0.00006796864,0.000016023721],"category_scores_gemma":[0.00002607753,0.00012920744,0.000025546082,0.000067173634,0.00025525512,0.000008683931,0.000046671223,0.000033998927,0.0000012465105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026721647,0.0000628575,0.0031668853,0.0000086284135,0.00009918522,5.6352553e-7,0.00029545766,6.0744554e-8,0.8412226,0.000009198495,0.00006699302,0.15480037],"study_design_scores_gemma":[0.00022324215,0.00009140431,0.040744115,0.00002141996,0.000006027147,0.0000036479255,0.000041442563,0.000012020272,0.95307344,0.000025570298,0.0055782865,0.00017936029],"about_ca_topic_score_codex":0.000012876623,"about_ca_topic_score_gemma":0.0000056948707,"teacher_disagreement_score":0.154621,"about_ca_system_score_codex":0.000004785454,"about_ca_system_score_gemma":0.00006900262,"threshold_uncertainty_score":0.52689266},"labels":[],"label_agreement":null},{"id":"W2897528830","doi":"10.2147/dddt.s172487","title":"Antioxidative stress effects of vitamins C, E, and B<sub>12</sub>, and their combination can protect the liver against acetaminophen-induced hepatotoxicity in rats","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"College of Pharmacy and Nutrition, University of Saskatchewan; University of Petra","keywords":"Acetaminophen; Oxidative stress; Pharmacology; Vitamin E; In vivo; Antioxidant; Chemistry; Hepatocyte; Glutathione; Vitamin C; Lipid peroxidation; Superoxide dismutase; Hepatoprotection; Liver injury; Biochemistry; In vitro; Enzyme; Medicine; Biology","score_opus":0.06731345294423799,"score_gpt":0.31041097095283504,"score_spread":0.24309751800859705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897528830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942097,0.0013270566,0.0005185351,0.00021319088,0.00032369525,0.0031713508,0.000015185392,0.000056471563,0.00016479095],"genre_scores_gemma":[0.99449897,0.0043299883,0.00017496268,0.0004518013,0.00007877432,0.00036784355,0.000015282203,0.00003172674,0.000050673298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99694425,0.001477027,0.00043764248,0.0005031773,0.00019736821,0.00044055126],"domain_scores_gemma":[0.99849194,0.0007570768,0.00028397603,0.00017651134,0.00014467839,0.00014584167],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016511607,0.00042784796,0.000454581,0.00024759484,0.00067743886,0.00005755287,0.00019359116,0.00035251916,0.000011743699],"category_scores_gemma":[0.000067387526,0.00032175164,0.000042736305,0.00033657058,0.0004463837,0.0002262572,0.000099913574,0.0005856079,0.000004463745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045828588,0.00033038048,0.0038519274,0.00012510733,0.00018856696,0.000011018578,0.019782161,0.0000028315471,0.7588941,0.00013852736,0.000034297613,0.21618278],"study_design_scores_gemma":[0.0029800048,0.00033870147,0.041495588,0.00013029137,0.00002096212,0.000007375349,0.00021633864,0.0015047617,0.9514976,0.00049358146,0.00093679497,0.00037799522],"about_ca_topic_score_codex":0.000031451007,"about_ca_topic_score_gemma":0.0003410229,"teacher_disagreement_score":0.21580479,"about_ca_system_score_codex":0.00008762668,"about_ca_system_score_gemma":0.00015754622,"threshold_uncertainty_score":0.99992347},"labels":[],"label_agreement":null},{"id":"W2900391822","doi":"10.2147/dddt.s138765","title":"CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia","year":2018,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Cytokine release syndrome; Chimeric antigen receptor; Context (archaeology); Medicine; Oncology; Internal medicine; Immunotherapy; Cancer; Biology","score_opus":0.06862769789823206,"score_gpt":0.32885039219268575,"score_spread":0.26022269429445366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900391822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031538457,0.9888503,0.0007121105,0.000042152864,0.0003639463,0.0061812876,0.000026960144,0.00014450992,0.00052489655],"genre_scores_gemma":[0.00005340739,0.95747125,0.0057746423,0.00027475163,0.0004611357,0.0011352854,0.00028235654,0.0003310518,0.034216136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99564517,0.0004053067,0.0010360274,0.0013053,0.0006625649,0.0009456179],"domain_scores_gemma":[0.9970195,0.0011185677,0.00042174288,0.0007186223,0.00024788346,0.0004736546],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015268752,0.0011346034,0.0024821854,0.0005840969,0.0004059251,0.0001763473,0.00038868334,0.0006532726,0.0005205207],"category_scores_gemma":[0.000035103407,0.0008487454,0.00042491956,0.0004291489,0.00031778397,0.00012293232,0.00009775831,0.0005800917,0.000075945405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013439057,0.00018148721,0.000007812578,0.0025054319,0.0016376538,0.000049893955,0.0013874675,2.9685317e-8,0.0010898972,0.0000051175493,0.006612908,0.9851784],"study_design_scores_gemma":[0.0084151905,0.0010801473,0.000017838189,0.002647165,0.00035063436,0.00013982334,0.000040801442,0.00001282244,0.00394208,0.00006454978,0.9823734,0.0009155481],"about_ca_topic_score_codex":0.000012217167,"about_ca_topic_score_gemma":0.0000020047094,"teacher_disagreement_score":0.9842628,"about_ca_system_score_codex":0.0007452839,"about_ca_system_score_gemma":0.0033439388,"threshold_uncertainty_score":0.9993963},"labels":[],"label_agreement":null},{"id":"W2902197007","doi":"10.2147/dddt.s186614","title":"Synthesis of small peptide compounds, molecular docking, and inhibitory activity evaluation against phosphatases PTP1B and SHP2","year":2018,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Allard Foundation","keywords":"Allosteric regulation; Biochemistry; Phosphatase; Docking (animal); Peptide; Chemistry; Enzyme; Protein tyrosine phosphatase; Active site; Tripeptide; Binding site; IC50; In vitro","score_opus":0.024099581247320437,"score_gpt":0.24976968129948887,"score_spread":0.22567010005216842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902197007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714653,0.026017776,0.001860118,0.000045138782,0.00004054574,0.0004543668,0.000014234305,0.0000110499805,0.00009150124],"genre_scores_gemma":[0.9880406,0.0024164235,0.009193535,0.00013237364,0.00004705556,0.00007875981,0.00005629297,0.000019868101,0.0000150363785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895906,0.00015830917,0.00018386617,0.00036206425,0.00016378022,0.00017288618],"domain_scores_gemma":[0.9994527,0.0000552512,0.00012579437,0.00017889777,0.000116031515,0.00007130626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006589762,0.00019797114,0.00018630644,0.000052796357,0.00014658124,0.000036646114,0.00008462472,0.00007404096,0.0000055015284],"category_scores_gemma":[0.0000672749,0.00018418817,0.000021148302,0.000057384586,0.00024021424,0.000012382445,0.0000881488,0.00004657418,6.3312166e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038361392,0.000091661954,0.004152095,0.000039740316,0.00015945447,0.000002958892,0.00029902757,0.000006421607,0.6842649,0.00009008947,0.0005431968,0.30996683],"study_design_scores_gemma":[0.0007767118,0.00011534697,0.0075076865,0.000055674296,0.00001777805,0.000004216799,0.000030996358,0.00016716664,0.98710465,0.0001301139,0.0038610913,0.0002285355],"about_ca_topic_score_codex":0.000022304945,"about_ca_topic_score_gemma":0.000010711228,"teacher_disagreement_score":0.3097383,"about_ca_system_score_codex":0.0000130349545,"about_ca_system_score_gemma":0.00014415041,"threshold_uncertainty_score":0.75109756},"labels":[],"label_agreement":null},{"id":"W2917800338","doi":"10.2147/dddt.s180836","title":"<p>siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo</p>","year":2019,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Shanghai Institute Of Planned Parenthood Research; Shanghai Municipal Health and Family Planning Commission; Science and Technology Commission of Shanghai Municipality","keywords":"In vivo; Gene knockdown; Gene silencing; Estrone; Chemistry; Cancer research; Cell growth; Small interfering RNA; Breast cancer; Pharmacology; Cancer; Biology; Apoptosis; Medicine; Internal medicine; Biochemistry; Hormone; RNA; Gene","score_opus":0.010325199561902046,"score_gpt":0.24328675180174203,"score_spread":0.23296155223984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917800338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690453,0.027736772,0.0022620244,0.000096013086,0.00006427794,0.0006816342,0.000018678378,0.00002082741,0.00007448191],"genre_scores_gemma":[0.9859928,0.006421754,0.006429308,0.00047065664,0.00001954555,0.00009057095,0.00020094136,0.00006385019,0.00031060365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980863,0.00029627752,0.00034479483,0.00065936556,0.00012911385,0.00048418294],"domain_scores_gemma":[0.99936795,0.000029028792,0.000113140115,0.00028094373,0.00005282978,0.00015608467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040466772,0.00040092663,0.00038341325,0.00016161481,0.00008130764,0.00005847329,0.0001959441,0.00033558684,0.000034484154],"category_scores_gemma":[0.0000020456844,0.000340686,0.000051170482,0.00017698598,0.00008704962,0.000020411182,0.000044134067,0.00016600927,0.000003038924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013835564,0.00021527849,0.0033566926,0.000015068294,0.000073517134,0.000008312056,0.00041764308,0.004062655,0.98712707,0.0000040151117,0.00025712766,0.0030790393],"study_design_scores_gemma":[0.0065719383,0.0002153216,0.00014298027,0.00004871172,0.000008044996,0.000008743108,0.000011735853,0.012399156,0.97610575,0.000033331504,0.003907507,0.0005468052],"about_ca_topic_score_codex":0.000012753971,"about_ca_topic_score_gemma":0.00001786859,"teacher_disagreement_score":0.021315018,"about_ca_system_score_codex":0.00003095492,"about_ca_system_score_gemma":0.00023101023,"threshold_uncertainty_score":0.9999045},"labels":[],"label_agreement":null},{"id":"W2937366373","doi":"10.2147/dddt.s196119","title":"<p>Beneficial effects of resveratrol and exercise training on cardiac and aortic function and structure in the 3xTg mouse model of Alzheimer’s disease</p>","year":2019,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Midwestern University; Diabetes Action Research and Education Foundation","keywords":"Resveratrol; Disease; Medicine; Cardiac function curve; Cardiology; Neuroscience; Internal medicine; Pharmacology; Physical medicine and rehabilitation; Psychology; Heart failure","score_opus":0.025725236446243693,"score_gpt":0.24283950326570813,"score_spread":0.21711426681946444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937366373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96893585,0.029632222,0.00015750919,0.000098028366,0.00007350013,0.0010609201,0.0000069817424,0.000011597394,0.000023402223],"genre_scores_gemma":[0.9931397,0.0056264475,0.0008475545,0.00013655935,0.000040068076,0.000029490573,0.000016078668,0.000022687098,0.00014145345],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989127,0.000097072894,0.00026092614,0.00028154725,0.00025627375,0.00019151419],"domain_scores_gemma":[0.99946254,0.00012988441,0.0000963748,0.00016890123,0.000036733763,0.00010558501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035147215,0.00021580225,0.00049081194,0.00014296362,0.00006840554,0.000017625314,0.00004144921,0.00009944542,0.0000049471214],"category_scores_gemma":[0.000015688775,0.00014783928,0.000031623742,0.00009832984,0.00006944246,0.00007980799,0.000016896174,0.00013455271,4.860179e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045580897,0.00019176018,0.008972716,0.00044085828,0.0005624633,0.000006182756,0.042818192,0.00014672517,0.5897653,0.0014459837,0.00012839031,0.35096332],"study_design_scores_gemma":[0.025450401,0.0012584099,0.71160275,0.0015978101,0.002114276,0.000012867538,0.0012406674,0.004961504,0.23821625,0.006385071,0.0056391973,0.0015207921],"about_ca_topic_score_codex":0.000004092526,"about_ca_topic_score_gemma":0.000002221778,"teacher_disagreement_score":0.70263004,"about_ca_system_score_codex":0.000007051428,"about_ca_system_score_gemma":0.00009850988,"threshold_uncertainty_score":0.60287106},"labels":[],"label_agreement":null},{"id":"W2975456987","doi":"10.2147/dddt.s217211","title":"<p>Hydrogels For Peptide Hormones Delivery: Therapeutic And Tissue Engineering Applications</p>","year":2019,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Hydrogels: synthesis, properties, applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Kerman University of Medical Sciences","keywords":"Self-healing hydrogels; Peptide; Hormone; Tissue engineering; Chemistry; Biomedical engineering; Internal medicine; Medicine; Biochemistry; Organic chemistry","score_opus":0.03921277430519101,"score_gpt":0.2653786315775983,"score_spread":0.22616585727240726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975456987","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000518876,0.9587726,0.036903925,0.000032412296,0.000046718873,0.003585265,0.000030758936,0.000051853036,0.000057584526],"genre_scores_gemma":[0.0007122411,0.97655654,0.01549513,0.00007593855,0.00017093033,0.0049731503,0.0003693968,0.0001521164,0.0014945535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979563,0.00009196858,0.00055857113,0.0008227727,0.00015976913,0.00041066136],"domain_scores_gemma":[0.99890506,0.0001243771,0.0002345373,0.0005207055,0.00008743686,0.00012790093],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046898617,0.0006224553,0.00085963996,0.00015231658,0.00022481156,0.00009967862,0.00037708128,0.00035815354,0.000008097689],"category_scores_gemma":[0.000011946385,0.0005283018,0.00014416923,0.00015002277,0.00007561704,0.000011777721,0.00009761339,0.0001149695,0.00003349055],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002425792,0.00004560449,0.0000015550878,0.0010220067,0.00048220783,3.900856e-7,0.00011333058,0.0000041208577,0.02437961,0.00012085469,0.0003069078,0.9734992],"study_design_scores_gemma":[0.00034588788,0.000060349306,0.0000033349465,0.0003100141,0.00015720399,0.000019016668,0.0000052839614,0.00004873878,0.026544875,0.000036180743,0.9717921,0.0006770289],"about_ca_topic_score_codex":0.0000014201739,"about_ca_topic_score_gemma":0.0000019155518,"teacher_disagreement_score":0.9728221,"about_ca_system_score_codex":0.00004365867,"about_ca_system_score_gemma":0.0003300181,"threshold_uncertainty_score":0.9997169},"labels":[],"label_agreement":null},{"id":"W2980521005","doi":"10.2147/dddt.s205820","title":"<p>Clinical And Bacteriological Impact Of Clarithromycin In Streptococcal Pharyngitis: Findings From A Meta-Analysis Of Clinical Trials</p>","year":2019,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Streptococcal Infections and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Pharyngitis; Medicine; Clarithromycin; Meta-analysis; Clinical trial; Internal medicine; Microbiology; Biology","score_opus":0.4968928949834816,"score_gpt":0.5101473942419875,"score_spread":0.013254499258505914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980521005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21445106,0.78181165,0.00013888416,0.000017168602,0.00014717711,0.003146785,0.00022426616,0.000023157083,0.000039821087],"genre_scores_gemma":[0.019185452,0.9763197,0.0030857017,0.000032225424,0.000079672514,0.0003801128,0.00067116675,0.00004826864,0.00019771009],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9898353,0.0030703861,0.0052318173,0.0011284243,0.00035435884,0.00037971215],"domain_scores_gemma":[0.9908595,0.0065659196,0.0015741981,0.00055409234,0.00013418116,0.00031209746],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0066303154,0.000829217,0.0154326875,0.00081373815,0.000054572207,0.00004205949,0.00018819454,0.0009482624,0.0015324284],"category_scores_gemma":[0.0005012933,0.0004699809,0.005312519,0.0008748984,0.0003349429,0.0000909017,0.00010020105,0.00063659524,0.000012612207],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007823409,0.001506298,0.075567424,0.0003742232,0.29462156,0.0000377695,0.00012916831,0.0000010864354,0.000027420421,0.00002092937,0.00015662424,0.62677515],"study_design_scores_gemma":[0.014669741,0.0025208546,0.51994896,0.0022817198,0.33899078,0.000026917307,0.000019562802,0.00008661457,0.00007122736,0.00012900568,0.12003871,0.0012159097],"about_ca_topic_score_codex":0.000064750944,"about_ca_topic_score_gemma":0.000018876834,"teacher_disagreement_score":0.6255592,"about_ca_system_score_codex":0.00007611949,"about_ca_system_score_gemma":0.000906585,"threshold_uncertainty_score":0.9997752},"labels":[],"label_agreement":null},{"id":"W2981860386","doi":"10.2147/dddt.s207856","title":"<p>Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis</p>","year":2019,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Swedish Orphan Biovitrum; JCR Pharmaceuticals; Amicus Therapeutics; Alexion Pharmaceuticals; Ultragenyx Pharmaceutical; Sanofi; Idorsia Pharmaceuticals; Shire Human Genetic Therapies; GlaxoSmithKline","keywords":"Medicine; Renal function; Internal medicine; Cohort; Urology; Left ventricular hypertrophy; Fabry disease; Cardiology; Endocrinology; Blood pressure","score_opus":0.043324552126888585,"score_gpt":0.29557840456518314,"score_spread":0.25225385243829457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981860386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889394,0.0041142297,0.0032562686,0.00038902508,0.00008998114,0.0021090496,0.000013891163,0.00013151672,0.0009566574],"genre_scores_gemma":[0.9672129,0.0013433701,0.0019753275,0.0005490155,0.00005142164,0.00018778954,0.00031361083,0.000103759376,0.028262764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952362,0.00060089515,0.0007730518,0.0010278702,0.001509811,0.000852157],"domain_scores_gemma":[0.99775696,0.00036697407,0.00023815453,0.00090015924,0.00034083662,0.00039693588],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027426097,0.00065596,0.0013251154,0.0006648843,0.00023502346,0.000180082,0.00036518386,0.0001808914,0.0018176709],"category_scores_gemma":[0.00006476483,0.00044598625,0.00027426888,0.0010906974,0.00013840753,0.0002010971,0.00010313485,0.00031195552,0.00027939698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061093317,0.00045154855,0.9603968,0.000047466205,0.0055309734,0.0001424882,0.0016891458,0.000021001539,0.0032773206,0.000016003087,0.0014287757,0.020889094],"study_design_scores_gemma":[0.011987214,0.0006399762,0.96660995,0.000066978195,0.00015140779,0.00001780369,0.00007403437,0.00008392533,0.0073636356,0.000011389791,0.012248266,0.0007454305],"about_ca_topic_score_codex":0.000048765945,"about_ca_topic_score_gemma":0.00013554892,"teacher_disagreement_score":0.027306106,"about_ca_system_score_codex":0.00023158027,"about_ca_system_score_gemma":0.00047256675,"threshold_uncertainty_score":0.9997992},"labels":[],"label_agreement":null},{"id":"W2981956000","doi":"10.2147/dddt.s215895","title":"<p>Glucoside Derivatives Of Podophyllotoxin: Synthesis, Physicochemical Properties, And Cytotoxicity</p>","year":2019,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Plant-derived Lignans Synthesis and Bioactivity","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"National Natural Science Foundation of China","keywords":"Podophyllotoxin; Etoposide; Cytotoxicity; Chemistry; Stereochemistry; Cell culture; Glucoside; Acetylation; In vitro; Pharmacology; Biochemistry; Biology; Chemotherapy; Medicine","score_opus":0.020595839385275348,"score_gpt":0.20405058636577636,"score_spread":0.18345474698050102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981956000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946688,0.003966181,0.00047053266,0.00007369825,0.0000353194,0.00046836556,0.000011358863,0.000017527886,0.0002882346],"genre_scores_gemma":[0.9938168,0.0025170096,0.0031339088,0.00010463305,0.000052115032,0.00006502029,0.000019963558,0.000029633185,0.000260928],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860793,0.00014451434,0.00028045845,0.0004820246,0.00019230862,0.00029277042],"domain_scores_gemma":[0.9993955,0.00008297725,0.00014341949,0.00022965275,0.000055352644,0.00009309508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000328052,0.0003063328,0.0003801476,0.000057968562,0.00009788657,0.000037076887,0.00017332262,0.00014199977,0.000016686045],"category_scores_gemma":[0.0000281699,0.00023574494,0.000060547565,0.00007823003,0.00016010691,0.000016923814,0.00009250261,0.000069314694,0.000004747782],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043696622,0.00015598882,0.0013624299,0.000047143247,0.00017498975,0.0000014664909,0.00034192603,0.0000010569432,0.98396623,0.00005203506,0.00013946884,0.013320288],"study_design_scores_gemma":[0.0005326216,0.0001038525,0.0048234803,0.00008470938,0.000009362661,0.000009260929,0.000048426464,0.000026527898,0.9856559,0.000040268696,0.008306506,0.00035909188],"about_ca_topic_score_codex":0.0000029476414,"about_ca_topic_score_gemma":0.000002817824,"teacher_disagreement_score":0.012961196,"about_ca_system_score_codex":0.000013048685,"about_ca_system_score_gemma":0.00013035975,"threshold_uncertainty_score":0.96133995},"labels":[],"label_agreement":null},{"id":"W3001770977","doi":"10.2147/dddt.s231293","title":"<p>Effect of Fimasartan versus Valsartan and Olmesartan on Office and Ambulatory Blood Pressure in Korean Patients with Mild-to-Moderate Essential Hypertension: A Randomized, Double-Blind, Active Control, Three-Parallel Group, Forced Titration, Multicenter, Phase IV Study (Fimasartan Achieving Systolic Blood Pressure Target (FAST) Study)</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Olmesartan; Valsartan; Medicine; Ambulatory blood pressure; Blood pressure; Placebo; Clinical endpoint; Ambulatory; Essential hypertension; Internal medicine; Diastole; Randomized controlled trial","score_opus":0.026727821750584642,"score_gpt":0.2597212978676969,"score_spread":0.23299347611711224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001770977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97507966,0.012311961,0.00025335018,0.00022516446,0.0001018132,0.0118952505,0.000023232764,0.00007725123,0.00003233445],"genre_scores_gemma":[0.99761754,0.00026130574,0.00084752036,0.00039394014,0.00009229616,0.000622667,0.000048250862,0.000083579944,0.00003286898],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99576527,0.0008064522,0.00094596506,0.0011331065,0.00083661015,0.0005125943],"domain_scores_gemma":[0.99762124,0.0008467944,0.0003997205,0.00036789195,0.00038337728,0.00038097674],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010487605,0.0008121157,0.0025983062,0.00030010813,0.00042120338,0.000109209555,0.00016292706,0.00015231798,0.000012980496],"category_scores_gemma":[0.00008939121,0.0005682378,0.00010510151,0.00033102612,0.00017752362,0.00027693235,0.000101892925,0.00035708974,0.0000015471159],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9275018,0.006172242,0.023432544,0.0002774638,0.016631208,0.00015253894,0.016700942,0.00012758307,0.0074571855,0.00002428484,0.00010538473,0.0014168542],"study_design_scores_gemma":[0.9457803,0.012615669,0.018213283,0.00040077907,0.0114211785,0.000010757424,0.0006579821,0.0020681212,0.0077481777,0.0000036225247,0.00028074547,0.000799391],"about_ca_topic_score_codex":0.000032190583,"about_ca_topic_score_gemma":0.00012335068,"teacher_disagreement_score":0.022537928,"about_ca_system_score_codex":0.000007962259,"about_ca_system_score_gemma":0.00009985503,"threshold_uncertainty_score":0.9996769},"labels":[],"label_agreement":null},{"id":"W3004841311","doi":"10.2147/dddt.s232325","title":"<p>Potential Use of Microbial Surfactant in Microemulsion Drug Delivery System: A Systematic Review</p>","year":2020,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Kerman University of Medical Sciences","keywords":"Microemulsion; Pulmonary surfactant; Bioavailability; Lipopeptide; Drug; Chemistry; Pharmacology; Medicine; Biology; Biochemistry; Bacteria","score_opus":0.11281858157409172,"score_gpt":0.36106915020987007,"score_spread":0.24825056863577835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004841311","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010033586,0.98902357,0.0006296886,0.000051988933,0.001191276,0.007814979,0.00014096293,0.00011737602,0.000026779238],"genre_scores_gemma":[0.0006441013,0.99471414,0.002437594,0.000567782,0.00009452775,0.00060741877,0.00026402567,0.0001561959,0.0005142221],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99023575,0.0039817807,0.0032664132,0.0010818869,0.00053381425,0.0009003835],"domain_scores_gemma":[0.9964197,0.0010490897,0.0015143013,0.00047450903,0.00020587296,0.00033649418],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0024213474,0.0012956577,0.0048504644,0.000495371,0.0002754915,0.00006469248,0.00082944747,0.0006186453,0.00013530001],"category_scores_gemma":[0.000062349354,0.0010792842,0.0005450774,0.00068243744,0.00022779978,0.00029645758,0.00020918259,0.0011399683,0.00013000569],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005950245,0.0004968682,0.0000053602053,0.793826,0.0023190617,0.0006894182,0.0016071422,0.000035794703,0.003784322,0.000048174978,0.0033825974,0.19321024],"study_design_scores_gemma":[0.0019043077,0.00005143609,0.0000015261953,0.22090338,0.0024099152,0.00013603126,0.000031446132,0.00015737783,0.0022501135,0.000005191051,0.7709602,0.0011890816],"about_ca_topic_score_codex":0.0000068609206,"about_ca_topic_score_gemma":0.000009760663,"teacher_disagreement_score":0.7675776,"about_ca_system_score_codex":0.00048660205,"about_ca_system_score_gemma":0.0007980093,"threshold_uncertainty_score":0.9999795},"labels":[],"label_agreement":null},{"id":"W3014583199","doi":"10.2147/dddt.s217010","title":"<p>The Efficacy of N-Butylphthalide and Dexamethasone Combined with Hyperbaric Oxygen on Delayed Encephalopathy After Acute Carbon Monoxide Poisoning</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hyperbaric oxygen; Carbon monoxide poisoning; Dexamethasone; Medicine; Anesthesia; Carbon monoxide; Encephalopathy; Oxygen; Pharmacology; Chemistry; Internal medicine; Poison control; Emergency medicine; Organic chemistry","score_opus":0.011834477130791134,"score_gpt":0.21070002678204897,"score_spread":0.19886554965125783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014583199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99355036,0.004405796,0.00076479506,0.00044266216,0.000035933474,0.00055477547,0.0000059816357,0.000025319934,0.00021439847],"genre_scores_gemma":[0.99316585,0.0014313757,0.0038435392,0.0010508177,0.00006808437,0.00011239307,0.000034347016,0.000052062853,0.00024154222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982955,0.0001746453,0.0003465964,0.00056242355,0.0002658192,0.0003550302],"domain_scores_gemma":[0.9992014,0.000089828725,0.00014369859,0.0002877039,0.00007428019,0.00020307531],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034921762,0.0003801418,0.00035878306,0.0000453815,0.00011283573,0.00004518307,0.00022367068,0.00012923035,0.000008844955],"category_scores_gemma":[0.000026009946,0.00026315887,0.00005989359,0.0001974449,0.00013808286,0.000008469852,0.00007630917,0.0001260788,0.0000023505968],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007360058,0.00013550528,0.0033161442,0.000018507688,0.0006419895,0.000055691937,0.0027699026,0.000035354034,0.9731729,0.000038454582,0.00025401794,0.01220145],"study_design_scores_gemma":[0.0045204526,0.0017198604,0.019660905,0.00004707649,0.00007625995,0.00002726356,0.000121075136,0.0002227002,0.9593872,0.000027687125,0.013559067,0.00063048286],"about_ca_topic_score_codex":0.0000062360045,"about_ca_topic_score_gemma":0.0000099677645,"teacher_disagreement_score":0.01634476,"about_ca_system_score_codex":0.000013252369,"about_ca_system_score_gemma":0.00015495512,"threshold_uncertainty_score":0.99998206},"labels":[],"label_agreement":null},{"id":"W3026086046","doi":"10.2147/dddt.s242514","title":"<p>A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of British Columbia; Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada; Queen's University; Russian Foundation for Basic Research","keywords":"Triple-negative breast cancer; Cancer research; Viability assay; Breast cancer; Apoptosis; Cancer; Medicine; Biology; Chemistry; Internal medicine; Biochemistry","score_opus":0.013722722877537168,"score_gpt":0.2355998324564319,"score_spread":0.22187710957889473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026086046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84183514,0.1571344,0.00024421467,0.00013492344,0.000058678284,0.00049978413,0.000033319404,0.000010923674,0.000048626065],"genre_scores_gemma":[0.908268,0.09024146,0.00091392704,0.00028011872,0.000047949467,0.000101053934,0.000033885117,0.000024921072,0.000088733854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998459,0.00013677907,0.0003994451,0.0005019105,0.00019344078,0.00030941688],"domain_scores_gemma":[0.99933755,0.000033547694,0.00020257043,0.00013972234,0.00011433536,0.00017225266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057745946,0.00029663165,0.0004443718,0.00005062584,0.00009160276,0.000039608534,0.00013454443,0.000115341696,0.000031684336],"category_scores_gemma":[0.00005103643,0.00026472614,0.00004062376,0.00022738198,0.00014410738,0.000035547455,0.000058640497,0.000089349596,5.758028e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018380786,0.00014846404,0.004976808,0.00015066253,0.00017652282,0.0000024711228,0.003651723,0.000004045724,0.6766009,0.00011481955,0.0006032489,0.31173226],"study_design_scores_gemma":[0.0052522155,0.00012242157,0.05351997,0.000038738537,0.000017379652,0.0000028038587,0.00011154857,0.00011064021,0.92617965,0.0002997362,0.013989319,0.0003556073],"about_ca_topic_score_codex":0.000022764341,"about_ca_topic_score_gemma":0.00010029109,"teacher_disagreement_score":0.31137666,"about_ca_system_score_codex":0.000033752385,"about_ca_system_score_gemma":0.00022585894,"threshold_uncertainty_score":0.9999805},"labels":[],"label_agreement":null},{"id":"W3045514455","doi":"10.2147/dddt.s262141","title":"<p>The Climate is Changing for Metered-Dose Inhalers and Action is Needed</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Action (physics); Pharmacology; Computer science; Medicine; Physics","score_opus":0.07847897795096846,"score_gpt":0.28249766652401775,"score_spread":0.20401868857304928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045514455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806105,0.003588854,0.0035072784,0.010283948,0.00022951487,0.0013167175,0.0000074416666,0.00010986206,0.00034590997],"genre_scores_gemma":[0.954468,0.00525902,0.005545112,0.032354508,0.00039051718,0.000159263,0.000031659947,0.000067799905,0.0017240932],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988014,0.00006087198,0.0002833514,0.0003174206,0.00021819377,0.00031876934],"domain_scores_gemma":[0.99943775,0.00009633919,0.00010635934,0.00011487627,0.0000861762,0.00015848088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004935331,0.00022494244,0.00026397957,0.00014638841,0.000443222,0.000070840186,0.000065368564,0.00008550919,0.00010252474],"category_scores_gemma":[0.0000145152035,0.00015721282,0.00006466395,0.00022883127,0.000061413215,0.00012505933,0.000031962965,0.00010469509,0.000022879512],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003595977,0.00015379029,0.00096184463,0.0004336135,0.00080624776,0.000035729812,0.12797958,0.000009160144,0.25020707,0.0003138226,0.03976758,0.57573557],"study_design_scores_gemma":[0.0060498016,0.0002550527,0.0008560467,0.00011914238,0.00008577693,0.000030428566,0.0027551537,0.004614273,0.3823787,0.00004588794,0.60229665,0.0005130836],"about_ca_topic_score_codex":6.338395e-7,"about_ca_topic_score_gemma":6.104848e-7,"teacher_disagreement_score":0.5752225,"about_ca_system_score_codex":0.000030861847,"about_ca_system_score_gemma":0.000090823145,"threshold_uncertainty_score":0.64109534},"labels":[],"label_agreement":null},{"id":"W3048993600","doi":"10.2147/dddt.s247584","title":"<p>Cannabis Extract CT-921 Has a High Efficacy–Adverse Effect Profile in a Neuropathic Pain Model</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Neuropathic pain; Analgesic; Adverse effect; Anesthesia; Allodynia; Clinical trial; Cannabis; Pharmacology; Internal medicine; Hyperalgesia; Nociception; Receptor","score_opus":0.032586292228379214,"score_gpt":0.26012517400838764,"score_spread":0.22753888178000842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048993600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96930724,0.0030488917,0.005202201,0.018598942,0.0001030061,0.0031130165,0.000008203615,0.00019879214,0.0004197116],"genre_scores_gemma":[0.9864624,0.0006819204,0.002409486,0.002499306,0.00015071912,0.0006388723,0.00005946904,0.00011292607,0.006984896],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960547,0.0009733261,0.00058088114,0.00082734134,0.000784504,0.0007792296],"domain_scores_gemma":[0.99873334,0.00014208638,0.00011493621,0.00032714984,0.000121059966,0.00056140963],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035429457,0.0005192425,0.0007380714,0.0003000823,0.00024650883,0.00010681583,0.00024775934,0.00011766894,0.00021662361],"category_scores_gemma":[0.0003721045,0.00040569043,0.0001438602,0.00070717523,0.00017012203,0.0001432318,0.00008585242,0.000551789,0.000062550964],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074124266,0.0010550118,0.0026079947,0.00057690765,0.00029125385,0.002188234,0.013318743,0.0005738783,0.18495034,0.00017146998,0.14965533,0.6371984],"study_design_scores_gemma":[0.026128454,0.00294887,0.026282882,0.00061364303,0.00008278568,0.00013758763,0.00017825235,0.10933627,0.15966812,0.00015189148,0.67250925,0.0019619947],"about_ca_topic_score_codex":0.000016236214,"about_ca_topic_score_gemma":0.000010184705,"teacher_disagreement_score":0.63523644,"about_ca_system_score_codex":0.00014222457,"about_ca_system_score_gemma":0.0010558241,"threshold_uncertainty_score":0.9998395},"labels":[],"label_agreement":null},{"id":"W3092098441","doi":"10.2147/dddt.s264122","title":"<p>Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Cancer research; Epidermal growth factor receptor; Apoptosis; Pancreatic cancer; Mechanism (biology); Signal transduction; Epidermal growth factor; Growth factor receptor; Chemistry; Receptor; Medicine; Pharmacology; Internal medicine; Cancer; Cell biology; Biology; Biochemistry","score_opus":0.022504205350056743,"score_gpt":0.23305503989233625,"score_spread":0.21055083454227952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092098441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932936,0.0040470273,0.0012715716,0.00039298704,0.00009559911,0.00083492015,0.000009365742,0.00004136801,0.0000135556365],"genre_scores_gemma":[0.988039,0.0018381139,0.009362548,0.0004778597,0.00008740094,0.00010485001,0.000016427275,0.000055023083,0.000018775589],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99802583,0.00017760013,0.0005621993,0.00049793423,0.0003116206,0.00042479005],"domain_scores_gemma":[0.9990573,0.00024584567,0.00021270852,0.00009279112,0.00007992671,0.00031143907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005709067,0.0003888369,0.0006699115,0.00018222607,0.00011870506,0.000042897944,0.000086839966,0.00014936816,0.000058617523],"category_scores_gemma":[0.000070673595,0.00033363616,0.000048266902,0.00023994772,0.00007926925,0.00013395342,0.000049338094,0.00020354666,0.0000017384186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003587272,0.000056857465,0.0048675435,0.00042334304,0.00014568209,0.000024068517,0.0071915756,0.0000035971514,0.97784895,0.000095467854,0.00004104374,0.008943155],"study_design_scores_gemma":[0.002579717,0.00024791062,0.0033013455,0.0002518282,0.000042011077,0.0000033565484,0.00020824834,0.00035422063,0.992258,0.000044651468,0.00033555855,0.0003731386],"about_ca_topic_score_codex":0.000028063749,"about_ca_topic_score_gemma":0.0000032280814,"teacher_disagreement_score":0.014409075,"about_ca_system_score_codex":0.000041849064,"about_ca_system_score_gemma":0.0001781947,"threshold_uncertainty_score":0.99991155},"labels":[],"label_agreement":null},{"id":"W3101238129","doi":"10.2147/dddt.s259547","title":"<p>Synthesis and Cytotoxic Property of Annonaceous Acetogenin Glycoconjugates</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Traditional and Medicinal Uses of Annonaceae","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"South China Sea Institute of Oceanology, Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Oceanology, Chinese Academy of Sciences; National Natural Science Foundation of China","keywords":"Acetogenin; HeLa; Chemistry; Galactose; Cytotoxicity; MTT assay; Glycoconjugate; Glycosyl; Cell culture; Biochemistry; Stereochemistry; In vitro; Annonaceae; Biology","score_opus":0.02503340349993544,"score_gpt":0.21646052997890053,"score_spread":0.1914271264789651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101238129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98874396,0.008257248,0.00075693545,0.0013649546,0.000040630148,0.0003794975,0.000014625722,0.000021400938,0.000420768],"genre_scores_gemma":[0.98777735,0.0049437038,0.0054999413,0.0008945212,0.00013194536,0.000062801635,0.00004257039,0.000025546718,0.000621613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893564,0.00006509255,0.00024553467,0.0003634852,0.00017863503,0.00021163339],"domain_scores_gemma":[0.99952275,0.000040117553,0.00008201275,0.00010609882,0.00006858389,0.00018046425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019883772,0.0002191529,0.0002447965,0.000037087895,0.00010016257,0.000018088609,0.00013319468,0.0000902377,0.000030697807],"category_scores_gemma":[0.000031750402,0.0001521943,0.000043770677,0.000079571575,0.0001426204,0.000008936961,0.0000493619,0.00005781508,0.0000059548497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007934678,0.000071603754,0.00035545536,0.000039257015,0.00015259966,0.00001194886,0.00074847863,0.0000036908475,0.9508618,0.00007370529,0.0030442446,0.043843713],"study_design_scores_gemma":[0.00082051137,0.00030219732,0.0019028843,0.00002985502,0.0000115784505,0.000021302956,0.0000423731,0.000023348026,0.73970205,0.000048144535,0.2568667,0.00022905959],"about_ca_topic_score_codex":0.0000016477873,"about_ca_topic_score_gemma":0.0000021709163,"teacher_disagreement_score":0.25382245,"about_ca_system_score_codex":0.000006273657,"about_ca_system_score_gemma":0.00015232712,"threshold_uncertainty_score":0.6206304},"labels":[],"label_agreement":null},{"id":"W3110799083","doi":"10.2147/dddt.s289753","title":"<p>Super Activated Platelet Lysate, a Novel Autologous Platelet Lysate, Regulates the Expression of Inflammasome and Cytokine in the Experimental Periodontitis in Rats</p>","year":2020,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Oral microbiology and periodontitis research","field":"Dentistry","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Natural Science Foundation of China","keywords":"Ligature; Periodontitis; Saline; Medicine; Cytokine; Inflammasome; Dental alveolus; Inflammation; Chemokine; Andrology; Pathology; Internal medicine; Immunology; Dentistry","score_opus":0.031028049467704464,"score_gpt":0.25970447835321425,"score_spread":0.2286764288855098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110799083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463797,0.0034450141,0.00002170272,0.00071667356,0.000092818234,0.00092525093,0.000024969297,0.000042110165,0.00009351356],"genre_scores_gemma":[0.99730754,0.0011377085,0.0007513108,0.00029853574,0.00004403519,0.0001384625,0.00006300919,0.000036086112,0.0002233048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99753267,0.00056433637,0.0006101939,0.0005230826,0.00027316477,0.0004965545],"domain_scores_gemma":[0.99912095,0.00033764454,0.00014361046,0.00025956918,0.000051285668,0.000086957334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008559846,0.0003763013,0.0005412066,0.0001766028,0.00029436054,0.00014269521,0.00049109216,0.00025617596,0.00021983408],"category_scores_gemma":[0.000040637497,0.00023703375,0.00005655992,0.0004627858,0.00037992312,0.00027897547,0.00019254751,0.0004296705,0.00001433194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012866248,0.0001539379,0.0054138415,0.000026134103,0.000070095055,0.00016342764,0.02232733,0.000009823785,0.96495616,0.000063216714,0.0007437701,0.0047856425],"study_design_scores_gemma":[0.0033829827,0.00014018275,0.04771134,0.000095318006,0.0000029680634,0.00011808217,0.0009213718,0.000073974596,0.93212247,0.000031118474,0.01508261,0.00031756217],"about_ca_topic_score_codex":0.00004282509,"about_ca_topic_score_gemma":0.00012075466,"teacher_disagreement_score":0.042297497,"about_ca_system_score_codex":0.0000466604,"about_ca_system_score_gemma":0.00012671425,"threshold_uncertainty_score":0.96659553},"labels":[],"label_agreement":null},{"id":"W3164945230","doi":"10.2147/dddt.s299591","title":"A Review of Romiplostim Mechanism of Action and Clinical Applicability","year":2021,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Amgen","keywords":"Romiplostim; Thrombopoietin; Medicine; Eltrombopag; Aplastic anemia; Megakaryocyte; Thrombopoietin receptor; Platelet; Internal medicine; Immunology; Oncology; Haematopoiesis; Bone marrow; Stem cell; Immune thrombocytopenia","score_opus":0.16127100110894912,"score_gpt":0.40991094415966867,"score_spread":0.24863994305071954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164945230","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005120918,0.9973055,0.00034337895,0.000028360864,0.00004373178,0.0016952284,0.0000059054555,0.000011131006,0.00005464892],"genre_scores_gemma":[0.000031930467,0.9944804,0.0050506457,0.00010031527,0.000014538727,0.000100024525,0.0001109993,0.000022749968,0.000088405104],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982215,0.00022367478,0.0009068788,0.00036500764,0.0001615926,0.00012130994],"domain_scores_gemma":[0.9989321,0.00026424424,0.00040726483,0.0002223979,0.000085445834,0.00008851722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083266525,0.00027656884,0.0025198956,0.00006762291,0.000031230174,0.0000047404606,0.00005132933,0.000168529,0.00004567342],"category_scores_gemma":[0.000041894735,0.00018952631,0.00022697724,0.00015874932,0.00006251164,0.000023580438,0.000032794578,0.00015866385,0.0000021253636],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003283782,0.00031789514,0.000029882862,0.039955508,0.00079573435,0.00001536015,0.0000374044,6.416333e-10,0.000001520607,0.00003891769,0.00013841195,0.9586365],"study_design_scores_gemma":[0.0015163264,0.00018876178,0.000035913086,0.09774419,0.0010357858,0.00009307701,0.000013728945,0.0000014881228,0.00025399466,0.00018824781,0.89868355,0.00024495635],"about_ca_topic_score_codex":0.0000037451923,"about_ca_topic_score_gemma":4.921882e-7,"teacher_disagreement_score":0.95839155,"about_ca_system_score_codex":0.000026604268,"about_ca_system_score_gemma":0.00048105328,"threshold_uncertainty_score":0.7728659},"labels":[],"label_agreement":null},{"id":"W3177211387","doi":"10.2147/dddt.s304708","title":"Network Pharmacology Analysis of the Mechanisms of Compound Herba Sarcandrae (Fufang Zhongjiefeng) Aerosol in Chronic Pharyngitis Treatment","year":2021,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Natural Science Foundation of China","keywords":"KEGG; Signal transduction; Computational biology; Pharmacology; Receptor; G protein-coupled receptor; Biology; Chemistry; Gene; Gene expression; Gene ontology; Biochemistry","score_opus":0.03019942623124172,"score_gpt":0.2810780049760161,"score_spread":0.25087857874477437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177211387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9559048,0.041426383,0.0013409851,0.0004756323,0.000104263454,0.0005942361,0.0000061961405,0.000013298221,0.00013420242],"genre_scores_gemma":[0.95367986,0.043805666,0.0019254459,0.0001582679,0.000027252347,0.00005240072,0.000032666772,0.00001537537,0.00030309317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849117,0.00027776844,0.00040332423,0.00024518068,0.00026376988,0.00031877597],"domain_scores_gemma":[0.99935204,0.00018011757,0.00011310607,0.00018092697,0.00009372018,0.0000801181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033727867,0.00017670929,0.0006138921,0.0001599393,0.00010427842,0.000014285948,0.000099062876,0.000050079456,0.0003514004],"category_scores_gemma":[0.000005686611,0.00012281851,0.00012793267,0.0008257318,0.00012304152,0.000045920417,0.00003836701,0.00009882594,0.0000013989932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022794546,0.0017203619,0.045300134,0.00014241452,0.015016801,0.00037187405,0.012776544,0.0011267953,0.69505966,0.0016793045,0.0011298298,0.22339685],"study_design_scores_gemma":[0.0076674595,0.00032505213,0.01506507,0.00021643704,0.00007563704,0.00002345672,0.00035590774,0.000760061,0.9701318,0.00066905085,0.004518233,0.00019183007],"about_ca_topic_score_codex":0.00009078693,"about_ca_topic_score_gemma":0.00028402344,"teacher_disagreement_score":0.27507216,"about_ca_system_score_codex":0.00018494173,"about_ca_system_score_gemma":0.0006610593,"threshold_uncertainty_score":0.50083935},"labels":[],"label_agreement":null},{"id":"W3179565049","doi":"10.2147/dddt.s281602","title":"Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date","year":2021,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Type 2 diabetes; Adverse effect; Hypoglycemia; Renal glucose reabsorption; Intensive care medicine; Diabetes mellitus; Diabetes management; Pharmacology; Internal medicine; Endocrinology","score_opus":0.15371710382983725,"score_gpt":0.36263580421117464,"score_spread":0.2089187003813374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179565049","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019012974,0.9908744,0.00014680138,0.00020934615,0.00024140286,0.006560372,0.000013024437,0.00002122692,0.000032117263],"genre_scores_gemma":[0.0001424979,0.98826814,0.0072750044,0.00013876814,0.00010810851,0.0017894395,0.0001734021,0.00005279938,0.0020518382],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982007,0.00019062305,0.000609603,0.00041928823,0.00027928545,0.0003005135],"domain_scores_gemma":[0.9981298,0.00073096174,0.00027834406,0.00057704205,0.00018692766,0.00009691941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007139105,0.00043698333,0.0013787998,0.00012623695,0.00012705059,0.00004124164,0.0002363638,0.00008273328,0.000054539167],"category_scores_gemma":[0.00003751958,0.00019882829,0.00022893466,0.000381624,0.000076911805,0.00006604823,0.00004733361,0.000062564664,0.000007884826],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121660705,0.00045818218,0.000048713315,0.0014838396,0.0018173532,0.0000028016138,0.001547761,5.718617e-7,0.000014878881,0.000045184403,0.002052552,0.9924065],"study_design_scores_gemma":[0.0008485679,0.0015933792,0.00003370695,0.005050299,0.0011831954,7.6150167e-7,0.00013439721,0.000011862686,0.0030377079,0.000007149108,0.9878869,0.00021207154],"about_ca_topic_score_codex":0.000005229791,"about_ca_topic_score_gemma":0.0000030486779,"teacher_disagreement_score":0.9921944,"about_ca_system_score_codex":0.000073077696,"about_ca_system_score_gemma":0.00049149746,"threshold_uncertainty_score":0.8107982},"labels":[],"label_agreement":null},{"id":"W4212951396","doi":"10.2147/dddt.s330947","title":"Network Pharmacology and Molecular Docking Study of the Chinese Miao Medicine Sidaxue in the Treatment of Rheumatoid Arthritis","year":2022,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Science and Technology Program of Guizhou Province; Guizhou University; Guizhou Medical University; National Natural Science Foundation of China","keywords":"Rheumatoid arthritis; Systems pharmacology; Signal transduction; Traditional Chinese medicine; Arthritis; Molecular Pharmacology; Animal model","score_opus":0.019271023358547457,"score_gpt":0.28233306037643263,"score_spread":0.26306203701788516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212951396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91996205,0.07723942,0.000018700475,0.001190125,0.00008313358,0.0014476761,9.199607e-7,0.0000075911453,0.000050366918],"genre_scores_gemma":[0.9064407,0.09284116,0.000103200706,0.0002673843,0.000019532936,0.00029829136,0.0000033430413,0.000012914709,0.00001347002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981601,0.0006276538,0.00037963063,0.00019877026,0.0004025053,0.00023134174],"domain_scores_gemma":[0.9993602,0.00027411623,0.00011365337,0.0001708079,0.000035203575,0.000046029523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008082767,0.00016883091,0.00041586036,0.000109580855,0.0002710294,0.000008415904,0.00013978987,0.000018687018,0.000088277455],"category_scores_gemma":[0.00001012567,0.00008805246,0.00003161303,0.00040893702,0.00016286547,0.000028281876,0.000046580877,0.00013322239,1.7378319e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033030433,0.004433908,0.36363015,0.000031282452,0.001074326,0.00028838022,0.26331267,0.0005217144,0.01893013,0.00024791757,0.0010516396,0.34317484],"study_design_scores_gemma":[0.14238131,0.02414904,0.57107687,0.00095334684,0.000032516924,0.00091797876,0.06518623,0.0010556405,0.04734066,0.0066788225,0.1390529,0.0011746759],"about_ca_topic_score_codex":0.0001285702,"about_ca_topic_score_gemma":0.00004726385,"teacher_disagreement_score":0.34200016,"about_ca_system_score_codex":0.000029495695,"about_ca_system_score_gemma":0.000096456475,"threshold_uncertainty_score":0.35906753},"labels":[],"label_agreement":null},{"id":"W4378232952","doi":"10.2147/dddt.s368584","title":"Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy","year":2023,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Thalassemia; Medicine; Anemia; Transfusion therapy; Intensive care medicine; Blood transfusion; Pediatrics; Surgery; Internal medicine","score_opus":0.02885699474887819,"score_gpt":0.27027301678548066,"score_spread":0.24141602203660248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378232952","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32989052,0.663238,0.00020012843,0.000049789713,0.000060829272,0.006494233,0.0000054807983,0.000020928612,0.000040090777],"genre_scores_gemma":[0.0121362815,0.98368096,0.002823427,0.000023363496,0.000015656804,0.00093003135,0.00009665445,0.0000799612,0.00021365103],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966616,0.0004251241,0.0012711997,0.00065067405,0.00051143067,0.00047994877],"domain_scores_gemma":[0.99896103,0.0002774315,0.00033005507,0.0002783501,0.000057433976,0.00009567175],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010849766,0.00069856865,0.0017955531,0.00071111944,0.00007390186,0.000022894244,0.00019952327,0.00040056914,0.00002517473],"category_scores_gemma":[0.000005877514,0.00038560294,0.00008879007,0.0007974105,0.00011682198,0.00005632906,0.000022525497,0.00036956105,0.0000039791776],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002424979,0.0012169342,0.0014202605,0.0036845214,0.00032730016,0.00037687004,0.047707435,0.000022783346,0.0000702807,0.0000011716995,0.000028495273,0.942719],"study_design_scores_gemma":[0.22123992,0.021539642,0.06136287,0.30828133,0.0015133629,0.0013444556,0.049714405,0.0005835897,0.040715747,0.00015386648,0.2835913,0.009959473],"about_ca_topic_score_codex":0.00017907143,"about_ca_topic_score_gemma":0.00015022051,"teacher_disagreement_score":0.9327595,"about_ca_system_score_codex":0.0002327318,"about_ca_system_score_gemma":0.0013673061,"threshold_uncertainty_score":0.9998596},"labels":[],"label_agreement":null},{"id":"W4380629765","doi":"10.2147/dddt.s407905","title":"Effects of Different Injection Rates of Propofol on Postoperative Cognition in Elderly Patients Undergoing Laparoscopic Inguinal Hernia Repair","year":2023,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Propofol; Medicine; Anesthesia; Remifentanil; Bispectral index; Inguinal hernia; Incidence (geometry); Hernia; Surgery","score_opus":0.024818633385021473,"score_gpt":0.2707158124073964,"score_spread":0.24589717902237493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380629765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99876326,0.0000995862,0.00007161875,0.000038830785,0.000040570503,0.0009076099,3.983539e-7,0.00003230922,0.000045804263],"genre_scores_gemma":[0.999096,0.00027669765,0.00023849758,0.00008400584,0.000007562882,0.000060209633,0.00003687514,0.000012294855,0.00018788392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912155,0.00014700374,0.00024417666,0.00017067743,0.00019281488,0.00012376427],"domain_scores_gemma":[0.99954474,0.00020256476,0.00009215462,0.00005127666,0.000076817065,0.000032465618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015391503,0.00013130289,0.0002596418,0.0001728019,0.00005071689,0.0000048504066,0.000025413661,0.000043613298,0.000006290679],"category_scores_gemma":[0.000043177424,0.000096634496,0.000027390246,0.00019094504,0.00003409275,0.000044499637,0.0000082665065,0.00007161311,0.0000045104994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034569656,0.0013791557,0.8952961,0.0005488094,0.00028128296,0.00004276852,0.02020762,0.000009747593,0.037576392,0.00008676277,0.00015403077,0.040960394],"study_design_scores_gemma":[0.003885098,0.0016519482,0.60454834,0.000517001,0.000010654521,7.3070316e-7,0.000235756,0.00005251099,0.38889137,0.00010038871,0.000026607828,0.000079591126],"about_ca_topic_score_codex":0.0000065450104,"about_ca_topic_score_gemma":0.000005334793,"teacher_disagreement_score":0.351315,"about_ca_system_score_codex":0.000036421006,"about_ca_system_score_gemma":0.00007582289,"threshold_uncertainty_score":0.39406404},"labels":[],"label_agreement":null},{"id":"W4400694331","doi":"10.2147/dddt.s388410","title":"Evaluating the Therapeutic Potential of Ublituximab in the Treatment of MS: Design, Development and Place in Therapy","year":2024,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"University of Toronto","keywords":"Medicine; Medical physics","score_opus":0.33816580930928175,"score_gpt":0.43977076543208676,"score_spread":0.10160495612280501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400694331","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025158437,0.9684412,0.00017229732,0.00020665234,0.000073117946,0.0059024272,0.000003888968,0.000017881917,0.000024092931],"genre_scores_gemma":[0.0058290167,0.98685354,0.0052766185,0.000057624722,0.000053354393,0.0016755345,0.000022792748,0.00006375612,0.00016777238],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951673,0.0015013873,0.0013026571,0.00062605186,0.0009021565,0.0005004161],"domain_scores_gemma":[0.99747056,0.0016032521,0.00033680876,0.00041238606,0.0001100747,0.00006692096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0043200282,0.00070040696,0.0018612394,0.0005702554,0.00016652595,0.00007481868,0.00033738726,0.00017265817,0.0000199649],"category_scores_gemma":[0.000043840017,0.00031672118,0.00016556386,0.0007607293,0.0002685137,0.00005621332,0.00006709643,0.00038319267,0.000003931311],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005941679,0.0006105184,0.00006658938,0.0015956011,0.0011253167,0.000019781755,0.026201326,0.0000046483297,0.0001627275,0.000007566207,0.00003893454,0.96957284],"study_design_scores_gemma":[0.017958073,0.0039290944,0.00501106,0.020411376,0.0007977404,0.00008717822,0.003866366,0.0006154822,0.0051328978,0.00019051658,0.9405763,0.0014238941],"about_ca_topic_score_codex":0.00004243018,"about_ca_topic_score_gemma":0.000020806736,"teacher_disagreement_score":0.96814895,"about_ca_system_score_codex":0.000280428,"about_ca_system_score_gemma":0.0016196612,"threshold_uncertainty_score":0.9999285},"labels":[],"label_agreement":null},{"id":"W4405194730","doi":"10.2147/dddt.s491223","title":"Effect of Remimazolam vs Midazolam on Early Postoperative Cognitive Recovery in Elderly Patients Undergoing Dental Extraction: A Prospective Randomized Controlled Study","year":2024,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Chinese Stomatological Association","keywords":"Midazolam; Medicine; Anesthesia; Prospective cohort study; Randomized controlled trial; Dental extraction; Extraction (chemistry); Surgery; Sedation","score_opus":0.008821822727912045,"score_gpt":0.272765986510034,"score_spread":0.26394416378212193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405194730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848823,0.0011029819,0.0003587074,0.00008563973,0.00029094456,0.012165488,0.0000037610791,0.000054019903,0.001056171],"genre_scores_gemma":[0.9974338,0.0004335863,0.00010416443,0.00048220463,0.000023545817,0.0011090807,0.00003036936,0.000046556488,0.0003367327],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99701846,0.0011590129,0.0006227053,0.00051401695,0.00042867824,0.00025713613],"domain_scores_gemma":[0.9930213,0.0053831753,0.00014434768,0.00008461169,0.0012987417,0.00006783738],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001599243,0.00040115393,0.001399624,0.0008278759,0.000102089456,0.00007130677,0.000047404737,0.00008635961,0.000036620506],"category_scores_gemma":[0.0018909046,0.0002777265,0.00020332349,0.00044994685,0.00012408795,0.00018497262,0.00001712605,0.000354323,0.000014933982],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89280295,0.00096526905,0.044385042,0.00008108108,0.0026078715,0.0001994604,0.022543145,0.0000014499091,0.000751423,0.000023599003,0.000078654564,0.035560027],"study_design_scores_gemma":[0.8442696,0.016328791,0.051293094,0.0028043329,0.00040014682,0.000014828857,0.00911827,0.00008181162,0.07505006,0.00010646682,0.000015539294,0.00051708485],"about_ca_topic_score_codex":0.000020586485,"about_ca_topic_score_gemma":0.000020082689,"teacher_disagreement_score":0.074298635,"about_ca_system_score_codex":0.00016029338,"about_ca_system_score_gemma":0.00026086616,"threshold_uncertainty_score":0.9999675},"labels":[],"label_agreement":null},{"id":"W4406808042","doi":"10.2147/dddt.s504485","title":"Tanshinone I Ameliorates Psoriasis-Like Dermatitis by Suppressing Inflammation and Regulating Keratinocyte Differentiation","year":2025,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Natural Science Foundation of China","keywords":"Psoriasis; Keratinocyte; Inflammation; Medicine; Dermatology; Immunology; Biology; Cell culture; Genetics","score_opus":0.014999870614813655,"score_gpt":0.22261221925640662,"score_spread":0.20761234864159298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406808042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97490746,0.017079845,0.006809377,0.00028781887,0.00034555368,0.00036276138,0.0000061057112,0.00008432162,0.000116730684],"genre_scores_gemma":[0.9903379,0.0021539375,0.003996307,0.00011086228,0.000022486247,0.00008884572,0.00034806252,0.000014624573,0.002926972],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888194,0.00025599022,0.0003171629,0.0002811353,0.000042566662,0.00022122495],"domain_scores_gemma":[0.99951965,0.0001814668,0.00012526284,0.00010749266,0.000046410136,0.000019695282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023782601,0.00022864444,0.00024077538,0.00013712909,0.0005351911,0.00011299914,0.00006875086,0.00013811332,0.000047014943],"category_scores_gemma":[0.00001180193,0.00019731374,0.00002378085,0.00013569882,0.00006125739,0.0002025062,0.00003064424,0.00008019386,0.000009638963],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013750473,0.000041183626,0.00834161,0.000024532197,0.00034097888,0.0000011115051,0.0034850321,0.0000021611656,0.2771702,0.00012352048,0.0021451262,0.70818704],"study_design_scores_gemma":[0.0029404676,0.000025264215,0.038251687,0.00010450798,0.00004727606,0.0000055968567,0.00022204057,0.000058900754,0.93901426,0.0003762099,0.018686974,0.00026681842],"about_ca_topic_score_codex":0.000011788244,"about_ca_topic_score_gemma":0.0000071842956,"teacher_disagreement_score":0.7079202,"about_ca_system_score_codex":0.000029382836,"about_ca_system_score_gemma":0.00005180073,"threshold_uncertainty_score":0.8046221},"labels":[],"label_agreement":null},{"id":"W4409964874","doi":"10.2147/dddt.s505751","title":"Bibliometric Analysis of Non-Vitamin K Antagonist Oral Anticoagulants (NOACS) in the Prevention of Venous Thrombosis and Pulmonary Embolism","year":2025,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Science Foundation of Hunan Province; Central South University; National Natural Science Foundation of China","keywords":"Vitamin K antagonist; Medicine; Pulmonary embolism; Venous thrombosis; Vitamin k; Venous thromboembolism; Thrombosis; Intensive care medicine; Internal medicine; Warfarin; Atrial fibrillation","score_opus":0.07940201947080826,"score_gpt":0.36455686739936366,"score_spread":0.2851548479285554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409964874","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032776393,0.96413416,0.00036359695,0.00004666826,0.00007887323,0.0023252124,0.000017590493,0.000012361485,0.00024514267],"genre_scores_gemma":[0.029045751,0.96924263,0.0011208957,0.00006169943,0.000017215518,0.00018471987,0.00018850983,0.000024999354,0.000113577335],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974135,0.00033882598,0.0010236282,0.00047480135,0.00045563115,0.00029362258],"domain_scores_gemma":[0.99855644,0.00041326674,0.00051056105,0.00037812188,0.000082314495,0.0000592797],"candidate_categories":["metaepi_narrow","bibliometrics"],"consensus_categories":["bibliometrics"],"category_scores_codex":[0.0016261732,0.00042649108,0.0034412052,0.03228178,0.00009842233,0.00004569337,0.00025716628,0.00017690202,0.000020523343],"category_scores_gemma":[0.000023691433,0.00028341153,0.00031045757,0.04175227,0.000108657274,0.000068190115,0.00009413547,0.00018303328,0.0000010636285],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027832446,0.0015775239,0.0015869944,0.0071306406,0.0043493994,0.000018137478,0.0011127825,0.0000010301613,0.000013151192,0.00004022046,0.00019395021,0.98394835],"study_design_scores_gemma":[0.0029613355,0.0007983767,0.7207723,0.027280008,0.021344442,0.000023247409,0.00083426374,0.00013644926,0.00037700962,0.00014187767,0.22407416,0.0012565127],"about_ca_topic_score_codex":0.00010046994,"about_ca_topic_score_gemma":0.000011234419,"teacher_disagreement_score":0.9826918,"about_ca_system_score_codex":0.000047596022,"about_ca_system_score_gemma":0.0003730172,"threshold_uncertainty_score":0.9999618},"labels":[],"label_agreement":null},{"id":"W4410484671","doi":"10.2147/dddt.s513461","title":"Exploring the Potential of Pyridine Carboxylic Acid Isomers to Discover New Enzyme Inhibitors","year":2025,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"","keywords":"Enzyme; Carboxylic acid; Pyridine; Chemistry; Stereochemistry; Biochemistry; Combinatorial chemistry; Computational biology; Organic chemistry; Biology","score_opus":0.08459063998253667,"score_gpt":0.28777176377069424,"score_spread":0.20318112378815756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410484671","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025501768,0.995341,0.00047745075,0.00020502246,0.00013556388,0.0005306458,0.000020834026,0.0000524802,0.00068679487],"genre_scores_gemma":[0.0011328913,0.9918354,0.0004453089,0.00004096635,0.00029184975,0.00060156174,0.00009797685,0.000040713065,0.0055133463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99838686,0.00003198235,0.00060916896,0.00045988776,0.00023665481,0.000275437],"domain_scores_gemma":[0.998986,0.00020344302,0.00022179693,0.00042495623,0.00003122113,0.00013256876],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019030436,0.00044976734,0.0007834501,0.000072490206,0.00018451888,0.000059343714,0.0004555712,0.000114741604,0.00013417871],"category_scores_gemma":[0.000019660916,0.00031280736,0.0002105135,0.00040744405,0.0000512943,0.00007059992,0.0001309984,0.00026709284,0.000010298922],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020324824,0.000043169166,8.6114824e-7,0.0019507738,0.0002587102,0.0000018232029,0.0006473949,0.0000049234186,0.0035222117,0.000031021154,0.0019377945,0.99158096],"study_design_scores_gemma":[0.00019588214,0.000003238509,6.8132033e-7,0.002570045,0.0000870161,0.0000027798758,0.00008475538,7.2032293e-7,0.22771424,0.00002434227,0.76902336,0.0002929624],"about_ca_topic_score_codex":0.000013336568,"about_ca_topic_score_gemma":0.0000010903439,"teacher_disagreement_score":0.991288,"about_ca_system_score_codex":0.00006882364,"about_ca_system_score_gemma":0.0006799579,"threshold_uncertainty_score":0.9999324},"labels":[],"label_agreement":null},{"id":"W4411842837","doi":"10.2147/dddt.s502910","title":"Dose-Dependent Effects of Remimazolam on Early Perioperative Neurocognitive Disorders in Elderly Colorectal Cancer Patients Undergoing Laparoscopic Surgery","year":2025,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neurocognitive; Perioperative; Colorectal cancer; Laparoscopic surgery; Cancer; Laparoscopy; Surgery; Anesthesia; Internal medicine; Psychiatry; Cognition","score_opus":0.010462917643419197,"score_gpt":0.25213552543579215,"score_spread":0.24167260779237296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411842837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956923,0.00075799454,0.00014663438,0.00027929927,0.0003054388,0.0017796707,0.0000028847624,0.000028961884,0.0010067954],"genre_scores_gemma":[0.9946775,0.0025844718,0.000090068635,0.0020280785,0.000009204343,0.00031184626,0.000020946656,0.00002975307,0.00024815978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848,0.00022142775,0.00034832326,0.00039297098,0.00025690402,0.00030038075],"domain_scores_gemma":[0.9975424,0.0013282772,0.00010193938,0.000075918324,0.00089212146,0.000059358546],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017339572,0.00028575465,0.0004929638,0.0006860729,0.00010719844,0.000022961887,0.000057921767,0.00008225848,0.000013592664],"category_scores_gemma":[0.0006849854,0.00025223318,0.00006341272,0.0004961307,0.000115843955,0.00008313811,0.000025026657,0.00023216769,0.0000033076396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059518134,0.0010309969,0.77746785,0.0003550326,0.00060771056,0.000039584775,0.014688336,0.000006304389,0.010290491,0.00007396991,0.00043914586,0.18904874],"study_design_scores_gemma":[0.007692525,0.0007361809,0.6944632,0.0016503178,0.000029980882,4.000266e-7,0.0013149064,0.000009500988,0.2936303,0.0000776323,0.0001297769,0.00026529812],"about_ca_topic_score_codex":0.00006801894,"about_ca_topic_score_gemma":0.00017015907,"teacher_disagreement_score":0.2833398,"about_ca_system_score_codex":0.000106024105,"about_ca_system_score_gemma":0.00052043237,"threshold_uncertainty_score":0.99999297},"labels":[],"label_agreement":null},{"id":"W4413848559","doi":"10.2147/dddt.s536225","title":"Effect of Ciprofol on Postoperative Cognitive Function in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass: A Prospective, Randomized, Controlled Trial","year":2025,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Guizhou Medical University; National Natural Science Foundation of China","keywords":"Cardiopulmonary bypass; Medicine; Randomized controlled trial; Cardiac surgery; Prospective cohort study; Anesthesia; Surgery","score_opus":0.007259522619073475,"score_gpt":0.23633310202954144,"score_spread":0.22907357941046796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413848559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979322,0.0010617177,0.0007136945,0.00011098254,0.0003049557,0.016306065,0.000003504471,0.000027634966,0.0021494161],"genre_scores_gemma":[0.99591225,0.0002595978,0.000044541164,0.0009857711,0.000018707064,0.0023453743,0.000071511684,0.000025726202,0.00033650655],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969939,0.0015457964,0.0005138635,0.00038124807,0.0003330937,0.00023210372],"domain_scores_gemma":[0.9918926,0.0059246337,0.00018056008,0.00008920429,0.0018670094,0.00004602028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017751568,0.0003429245,0.0021154752,0.00057686545,0.00010070615,0.000016725442,0.000028356471,0.000086639564,0.0000072153707],"category_scores_gemma":[0.0021649357,0.00021785141,0.00025537508,0.00035462301,0.00015925347,0.00007390884,0.00001287933,0.00020141853,0.0000020328437],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93213487,0.0002634865,0.04687329,0.000054293945,0.0029012423,0.000012998422,0.0010735919,0.0000014474656,0.000049397648,0.00003332996,0.00011814152,0.0164839],"study_design_scores_gemma":[0.95823884,0.0031847968,0.015300006,0.0013449856,0.000441437,5.3440704e-7,0.0010036106,0.000010387656,0.020180667,0.00003534034,0.000021876784,0.00023753832],"about_ca_topic_score_codex":0.000009297007,"about_ca_topic_score_gemma":0.0000020222571,"teacher_disagreement_score":0.031573284,"about_ca_system_score_codex":0.00010974999,"about_ca_system_score_gemma":0.0005330974,"threshold_uncertainty_score":0.88837224},"labels":[],"label_agreement":null},{"id":"W4416192077","doi":"10.2147/dddt.s553693","title":"The Impact of Intranasal Esketamine on Emergence Agitation in Children Undergoing Adenotonsillectomy: A Randomized Controlled Study","year":2025,"lang":"en","type":"article","venue":"Drug Design Development and Therapy","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nasal administration; Randomized controlled trial; Incidence (geometry); Ketamine; Adverse effect; Clinical trial","score_opus":0.016158718525234282,"score_gpt":0.30339033410370186,"score_spread":0.2872316155784676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416192077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921215,0.0015419251,0.0016327527,0.00027598607,0.000022934872,0.0042071277,1.3887833e-7,0.000013064307,0.00018456696],"genre_scores_gemma":[0.9973417,0.001556518,0.00022953593,0.0001167443,0.0000072735484,0.00022576441,0.0000051862826,0.000008343763,0.0005089481],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9985124,0.00050337106,0.0004751399,0.00017731103,0.00017828018,0.00015349801],"domain_scores_gemma":[0.99842334,0.0012182959,0.00012290821,0.00011146284,0.0000914165,0.000032590095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014229647,0.00016917422,0.0007364601,0.00021132102,0.00012263311,0.000018533654,0.00007034803,0.00002960463,0.000017633487],"category_scores_gemma":[0.00020777239,0.00008640907,0.000106622734,0.00028428622,0.000069257316,0.000035586792,0.000007982004,0.000092045935,0.0000012386145],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49302757,0.0016028825,0.4390606,0.000015866042,0.0052640243,0.000018417628,0.017847607,0.00014078834,0.001065609,0.00039353443,0.00049895473,0.04106415],"study_design_scores_gemma":[0.4660809,0.00045724594,0.5279277,0.00013413378,0.00007770713,0.000002305893,0.0010297917,0.0007389788,0.0029593112,0.0004364865,0.000013168947,0.00014225727],"about_ca_topic_score_codex":0.00004273422,"about_ca_topic_score_gemma":0.000009948565,"teacher_disagreement_score":0.08886712,"about_ca_system_score_codex":0.000041469277,"about_ca_system_score_gemma":0.0003340986,"threshold_uncertainty_score":0.35236594},"labels":[],"label_agreement":null}]}